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Chapter 1  
 




Cell polarization refers to the asymmetry that arises in cells based on their ability 
to sequester biomolecules to different subcellular localizations, resulting in membranes of 
specialized function.  The epithelial cell layer is a highly polarized layer of cells covering 
the surfaces of the body exposed to the outside environment and organ compartments 
such as the kidney.  In the case of polarized cubiodial epithelia found in the renal tubules, 
segregation of proteins and phospholipids results in the formation of distinct surfaces 
referred to as domains.  The formation of membrane domains in renal epithelial cells 
allows for a structure-function relationship that facilitates function of the kidney as a unit.  
Functions of renal epithelia derived from polarized epithelial structure include but are not 
limited to secretion, filtration, absorption, adhesion and sensory function.  An intricate 
framework that combines protein-protein interactions, regulated transcription, ion flux, 
genetics, and the environment establishes polarity and therefore structure-function 
relationship of renal epithelial cells.  The ability for epithelial cells to first establish and 
then maintain their polarized nature is essential to the physiology of any tubular organ 
system.  Abrogation of polarization factors leads to an either partial or perhaps overall 
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loss of polarity that may be temporary or chronic based on genetic predisposition or 
acquired through disease, injury, or infection.  Renal diseases, collectively referred to as 
nephropathies, can often be traced to a defect in a polarity mechanism at a molecular 
level.     
Understanding how renal epithelial polarization is acquired and maintained in 
higher mammals is essential for the treatment of nephropathies.  Due to a prevalence of 
polarized epithelial cells in the kidney, the kidney provides an excellent model system for 
the study of epithelial polarity in general.  The identification of patients suffering from 
various nephropathies has allowed for an in depth genetic study of renal polarity.  Model 
systems for the study of renal cell polarization in the mammalian system include cell 
culture and a limited number of mouse models.  Fortunately, epithelial polarization is a 
highly conserved evolutionary phenomenon.   Classic models such as the C. elegans 
zygote, Drosophila melanogaster (fruit fly), and Danio rerio (zebrafish) can be utilized to 
deduce the role of cell polarity in vivo in instances where manipulation of polarity 
genes/proteins is not practical.   Albeit slightly different, polarity in lower organisms is 
often analogous to mammalian polarity, and many functional homologues of polarity 
proteins have been identified (10).  Additionally, advancements in cell culture technique 
and imaging have allowed for a more accurate representation of cell polarity in a 3-
dimesional context, allowing for study of polarization and development at the molecular 
level (reviewed in (214, 245)). 
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Figure 1-1:  Model of basic cubodial epithelial cells.  Epithelial cells 
arrange themselves in monolayers and are connected by junctions.  Tight 
junctions (red) delineate apical versus basolateral sufaces while adherens 
junctions (blue) adhere cells to eachother.  A primary cilium extends from 
the apical surface of many polarized epithelial cells, such as MDCKII 








1.2 Molecular Interactions Governing the Establishment of Mammalian Epithelial 
Cell Polarity 
 
The structure of basic, cuboidal epithelia allows these cells to form a continuous 
monolayer which lines the tubular network of a particular organ, forming a barrier 
between the luminal space and the underlying tissue (Figure 1-1).  Two major 
subdomains are created in polarized epithelial cells to facilitate the formation of the 
monolayer.  The membrane subdomain facing the luminal space is termed the apical 
domain.  The apical membrane surface is comprised of a network of microvilli, and the 
membrane contains a specific compliment of apical transporters and receptors as well as 
a distinct preference for particular phospholipids of which the membrane is constructed 
(45, 175).  In the case of renal epithelia, there also exists a single non-motile primary 
cilium (reviewed in (80)).  The second major subdomain of the epithelial membrane is 
known as the basolateral domain. The basolateral domain extends from just below the top 
of the cell, comprising both the lateral edges and the basement membrane.  The 
basolateral domain faces neighboring cells and the underlying tissue making it distinctly 
different from the apical domain.  The basolateral domain has its own set of transporters, 
receptors, phospholipids along with a host of cell-to-cell adhesion molecules and the 
extracellular matrix. The ability of epithelial cells to form distinct apical versus 
basolateral surfaces and therefore establish polarity is a result of protein-rich cell-to-cell 
contact points known as junctions.  Junctions form a continuous belt around single 
polarized epithelial cells allowing for the formation of a continuous epithelial monolayer 
where the cell is an individual unit in 3-dimensional space.  This phenomenon is referred 
to as apical-basal polarity (A-B polarity) in the context of planar-cell polarity (PCP).  
Both types of polarity are essential to the physiology of the epithelial monolayer.  This 
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chapter will focus on the establishment and maintenance of A-B polarity, but it is 
important to keep PCP in mind, and it will be discussed by name where appropriate. 
Junction formation, and therefore maintenance of epithelial polarity, is regulated 
by a series of protein-protein interactions.  There are at least four types of junctions 
formed in polarized epithelial cells as a result of protein-protein interactions: tight 
junctions, adherens junctions, desomosomes, and gap junctions.  Tight junctions are the 
most apical of the junctions, delineating apical versus basolateral surfaces and preventing 
“mixing” of the components of each respective membrane domain.  This ability to 
establish preventative delineation of membranous surfaces is often referred to as the 
“fence” function of tight junctions.  Yet another function of the tight junction is to be 
selectively permeable, preventing material from the luminal space from moving in 
between epithelial cells towards the underlying tissue.   The selective permeability of the 
tight junction is referred to as the “gate” function.  In essence, the tight junction allows 
for the epithelial monolayer to function as an entire unit, where each individual cell 
combines to maintain the integrity of the barrier layer.  The formation of the tight 
junctions in a single cell gives context to the physiology of the entire epithelial 
monolayer.   With the formation of the tight junction, the epithelial monolayer can be 
seen as a sealed sheet, covered with specialized surfaces for absorption and sensation.  
Since the majority of material passing through the luminal space is unable to directly pass 
between cells (passive transport), most material that the cell may need must be actively 
transported or endocytosed across the apical membrane into the cell.  Likewise, any 
solute that must be expelled from the epithelial cell in to the lumen must be actively 
transported in the opposing direction.  Additionally, the presence of the primary cilium on 
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the apical surface is essential for signal transduction from the luminal space to the cell 
interior (80). 
Adherens junctions, desomosomes, and gap junctions are found on the lateral 
membrane of polarized epithelial cells.  These junctions are protein-rich cell-to-cell 
contacts, but primarily function to facilitate adherence of neighboring cells.  Cell-to-cell 
adhesion is important, as proximity and adhesion result in cell signaling and feedback.   
These feedback signals have been dissected and have illustrated the epithelial cell’s 
ability to distinguish area and orientation and adjust cell morphology accordingly. 
Although the major focus of this review is not concerned with cell adhesion, it is 
important to note its role in cell polarity.  The major epithelial adhesion protein, E-
cadherin, has an extensive role in maintaining the epithelial monolayer through genetic 
and physical interactions with conserved proteins that are involved with the establishment 
of apico-basal polarity (92). 
Large conserved polarity complexes are formed to facilitate tight junction 
formation. There are at least three major polarity complexes: the Par complex, the 
Scribble complex, and the Crumbs complex (10).  Polarity protein complexes function 
both independently and synergistically and are complemented by a number of associated 
proteins not considered part of the core complex but essential to the stability, signaling, 
and/or localization of conserved polarity proteins.  A general model for the mechanisms 
of polarity complexes is as follows: the Crumbs complex establishes and maintains the 
distinct apical domain in balance with the Scribble complex, which establishes and 
maintains the lateral domain. This balance is regulated through a system of exclusivity 
through phosphorylation by the Par complex. Polarity complexes consist of proteins 
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involved in a multitude of cellular functions including scaffolding, signaling, and 
membrane anchorage.  Each member of the core polarity complexes is discussed in detail 
below, including important interactions, the role each protein plays in it’s respective 
complex, and the role each protein has in overall epithelial cell polarity.  For brevity, only 
established interactions and mechanisms of mammalian homologues will be discussed 
while homologues of lower organisms will only be mentioned to highlight specific 
interactions.   
 
1.3 Mammalian Polarity Complexes and Their Interactions 
1.3.1 The Par Complex Overview 
 The mammalian Par complex is comprises the proteins Partitioning defective-3 
(Par3/Par-3/Pard3), Partitioning defective-6 (Par6/Par-6/Pard6), and Atypical Protein 
Kinase C isoform zeta (aPKCζ).  The Par complex provides us with the classical model 
of cell polarity, first studied in the C. elegans zygote (reviewed in (169)).  Knockout 
studies in C. elegans provided the first insights into the asymmetrical distribution of 
proteins in developing organisms, as removal of the Par proteins leads to a failure of the 
zygote to correctly segregate proteins needed to begin proper development through 
asymmetrical cell division (62).  The Par polarity complex is a transient complex, where 
Par3 is excluded or included to modulate the formation of both the apical surface and the 






Figure 1-2:  The conserved polarity complex interactome.  The Crumbs, 
Par, and Scribble polarity complexes interact with eachother to modulate 
the formation of junctions and epithelila polarity.  The Crumbs complex 
regulates the formation of the apical surface.  The Scribble complex 
regulates formation of the lateral surface.  The Par complex modulates the 






Figure 1-3:  Sizes and domains of conserved polarity proteins.  (A) 
Relative sizes of polarity proteins in amino acids (AA).  (B) Domain 
structures of polarity proteins.  Scale is approximate with the exception of 
Crb3a which is enlarged to show domains. 
 10 
1.3.2 Par3 
Par3 was first identified in a genetic screen for defects in asymmetrical cell 
division in the C. elegans zygote (62, 138).  Deletion of the Par3 gene leads to the 
defective partitioning of biomolecules during the first cell division, hence its namesake 
(138).  In mammalian epithelia, Par3 is localized to both the tight junction and lateral 
membrane and has been shown to be necessary for tight junction formation and the 
localization of other members of the Par complex (73, 142, 268).  Par3 is a multi-domain 
scaffold protein, consisting of multiple phosphorylation sites and three important protein-
protein interaction domains, known as PSD95/DlgA/Zona Occludins-1 (PDZ) domains 
(Figure 1-3 and (120)).  
In mammals, there are two Par3 proteins Par3A and Par3B (73).  Although 
expressions of these proteins overlap in renal epithelial and localize to the lateral 
membrane, Par3B does not interact with aPKCζ (73).  This exclusion is not fully 
understood as Par3B can still bind Par6 and overexpression of the N-terminus of Par3B 
can block tight junction formation similar to overexpression of Par3A (73).  Interestingly, 
there are also three different Par3A protein isoforms due to alternate splicing in 
mammalian epithelia, and only two of which can bind aPKCζ (73).  Each Par3A isoform 
is distinguishable due to significant differences in the molecule weights of the transcribed 
sequence (180kd, 150kd, and 100kd respectively); they still possess a similar domain 
structure. The 180kd and 150kd isoforms of Par3A bind aPKCζ on their C-terminus while 
the 100kd isoform lacks such a domain but is still considered an isoform of Par3A due to 
sequence homology (159).  
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Although Par3A is found in an evolutionarily conserved polarity complex with 
with Par6 and aPKCζ, Par3A is also found as a homodimer, which may be significant 
with regards to cell polarity.  It has been demonstrated that Par3A can dimerize via its N-
terminus and this interaction is important to the apical localization of Par3A (191).  In the 
same study, the authors showed that the extreme N-terminus of Par3A is necessary for 
proper localization of the other Par complex and tight junction proteins (191).  Like other 
PDZ-domain containing proteins, Par3A acts as a molecular scaffold at the tight junction.  
The first PDZ domain of Par3A interacts with Par6 (125).  The interaction between Par3A 
with Par6 and aPKCζ is indispensable for the development of cell polarity (104, 125, 
159).  Interestingly, the binding between Par3A and Par6 is atypical.  Normally, PDZ 
domain is found at the extreme C-terminus of a protein and is bound to a PDZ binding 
domain found somewhere on the internal structure of the binding partner.  In the case of 
Par3A and Par6, there is an internal PDZ to PDZ binding not often described (125).  
Typical PDZ domain interactions involve a single PDZ domain that binds to a PDZ 
binding domain (PBD) located at the extreme C-terminus of the interacting protein (65, 
238).  
The identity of the Par polarity complex is regulated at least in part by the ability 
of aPKCζ to interact with and phosphorylate Par3A (97, 120).  Phosphorylation of Par3 at 
S827 by aPKCζ is required for proper tight junction localization of Par3A (97, 201, 267).  
Overexpression of either a non-phosphorylatable mutant of Par3A or a dominant negative 
aPKCζ result a similar phenotype, an expanded lateral surface and a reduced apical 
surface suggesting this phosphorylation event is key to epithelial structure (201).  The 
necessity of Par3A-aPKCζ interaction has been further demonstrated as essential by 
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knockdown experiments in both two and three dimensional tissue culture models. In a 
Par3A knockdown system, MDCKII cells formed intercellular lumens in monolayer 
culture and exhibited a multiple lumen phenotype in three-dimensions (104).  In 
complementation assays, these Par3A knockdown phenotypes can only be rescued by 
introduction of Par3A that can specifically interact with aPKCζ (104).  
In addition to phosphorylation by aPKCζ, it seems that phosphorylation of Par3A 
by other kinases also dictate functions of the protein in polarized epithelia. De-
phosphorylation of serines in Par3A is mediated by Protein Phophastase 1 alpha (PP1α).  
Repression of PP1α in MDCKII cells caused delays in tight junction formation, further 
supporting the view of Par3A as a potent antagonist to cell polarity in PP1α regulated 
manner (278).  Phosphorylation of S144 and S885 of Par3A by polarity kinase Par-1 
(EMK1/MARK2) are necessary for the binding of protein 14-3-3 (also known as Par5) to 
Par3A in both canine and murine models (16).  Disruption of Par3A S144 
phosphorylation prevents a Par3A 14-3-3 interaction, resulting in polarity defects in 
three-dimensional culture (109).  Importantly, 14-3-3 isoforms bind many other proteins 
including phosphorylated Yes-Associated-Protein (Yap), a terminal transcription factor of 
the Hippo signaling pathway known to be responsible for growth in a cell density 
dependent manner (304). Important questions remain to be answered on how the Hippo 
signaling pathway intersects with epithelial polarity, however recent studies in 
Drosophila suggest further roles for polarity proteins in attenuation of the Hippo pathway 
(14, 88, 160, 233, 304). 
In MDCKII cells, Y1127 of Par3A is phosphorylated by c-Src or c-Yes through an 
epidermal growth factor (EGF) dependent mechanism and the phosphorylation event is 
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necessary for EGF induced tight junction formation (290).  It is speculated that Y1127 
phosphorylation of Par3A may contribute to its interaction with Ras-family GTPases that 
also bind the C-terminus of Par3A (290).  Ras-family GTPases are famously known for 
regulating a multitude of cellular functions, including modulating cytoskeleton and 
perhaps epithelial architecture through cytoskeleton dynamics.  Tiam1/2 is a Rac1 
guanine nucleotide exchange factor (GEF) that binds the C-terminus of Par3A.  The 
interaction of Tiam1/2 to Par3A spatially regulates activation of Rac1 at the cell 
periphery leading to a stabilization of epithelial junctions (39). Another Ras-family 
member, RhoA, is a potent antagonist of Rac1 activity (39).  RhoA activates Rho-kinase 
(ROCK) downstream, leading to phosphorylation of yet another site on Par3A, T833 
(204).  The phosphorylation of Par3 at T833 has been recently demonstrated to prevent 
formation of the Par polarity complex, leading to the inactivation of Rac1, presumably by 
impairing the function of Tiam1/2 bound to Par3A (204).  Overexpression of Par3A in 
subconfluent and non contact-inhibited MDCK cells leads to Rac1-induced fibroblastic 
phenotypes suggesting that the binding of Par3A to Tiam1/2 alone is not sufficient for the 
entire mechanism of junctional stability (190).   In fact, evidence has shown that a 
functional Par polarity complex (consisting of Par3A, Par6, and aPKCζ) enhances Rac1 
activity and is antagonized by Rho activity (204).  Mechanisms for spatial and temporal 
control of Rac/Rho activity has been recently put forth that may explain how epithelial 
cells so carefully control their morphology.  It has been suggested that aPKCζ 
phosphorylation of Par3 decreases the stability of the Par polarity complex which 
subsequently has the downstream effect of modulating Rac/Rho GTP levels, ultimately 
controlling the cytoskeletal framework of the epithelial cell (195).  In this model, aPKCζ 
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phosphorylation of Par3A defines the apical-lateral border by controlling the identity of 
the Par polarity complex at a given time (195).  
Par3A also has been shown to interact with cytoplasmic keratin via the keratin 
binding protein Albatross.  The association of Par3A with Albatross enforces the identity 
of the basolateral surfaces (266).  In an Albatross knockdown cell, lateral membrane 
components are mislocalized in the cell (266).  Also, Par3A is implicated in the genesis of 
the primary cilium in epithelial cells by interacting with Kinesin-II (249).  In this study, it 
is suggested that Par3A is dispensable for end-stage polarity, but absolutely required for 
ciliogenesis indicating that Par3A has a role in creating new apical membrane but not 
maintaining existing membrane. The authors of this study found that stable Par3A 
knockdown delayed tight junction formation, suggesting that Par3A only plays a role in 
early polarization, a process that is analogous to new apical membrane formation (249). 
The second and third PDZ domains of Par3A have been suggested to anchor the 
Par complex to the cell membrane and to be associated with phosphoinositide signaling. 
PDZ2 of Par3A binds phospholipids found in the inner leaflet of the plasma membrane 
while PDZ3 of Par3A has been shown to bind the protein Phosphatase and Tensin 
homolog (PTEN) (67, 297).  The localization of PTEN to the lateral membrane of 
polarized MDCKII cells is essential for proper cell polarization (67).  Studies suggesting 
a link between cell polarity and phosphoinositide signaling will provide ground for 
studying the integrated signaling networks involve in epithelial polarization and 
cytokinesis (45, 175)(45, 168).  Par3A also directly interacts with Junction Adhesion 
Molecule (JAMS) via PDZ domains 1 and 3 (61, 117).  The binding of JAMs to Par3A is 
found at the lateral membrane and not in the cytosol and occurs specifically at the tight 
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junction, suggesting that JAMs are an anchor for the Par polarity complex at the tight 
junction as cells polarize.  It has yet to be determined if PDZ3 of Par3 exhibits mutually 
exclusive binding between the JAMs and PTEN, and further study is needed to elucidate 
whether or not this binding is polarization dependent. 
 
1.3.3 Par6 
Par6 is a multi-domain protein localized to tight junctions of renal epithelial cells 
and a member of the conserved Par polarity complex.  In mammals, there are three 
identified Par6 genes, Par6A, Par6B, and Par6G, and all appear to be ubiquitously 
expressed, albeit with slightly different temporal-spatial and sub-cellular localizations 
(72).  Par6A and Par6B are more enriched in the kidney, and will thus be the focus of this 
review.  Regardless of the isoform, it appears that Par6 is a multifunctional protein in 
kidney epithelial cells, being a key adapter protein that allows the Par complex to interact 
with both the Crumbs and Scribble polarity complexes (110, 153, 289).  Par6 contains an 
N-terminal Phox and Bem1 (PB1) domain, followed by a semi-Cdc42/Rac Interactive 
Binding (Semi-CRIB) domain, and a C-terminal PDZ domain (Figure 1-3).   
Par6A directly interacts with Crumb3 (Crb3) via Par6A’s PDZ domain and this 
binding is an absolute requirement for proper tight junction formation (110, 153).  
Interestingly, Par6 binding to Crb3 appears to be isoform dependent (72).  Although the 
PDZ domain of Par6A binds Crb3, the PDZ domain of Par6B binds a different member of 
the Crumbs complex, Protein Associated with Lin Seven 1 (PALS1), with higher affinity 
(72).  Par6B binding to PALS1 can interrupt the binding of PALS1 to the third member of 
the Crumbs polarity complex, PALS1 Associated Tight Junction Protein (PATJ). 
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Interruption of PALS1-PATJ binding by Par6-PALS1 binding interferes with the 
formation of the tight junction (289).  The difference in binding preference between 
Par6A and Par6B may be explained by the conformation of the protein when bound with 
another binding partner, Cdc42, which is discussed below (72). 
The Par6 isoforms interact with members of the aPKC family in a multitude of 
tissues.   In the kidney, the most notable contribution to renal polarity is aPKCζ, which 
binds Par6 via an N-terminal PB1 domain (268).  The function of Par6 binding to aPKCζ 
is to link Par6 and the previously mentioned Par3 into a complex that may be dependent 
on the phosphorylation status of Par3 and to control the activity of the complex. The 
semi-CRIB domain and the PDZ domain of Par6 binds the N-terminus of Par3 forming a 
stable tripartite complex that promotes junction formation (125).  Par6 is thought to 
activate aPKCζ through direct interaction, allowing aPKCζ to phosphorylate Par3 (301).  
Par6 has the ability to activate aPKCζ and begin the cascade of polarization due 
its ability to bind the GTP-bound forms of Cdc42 and Rac1.  Par6 interacts with Cdc42 
and Rac1 via the semi-CRIB domain (125, 126).  The interaction between Par6 and 
Cdc42 and/or Rac1 leads to dynamic cytoskeletal rearrangement for overall epithelial 
polarization.  Par6 is able to bind the GTP-bound form of Cdc42 as a result of Cdc42-
GTP assembly via E-cadherin trans-homodimerization at the adherens junction between 
neighboring epithelial cells (126).  The interaction of Par6 with Cdc42 renders a 
conformational change in Par6 altering the binding between Par6 to PALS1 and/or Crb3 
(72, 76).  When activated, GTP-bound Cdc42 binds Par6; the PDZ domain of Par6 most 
likely becomes hidden through conformational change resulting in masking of the PDZ 
domain of Par6, leaving Par6 unable to bind PALS1 or Crb3 (72).    
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It is through this conformational change that Par6, and the entire Par complex for 
that matter, is thought to antagonize the formation of polarity and/or the tight junction.  
There is conflicting evidence however, on whether Par6 function is related to promotion 
or prevention of polarization. Overexpression of Par6 in MDCK cells inhibits tight 
junction formation but not adherens junction formation, providing evidence that Par6 
does act as an antagonist to the establishment of tight junctions (71).  On the other hand, 
Par6 overexpression has also been linked to cell hyperproliferation without loss of apico-
basal polarity suggesting tight junction formation is not regulated via Par6 and that the 
hyperproliferative phenotype is due to increased levels GTP-Cdc42 induced cytoskeletal 
changes (213).  Hypothetically, the phenotypes described could possibly describe the 
same scenario, with the suggestion that during Par6 overexpression, mature tight 
junctions are short lived due to the overwhelming presence of a potent antagonist to their 
formation.  An alternative and increasingly likely explanation for these phenotypes is that 
the Par complex as a whole acts in a context-dependent manner facilitating both the 
formation and disassembly of tight junctions depending on nature of the complex.  
Evidence suggesting that the Par complex contains transient components due to the 
presence of aPKCζ, an active kinase in the complex, supports this theory. Recent studies 
have shown that Par6 can interact directly with a member of conserved Scribble polarity 
complex, namely Lethal-giant Larvae (Lgl), and that this interaction is upstream of 
canonical Par complex formation (230, 299).  The basolateral Scribble polarity complex 
is hypothesized to antagonize formation of the apical surface.  Tony Pawson’s group 
illustrated that Lgl effectively interacts with PDZ domain of Par6B (230). The binding of 
Lgl to Par6B is mutually exclusive to that the binding of Par3 and PALS1 to Par6 (300).  
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With the binding between PALS1 and Lgl to Par6 being mutually exclusive, Par6 is likely 
a regulator of the delicate balance between the formations of distinct apical versus 
basolateral domains in polarized epithelial cells.  In this case, Par6 shuttles back and 
forth, reinforcing both basolateral and apical identities through alternate binding between 
conserved polarity complexes. 
 
1.3.4 aPKCζ  
Atypical protein kinase C zeta (aPKCζ) is the kidney specific isoform of the 
atypical protein kinase family that also includes lambda and iota isoforms (221, 248).  
Members of the atypical protein kinase C family lack most of the C1 and all of the C2 
domains, distinguishing themselves from typical PCKs (96).  However, the C-terminal 
kinase domains of aPCKs are active, placing them in the proteins kinase C family due to 
similarities of these kinase domains (5).  With regards to epithelial polarity, aPKCζ is a 
member of the Par polarity complex localized to the lateral membrane of renal epithelial 
cells via directly binding to Par6 and Par3 via an N-terminal PB1 domain on aPKCζ 
(Figure 1-3 and (120)).  aPKCζ can also localize to the nucleus.  Upon binding of GTP-
Cdc42 to Par6, aPKCζ is translocated from the nucleus to the cytoplasm to form a stable 
complex with Par6 (211).  Translocation from the nucleus and subsequent binding of 
aPKCζ to Par6 is downstream of cell-cell adhesion where GTP-loading of Cdc42 and 
other Rho GTPases occurs upon cadherin based cell to cell contacts (121).  Current 
models suggest that upon E-cadherin mediated cell adhesion; Cdc42 converts from its 
GDP-bound inactive form to its GTP-bound active form that then binds Par6, which in 
turn sequesters aPKCζ in the cytoplasm (211).   
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aPKCζ is the only conserved polarity protein that contains an active kinase 
domain.  It is believed that the function of aPKCζ in polarized epithelial cells is to act as 
a molecular switch controlling the identity of apical and lateral domains.  This is 
accomplished by the selective phosphorylation of known targets of aPKCζ in mammals, 
including the previously mentioned Par3A and Lgl (97, 120, 159, 230, 300).  aPKCζ 
phosphorylation of Par3 and Lgl is believed to modulate the identity of the Par-complex 
in mammalian cells where as the phosphorylated species of either Par3A or Lgl are 
excluded or included in a particular complex based on conformational change.  
Phosphorylation of Par3A by aPKCζ results in a Par3-Par6 dissociation, beginning a 
cascade resulting in the stabilization of tight junctions and the development of apical-
basal polarity (97, 201). In a similar way, aPKCζ phosphorylates Lgl inducing Lgl 
dissociation from Par6 and the inclusion of Lgl in the Scribble complex (230, 299, 300).  
Liberated phospho-Lgl is free to associate with other binding partners, reinforcing Par 
complex formation resulting in subsequent phosphorylation and dissociation of Par3 with 
the complex leaving Par6 free to potentially associate potentially, with either Crb3 or 
PALS1.  The dissociation of Lgl from Par6 leads to Par complex reformation, and results 
in cytoskeletal rearrangements that reinforce surface identity through Ras-family 
GTPases (section 1.3.3).  In Drosophila, aPKCs have been shown to also phosphorlyate 
dCrumbs (the Drosophila homologue of mammalian Crb) (259).  In mammals however, 
this phenomenon has not been observed. The above evidence suggests that in mammals, 
the Par complex and the Scribble complex are functional antagonists with regards to cell 
polarity where aPKCζ acts as the molecular switch to facilitate polarity and junction 
formation.   
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1.3.5 The Scribble Complex Overview 
 The mammalian Scribble complex comprises the genetically linked conserved 
polarity proteins Scribble (SCRIB), Discs Large (Dlg), and Lethal giant larvae (Lgl).  
Although the evidence for physical interaction between these proteins is limited, studies 
in lower organisms suggest that they function in the same genetic pathway.  The Scribble 
complex localizes to the lateral membrane in polarized epithelia; a location consistent 
with a role in defining the lateral versus the apical surface of these cells (Figure 1-2).   
 
1.3.6 Scribble 
 Scribble (SCRIB) is a large, cytoplasmic scaffold protein associated with the 
lateral membrane in polarized renal epithelial cells (56, 203).  Originally described in 
Drosophila, SCRIB’s name is derived from the disorganized phenotype described in the 
developing embryo, imaginal wing discs, and follicles of the fly (20, 21).  SCRIB is a 
member of the Leucine-rich repeat (LRR) and PDZ domain (LAP) family of proteins due 
to the 16 LRRs on the N-terminus and 4 PDZ domains on the C-terminus of its structure 
(Figure 1-3 and (19)).   
The functional role of Scribble in renal epithelia is still a mystery, however 
interactions between Scribble and its binding partners have given insight to how this 
protein affects cell polarity.  The N-terminal of 16 LRRs of SCRIB are necessary for 
binding to Lgl2 and targeting SCRIB to the lateral membrane in polarized renal epithelia 
(128, 206).  The association of Scribble with the lateral membrane however appears to be 
cell-type specific.  In intestinal epithelia, Scribble associates with the tight junction 
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structural protein ZO-1 and regulates tight junctions stability, a phenomenon not seen in 
renal epithelia (119).   The lateral targeting of SCRIB depends on the presence of E-
cadherin, and in MCF10A cells lacking E-cadherin; SCRIB is no longer associated with 
the membrane (206).  The association of SCRIB with intracellular domain of E-cadherin 
at the lateral membrane of polarized renal epithelia is necessary for proper cell-cell 
adhesion as SCRIB knockdown effects adherens junction stability (231).  In this study, 
shRNAs against SCRIB in MDCK cells was shown to increased motility and adhesion, a 
phenotype similar to that seen with the knockdown of E-cadherin (231).   The association 
of Scribble with E-cadherin suggests that Scribble may have a role in both epithelial cell 
migration and the initiation of epithelial polarity. The PDZ domains of SCRIB bind βPix, 
a Rac/Cdc42 GEF involved in exocytosis (11).  SCRIB has been shown to regulate 
directed migration and wound healing in association with Rac1, Cdc42, and presumably 
the Par complex (58, 212). Also, PDZ domains 3 and 4 of SCRIB bind the tight junction 
structural protein ZO-2 in contact naïve epithelial cells, but not fully polarized epithelia 
further suggesting a role for SCRIB in cell migration (187).  Similarly, mice displaying 
mutated variants of SCRIB display impaired directed epithelial migration phenotypes 
(58).  
  A SCRIB-E-cadherin genetic interaction also suggest SCRIB may associate with 
both canonical and non-canonical Wnt signaling.  SCRIB knockdown phenotypes could 
be rescued by expression of an alpha-catenin-E-cadherin fusion protein suggesting 
canonical-Wnt signaling is associated with SCRIB expression (231). PDZ domains 2, 3, 
and 4 of SCRIB bind to the planar cell polarity factor and non-canonical Wnt-signaling 
molecule Vangl2, and this interaction is responsible for proper orientation of polarized 
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structures in mammals (128, 194).  Abrogation of Vangl2 in mouse reproductive tract 
epithelium in turn resulted in a mislocalization of SCRIB and defects in apical membrane 
formation further strengthening the association of Scibble with both methods of Wnt-
signaling (284). 
Human SCRIB has been demonstrated to be an effective tumor suppressor; 
confirming apico-basal cell polarity, preventing tumorgenic overgrowth, and contributing 
to the proper orientation of planar cell polarity (56, 193).  A recent study suggests that 
SCRIB tumor suppressor function is related to the ability of SCRIB to regulate the Ras-
MAPK pathway, and overexpressed SCRIB was able to effectively suppress oncogenic 
Ras-associated invasiveness (57).   Drosophila models of tumor formation confirm that 
oncogenic-Ras and SCRIB mutants cooperate to form metastatic tumors similar to those 
found in human cancers (298).  The tumor suppressor APC also binds SCRIB through 
PDZ1 and PDZ4 suggesting that SCRIB is involved with cell signaling regulating the cell 
cycle, cell growth, and cell morphology (269).   Perhaps the most compelling evidence 
however, of SCRIB controlling growth in epithelial cells is the fact that the SCRIB 
protein is a target of oncogenic viruses.  High-risk human papilloma virus oncoprotein 
E6-E6AP is an ubiquitin ligase complex that tags SCRIB with an ubiquitin signature 
causing proteosomal degradation of the SCRIB protein (203).  Degradation of SCRIB via 
this pathway leads to a reduction in tight junctions and tumor formation.   
 
1.3.7 Lgl 
 Mammals contain multiple Lethal giant larvae (Lgl) proteins, termed Lgl1-4.  In 
mammalian renal epithelia, Lgl1 is highly expressed and however studies have shown 
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that Lgl proteins have highly similar/redundant functions and may be interchangeable and 
therefore are given the name mLgl for mammalian Lgl.  mLgl is characterized by a series 
of WD-40 repeats in its N-terminus that are thought to facilitate binding to SCRIB 
(Figure 1-3 and (128)).  No direct link to Dlg1 has been reported for mLgl, but they are 
thought to genetically interact via a similar mode of action.   
Mammalian Lgl localizes to basolateral membrane in renal epithelia upon cell-to-
cell contacts, and is localized to the cytoplasm in contact naïve cells (193).  mLgl binds 
Par6/aPKCζ prior to GTP Cdc-42 binding to Par6 and this binding is found only in the 
absence of Par3 (230, 300).  As mentioned previously, mLgl is phosphorlyated by aPKCζ 
and the phosphorylation of Lgl inactivates Lgl and restricts its localization to the 
basolateral membrane, as a non-phosphorylatable mutant of mLgl was shown to localize 
with apical membrane markers (200, 230).  In human cancers, overexpression of aPKC at 
the membrane results in a cytosolic accumulation of Lgl from the membrane, suggesting 
that membrane bound Lgl is necessary for tissue homeostasis (86, 161).  In terms of 
vertebrate development, it has been demonstrated that Lgl gives identity to the basolateral 
membrane and the interaction between Lgl and aPKC results in definition of apical 
versus basolateral surfaces (38).  Likewise, in depolarization models, knockdown of Lgl 
prevented the dissociation of the Par polarity complex resulting in cellular overgrowth 
(299).  This data suggests that there exists a coordinated series of events where the action 
of Lgl and aPKC function to define the apical and basolateral surfaces by mutual 
inhibition and scaffolding. 
Lgl has also been demonstrated to interact with trafficking machinery.  Lgl 
interacts with myosin II heavy chain and syntaxin-4 suggesting it plays a role in the 
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trafficking of membrane components (200).  More studies are needed on this 
phenomenon in mammalian systems, however work in Drosophila has illustrated that Lgl 
may be involved with the regulated endocytosis and exocytosis of dCrumbs (22, 167). In 
particular, disrupting exocytosis of dCrumbs resulted in an expanded lateral membrane 
but suppression of Lgl in this system resulted in a rescue of dCrumbs presentation on the 
apical surface (22). 
 
1.3.8 Dlg 
 Dlg (Discs large) is the mammalian homologue of the Drosophila gene Discs 
large of which there are 5 family members (Dlg1-5) with Dlg1 being the most throughly 
studied in the kidney (184).  Dlg1 (also known as SAP97) localizes to the lateral 
membrane in polarized epithelia (168).  Dlg1 contains from N-terminus to C-terminus: an 
L27 domain, 3 PDZ domains, and SH3 domain, a 4.1 binding domain, and a membrane 
associated kinase-deficient GUK (MAGUK) domain (Figure 1-3 and (168)).   
The Scribble complex consisting of SCRIB, Lgl, and Dlg1 have a strong genetic 
interaction, however any physical interaction between Dlg1 and the other members of the 
complex has yet to be determined.  Dlg1 contains a similar domain structure to other 
MAGUK domain containing proteins, including the polarity protein PALS1 (section 
1.3.10); suggesting Dlg1 is also a molecular scaffold protein.  The interactions of Dlg1 
and its binding partners have been extensively studied, yet the functional significance of 
these interactions is still poorly understood.  Proteins that bind the L27 domain of Dlg1 
include membrane palmitolyated protein (MPP) family members MPP2, MPP3, and 
MPP7 (130).  The interaction between Dlg1 and MPP7 demonstrates the necessity of a 
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tripartite complex consisting of Dlg1, MPP7, and the small polarity protein Lin-7 (section 
1.3.10) for tight junction formation and stability of Dlg1 (23, 264).  This interaction 
functionally links the Crumbs and Scribble complexes through the common binding 
partner Lin-7 and may help establish the tight junction (261).  Interestingly, knockdown 
of Lin-7 in MDCKII cells results in a destabilization of Dlg1 (Straight and Pieczynski, 
unpublished observation).  Dlg1 also interacts with Lin2, another associated MAGUK 
polarity protein via an L27-L27 domain dimerization interaction (151).  Lin2 (also known 
as CASK) is a serine-threonine kinase shown to be necessary for arrangement of the 
basolateral membrane (44).   
 The PDZ domains of Dlg1 interact with key signaling proteins in mammalian 
epithelia making Dlg1 essential to renal physiology.  Dlg1 interacts with adenomatous 
polyposis coli (APC) via it PDZ domains (181).  APC is a tumor suppressor that binds β-
catenin in polarized epithelial cells and negatively regulates Wnt signaling suggesting 
that Dlg1 may play a role in planar cell polarity (144, 198).  The interaction of Dlg1 and 
APC has been clearly shown to affect cell cycle progression as overexpressed Dlg1 leads 
to over proliferation most likely due to an increase in Wnt signaling (116).  Adey and 
colleagues also identified Dlg1 as a binding partner to the tumor suppressor PTEN via 
yeast two hybrid and show that unphosphorylated PTEN interacts with the second PDZ 
domain of Dlg1 (3).  Although the functional significance of PTEN binding to Dlg1 is not 
known at this time, it is possible that Dlg1 acts to stabilize PTEN.  Dlg1 would then 
facilitate PTEN phosphorylation effecting PTEN interactions with other PDZ domain 
containing proteins including Par3A (280). 
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 A Dlg1 knockout mouse has been generated, and the phenotype included many 
urogenital defects associated with lack of epithelial development (111).  The C-terminal 
SH3, Hook, and GUK domains alone of Dlg1 are also known to function in development.  
A gene trap mouse that leads to a C-terminal truncation of Dlg1 displays an array of 
developmental phenotypes including defects in nephrogenesis and cleft palate (35, 202).  
Identifying the protein-protein interactions needed at the C-terminus of Dlg1 will be 
essential to understanding these phenotypes.  Data suggests that the C-terminal SH3 
domain of Dlg1 may also bind Lin-2 and/or undergo internal regulation similar to other 
polarity proteins containing SH3 and GUK domains (210, 283).   
Post-translational modifications to the Dlg1 protein have also given insight into 
the role of Dlg1 in epithelial polarity.  Dlg1 is phosphorylated in epithelial cells, and 
phosphorylation appears to have a significant role in maintaining the structural integrity 
of the adherens junction (148).  Additionally, the phosphorylation of Dlg1 may confer its 
subcellular localization and stability during the cell cycle and be regulated by cyclin-
dependent kinases (CDK) 1 and 2 (205).  The stability and half-life of Dlg1 in epithelial 
cells is regulated by ubiquitination (172, 173).  Ubiquitination of Dlg1 can be a result of 
viral infection, where oncogenic viruses coding for ubiquitin ligases selectively target 
PDZ polarity proteins for degradation. Virally mediated ubiquitination of polarity 




1.3.9 Crumbs complex Overview 
In renal epithelia, the Crumbs complex consists of three major components, and 
multiple associated proteins.  The core complex itself consists of the proteins Crumbs3a 
(Crb3a), Protein Associated with Lin-Seven 1 (PALS1/MPP5), and PALS1 associated 
Tight Junction Protein (PATJ) or Multiple PDZ Domain Protein-1 (MUPP1) all of which 




PALS1 is a multi-domain adapter protein associated with the conserved Crumbs 
complex in mammalian epithelia (235, 237). In fully polarized epithelia, the PALS1 
protein is localized to the tight junction (12, 129).  PALS1 contains six distinct protein 
interacting domains: two Lin-2-7 (L27) domains (referred to as L27N and L27C 
respectively), a single PDZ domain, a single SH3 domain, a Hook domain, and a GUK 
domain (Figure 1-3 and (129)).  The GUK domain of PALS1 lacks kinase activity and is 
speculated to be involved in only protein-protein interactions (182, 183, 271).   
PALS1 an essential molecular scaffold with a multitude of binding partners that 
have been extensively mapped; most significantly it is found in a complex with the other 
essential polarity proteins Crb3a and PATJ (235, 237).  PALS1 binds Crb3a via its PDZ 
domain and PALS1 binds PATJ via its L27N domain (156).   Domain deletion analysis 
has illustrated that PALS1 interaction with both Crb3a and PATJ essential for tight 
junction formation in mammals (156, 262).  Also, PALS1 provides an important link 
between the Crumbs complex and the Par complex via the N-terminus of PALS1 binding 
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the PDZ domain of Par6 (109, 226, 289).  Knockdown studies of PALS1 indicate that 
PALS1 is necessary for timely junction formation, stability of PATJ, and the ability of 
aPKCζ to localize to the tight junction (262, 289).   
The regulation of PALS1 in mammalian epithelia is maintained by  association 
and binding to accessory proteins illustrating the complex nature of the tight junction.  
PALS1 was identified in a screen for proteins associated with the Lineage defective 
protein-7 (Lin-7, also known as MALS, or Veli3).  Lin-7 is a small PDZ domain 
containing protein necessary for proper development in C. elegans (129).  There are 3 
isoforms of mammalian Lin-7, with Lin-7c being highly enriched in the kidney (114). 
Lin-7 stabilizes PALS1 protein in MDCKII cells by binding to the L27C domain found in 
PALS1 (23, 217, 261).  In Lin-7 knockdown MDCKII cells, tight junction formation is 
delayed, but not destroyed suggesting that PALS1 is essential for the establishment of the 
tight junctions but not the maintenance of the tight junction (261).  Lin-7 also binds the 
lateral membrane protein IRSp53 which is a RhoA adapter protein therefore linking 
PALS1 to the cytoskeleton (180).  Additionally, PALS1 is destabilized by the lack of 
Crb3a in MDCK cells.   In the epithelial to mesenchymal transition (EMT) there is a 
decrease PALS1 protein and only a modest decrease in transcription of the PALS1 gene 
(294).  Likewise, interruption of the PALS1-PATJ binding results in PALS1 moving from 
the tight junction to being dispersed through the cytosol (109).  
The above data pose an interesting question of the dynamics concerning the 
continued expression and stability of junctional complexes.  It has been suggested that 
GUK domain containing proteins such as PALS1 may exist as dimers or be involved in 
internal regulation via conformational change dependent on the presence of specific 
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binding partners.  PALS1 may “fold back” on itself and be regulated by internal binding 
between its SH3 and GUK domains or exhibit “tail to tail” dimerization which would 
presumably effect the function of the protein by either exposing or blocking the 
availability of multiple protein-protein interaction domains.  A similar phenomenon is 
found in the MAGUK proteins Dlg1, which has a similar SH3 domain and GUK domain 
structure and has been shown to be highly flexible (183, 271, 283).   
Knockdown of PALS1 in MDCKII cells indicates that tight junction biogenesis 
may also affect the architecture of the lateral membrane.  Wang et al. illustrated that 
PALS1 knockdown effected the trafficking of E-cadherin to the lateral surface of 
MDCKII cells by affecting the exocyst complex (288).  This study implies that the 
formation of the tight junction is essential to the overall architecture of the epithelial cell, 
and there exists a complex feedback network coordinating exocytic events essential to 
maintain the integrity of the epithelial monolayer.   At this point, our understanding of the 
interplay between tight junction formation and modulation of epithelial cell structure is 
limited.  Functionally, likely candidates for studying this phenomenon are the spatio-
temporal interactions between PALS1 to Crb3a and Par6.   
 
1.3.11 PATJ and MUPP1 
PATJ (PALS1 Associated Tight Junction protein) and MUPP1 (Multiple PDZ-
domain Protein-1) are two highly related, multiple PDZ-domain containing proteins 
found in mammalian epithelia and localized to the tight junction (Figure 1-3).  With 
multiple PDZ domains, PATJ and MUPP1 are both molecular scaffolds at the tight 
junction (152, 279).  PATJ contains 10 PDZ domains while MUPP1 contains 13 PDZ 
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domains.  PDZ domains 6 and 8 of PATJ directly bind to the tight junction structural 
proteins ZO-3 and Claudin-1 respectively (236).  Claudin and Occludin family proteins 
are transmembrane proteins that form the physical “fence” and “gate” of the tight 
junction, while the Zona Occulidin (ZO)-family of protein are cytoplasmic adapters of 
the Occludin family of structural proteins (70).  The binding of the ZO and Claudin 
families to PATJ suggests a role of PATJ in maintaining the epithelial monolayer, 
distinguishing apical versus lateral surfaces, and maintaining the functional identity of the 
tight junction itself.  Similarly, MUPP1 is also linked to tight junction structural proteins, 
including those of the Claudin family but also to the Junctional Adhesion Molecule 
(JAM) family (91, 150).  Both PATJ and MUPP1 contain an N-terminal L27 domain that 
binds the L27N domain of PALS1, and MUPP1 has also been shown to directly interact 
with MPP4 (also known as Dlg6) via this L27 domain (237, 281).   The L27-L27 
interaction between PALS1 and either PATJ is necessary for tight junction in renal 
epithelia (237).   
Interestingly, PATJ has been illustrated to be significant in the process of 
maintenance and establishment of epithelial tight junctions, while the highly similar 
MUPP1 protein has been shown to be not necessary for tight junction formation (2).  
Knockdown studies have reinforced the role of PATJ in epithelial polarity.  Deletion of 
PATJ via shRNA in MDCKII cells reveal that PATJ is necessary for the formation of tight 
junctions in both 2D and 3D models but knockdown of PATJ does not effect stability of 
other members of the conserved Crumbs polarity complex (254).  However, abrogation of 
PATJ in epithelia did effect localization of apical and lateral components of the tight 
junction suggesting PATJ is a molecular scaffold and not functioning to define tight 
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junctions (189).  Wound healing assays performed on MDCKII monolayers have shown 
PATJ to be localized to the leading edge of migratory epithelia and to be partly 
responsible for the establishment of new cell-to-cell contacts upon wound repair. 
Additionally, knockdown of PATJ slowed this process (255).  PATJ at the leading edge of 
migrating cells seems to result in the localization of members of the Par polarity complex 
and wound healing seemed to be at least some what dependent on the cytoskeletal 
modulation provided by the Par polarity complex (255).  Related to wound healing and 
directional migration of epithelial cells is the question as to whether PATJ and MUPP1 
near the leading edge functions as a scaffold for proper membrane formation of if PATJ 
and MUPP1 are needed for positioning receptors key to signaling of extracellular 
migration cues, or both.  PATJ has recently been shown to interact with Angiomotin 
(AMOT) and his interaction may provide clues into the role PATJ plays as a signaling 
molecule in polarized epithelia (265).  AMOT binds PDZ 2 and 3 of PATJ and has a large 
number of interactions that may contribute to epithelial barrier maintenance.  AMOT, 
besides binding PATJ, also associates with Rich1, a Cdc42 GAP.  The PATJ-AMOT-
Rich1 interaction may  link the Crumbs complex with the Rho-family GTPases and the 
Par polarity complex through down-regulation of GTP-Cdc42 (265).  Cdc42 has been 
shown to affect the trafficking of PALS1 and Par3 to the plasma membrane through the 
polarity protein Par6 (125, 293).    A recent report by Leiw et al demonstrates a clear 
interaction between MUPP1 and the human somatostatin receptor 3 (hSSRT3), a G-
protein coupled receptor (GPCR) (158).  Leiw and colleagues demonstrate that the 
interaction between hSSRT3 and PDZ 10 of MUPP1 may allow for GPCR regulated 
transepithelial permeability (158).  Similarly, PATJ has recently been shown to interact 
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with members of the dopamine signaling family, most notably Na+/K+ ATPase subunit α 
(40).  Na+/K+ ATPase, in addition to regulating renal ion flux, has been suggested to be a 
member of a novel epithelial polarity complex also consisting of Yurt, Coracle, and 
Neurexin IV in Drosophila responsible for lateral membrane stability (147).  Although 
further study is needed in mammalian systems, this finding further strengthens the 
hypothesis that PATJ is a scaffold involved in the establishment of apico-basal polarity.   
 
1.3.12 Crumbs3 
The eponymous Crb3 protein is a human homologue of the Drosophila protein 
DCrumbs, a regulator of epithelial polarity (273).  There are three human homologues of 
the Crb gene termed Crb1, Crb2, and Crb3.  Crb1 is primarily localized to the retinal 
pigmented epithelium of the eye and mutations in the gene have been linked to retinitis 
pigmentosa and other retinal defects (52, 282).  Crb2 gene expression has been seen in 
brain, testis, uterus, eye, and embryonic tissue, but its full function remains to be fully 
elucidated and may play a role in the glomerulus (60, 134).  The Crb3 gene is highly 
expressed and is the predominant isoform in the kidney and therefore can be readily 
studied in cultured renal cells, such as MDCKII cells.   
Crb3 is the smallest and least conserved member of the Crb gene family.  Each 
member of the Crb family encodes for a single pass transmembrane protein with an 
extracellular N-termini and highly similar cytoplasmic C-terminus.  The cytoplamic C-
termini of the Crumbs proteins contains a FERM binding domain and a PDZ binding 
domain (170).   Crb1 and Crb2 share sequence homology in their EGF-repeat rich-
extracellular domains while the extracellular domain of Crb3 is markedly shorter and 
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lacks any identified domain structure (Figure 1-3 and (170)).   Additionally, Crb3 exists 
in two unique isoforms due to alternate splicing of the final exon of the Crb3 gene.  
Alternate splicing of Crb3 results in a 22 amino-acid difference in the C-termini of each 
isoform; changing the sequence of the PDZ binding domain at the extreme C-termini 
(63).  Crb3a is termed ERLI for the terminal glutamic acid-arginine-leucine-isoleucine 
(E-R-L-I in single letter code) amino acids that comprise its PDZ binding motif.  Crb3b is 
known as the CLPI isoform, named for the four terminal cysteine-leucine-proline-
isoleucine (C-L-P-I in single letter code) sequence comprising its PDZ binding domain 
sequence.   
The difference in PDZ binding domains of Crb3 has been shown to alter the 
function of each Crb3.  Both Crb3 isoforms have been shown to localize to the tight 
junction, the apical membrane, and the primary cilium of polarized MDCKII cells (63, 
64, 152, 170).  However, Crb3b has also been shown to localize to the spindle pole of 
mitotic MDCKII cells and specific knockdown of Crb3b disrupts cell division and 
cytokinesis, with cells showing a multinuclear phenotype (63).  Mutational analysis 
involving Crb3a illustrates the requirement of Crb3a for the formation of the tight 
junction and establishment of polarity (69, 153, 235).  These results indicate that both 
Crb3 isoforms are essential for epithelial formation and function.  Interestingly, the 
regulatory mechanism concerning the abundance of each splice variant is not yet 
understood.  The ability to accurately monitor the production of both splice variants of 
the Crb3 gene will be essential to understanding how epithelial integrity is maintained. 
Crb3a is localized to both the tight junction, along the apical membrane, and to 
the primary cilium (64).  Of both Crb3 isoforms, Crb3a is noted for its inclusion in the 
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Crumbs polarity complex.  Crb3a is found in a complex at the tight junction with PALS1 
and PATJ, and links the Crumbs complex with the Par complex via its interaction with 
Par6 (100, 110, 153, 237).   Crb3a binds to both PALS1 and Par6 via its C-terminal PDZ 
binding domain (110, 153).  The necessity of Crb3a binding to both PALS1 and Par6 is 
illustrated by specific deletion of the ERLI tail of Crb3a, mutation of the PDZ domain of 
Par6, or mutation of the PALS1 N-terminus; all of which inhibit tight junction formation 
(110, 153, 235).    
 The intracellular FERM binding domain of Crb3a has been shown to be 
functionally important for Crb3a in MDCK cells (69).  However, proteins interacting 
with the FERM binding domain of Crb3a are far less understood in mammalian cells, but 
are beginning to be identified.  The protein Yurt was shown to bind the FERM binding 
domain of Drosophila dCrumbs and function as a negative regulator of dCrumbs (146). 
Studies have also suggested the mammalian orthologs of Yurt, YMO1, EHM2, and 
EPB41L5 have a similar function in mammalian cells and form a novel complex with 
Crb3a and PALS1 (83, 146, 147).    Similarly, the homolouge for Yurt in zebrafish, 
known as mosaic eyes (moe), also codes for a FERM binding protein and knockouts of 
this gene give rise to a phenotype similar to that of a PALS1 knockdown (known as nagie 
oko in zebrafish nomenclature) (122).  Further characterization of these proteins in 
mammalian systems is needed to fully elucidate their specific functions in regards to 
apico-basal cell polarity. 
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1.4 Molecular Mechanisms Establishing Renal Epithelial Cell Polarity 
1.4.1 Establishing Renal Polarity: MET vs. EMT 
The developing kidney is a well-studied organ model, matching the development 
of polarity with acquired physiologic properties.  Epithelial to mesenchymal transition 
(EMT) and the converse mesenchymal to epithelial transition (MET) describe the process 
in which cells undergo phenotypic changes to facilitate growth and development, 
including organogenesis.   EMT is characterized by a morphological change where the 
cell undergoes massive reorganization to its transcription, translation, and cytoskeletal 
networks to become fibroblastic.  For the reciprocal process of MET, morphological 
changes again must take place, this time rearranging epithelial cells into their normally 
highly ordered morphology with specialized surfaces for function.  Change in 
morphology of cells during EMT/MET can be attributed at least partially due to loss and 
gain of expression of polarity proteins (27, 165, 197).  During EMT/MET polarity 
proteins can be either regulated at the transcription level by activation or suppression of 
transcription, at the translational level by microRNAs, or at the proteins level by 
redistribution of their subcellular localization and/or loss of stability (85).  In the case of 
EMT, in addition to silencing of genes there is a marked activation of genes that provide 
the cell with resistance to apoptosis, loss of contact inhibited growth, resistance to 
anoikis, and increased invasive properties (197, 274).   
Functional EMT/MET is a cornerstone of mammalian development initiating the 
ability of cells to form complex cells and tissues at the proper location with temporal 
significance.  During development, the initial steps in organogenesis of the renal tubule 
network are the condensation of unorganized mesenchymal cells to organized epithelia 
through the EMT/MET process (37, 59).   The canonical Wnt signaling cascade initiates 
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this process (247).  During MET of the kidney, the migrating ureteric bud secretes Wnt9b 
inducing the metanephric mesenchyme to aggregate and undergo planar cell division and 
forming the beginnings of the pretubular aggregate (34, 132).  Autocrine Wnt4 signaling 
from this initial condensation of the pretubular aggregate combined with continued 
activation from Wnt9b from the ureteric bud promotes β-catenin survival and TCF/Lef1 
mediated transcripitional activation beginning the process of cellular differentiation and 
the beginnings of renal tubule formation (222).  Interestingly, canonical Wnt-signaling 
derived from, Wnt4, Wnt9b, or forced β-catenin expression does not effectively induce 
Cdh1 (the gene for E-cadherin) transcription to allow for epithelial adhesion and 
progression to a polarized epithelial phenotype (222).   
How do polarized renal epithelial cells arise from these differentiated pro-
epithelial structures?   Regulatory proteins of EMT/MET program have been identified 
and the activities of these regulators may explain how mesenchyme can condense into 
epithelial structures.  The Snail family (Snail, Slug) consists of zinc-finger transcriptional 
repressors that can lead to EMT by binding E-boxes in the promoter regions of essential 
genes controlling the epithelial phenotype (26, 162, 208, 275).  In addition to the Snail-
family of transcription factors, the basic helix-loop-helix (bHLH) family of 
transcriptional repressors also initiates the EMT program (225, 258).   Although a 
multitude of EMT initiation factors have been described, it seems as though specific 
EMT transcriptional repressors each have common and unique targets of repression 
(196). 
EMT transcription factors in both the Snail and bHLH families repress the 
promoter activity of Cdh1 that codes for the major adherens junction molecule E-
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cadherin (33, 196).  Reduction of the Snail family of transcription repressors positively 
regulates the expression of cadherins and tight junction proteins and facilitates epithelial 
polarization by releasing E-box motif mediated gene silencing (33, 207, 276, 294).   With 
repression of EMT transcription repressors in the developing kidney, cadherin based cell-
to-cell adhesions could presumably form allowing for continued maturation of the 
pretubular aggregate into fully polarized epithelia (15, 26, 47).  At this stage in renal 
development however, Wnt-signaling must be attenuated as illustrated by the fact that 
canonical Wnt-signaling can lead to inhibition of the epithelial phenotype (222).  There is 
an established relationship between Wnt-signaling and control of EMT factors, however 
the exact mechanisms and temporal significance of these interactions during development 
are not well understood (162). 
 
1.4.2 Regulation and Maintenance of Renal Epithelial Polarity: A Trail of Crumbs 
As MET is essential to proper renal development, the converse EMT can be seen 
as, according to Boutet et al, a “reversed embryogeneis” with regards to renal fibrosis and 
carcinomas (27).  The regulation of proper renal epithelial phenotype is undoubtedly tied 
to the regulation of Crb3 transcript (26, 27, 294).  Not surprisingly, the Crb3 gene is also 
a target of the transcriptional repressors Snail1 and ZEB1 in renal epithelia implicating 
EMT transcription factors to the regulation of tight junction protein complexes (4, 294).  
At this time it is not known which bHLH factors repress Crb3 transcription but it will be 
important to further characterize the bHLH transcription factors to determine what role, if 
any; they have on repressing this gene.   Although EMT transcriptional repressors can 
only affect specific target regions within the promoter regions of certain genes, the 
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downstream effects of genetic repression often manifest in an extended EMT program.  
Deregulation of polarity genes by EMT factors forces feedback whereby transcriptional 
repression and stability of polarity proteins can be reduced furthering the cycle of EMT.  
Examples of such genes are those coding for PALS1 and PATJ, where Snail 
overexpression results in direct repression of the Crb3 promoter followed by a smaller, 
yet noticable decrease in transcription of the genes coding for these two conserved 
binding partners of Crb3a (294).  
The fact that the Crb3 gene is highly regulated suggests Crb3 may be at the 
centerpiece of the polarized epithelial program. There lies a body of evidence to suggest 
that Crb3a has the intrinsic ability to delineate epithelial morphology by establishment of 
the tight junction. Crb3a physically binds Par6 linking two highly conserved essential 
polarity complexes. Crb3a, being a transmembrane protein, also must be functionally 
exocytosed and endocytosed to modulate any activity.  Forced expression of high levels 
of the Crb3 gene in normally unpolarized epithelia can lead to the establishment of tight 
junctions, including the sequestering of tight junction structural proteins including those 
of the zona occludin (ZO-family), claudin, and occludin families (69). Also, 
overexpression of Crb3a in normally polarized epithelia leads to an expansion of the 
apical surface, an extended tight junction, and a reduced basolateral membrane similar to 
neoplastic tumor growth  (153, 235).  And finally, knockdown or reduction of the Crb3a 
transcript results in cells completely devoid of tight junctions (69, 133, 235).   
Crb3a is unique that it is the only transmembrane protein in any of the three 
conserved polarity complexes; it must travel through an exocytic pathway to arrive at its 
proper apical location. It is been hypothesized that transmembrane proteins destined for 
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the apical surface are recruited to that surface via N or O-linked glycosylation and lectins 
or via their association with lipid rafts.  Crb3a does not associate with lipid rafts (Hurd 
and Pieczynski, unpublished results); however Crb3a contains at least one N-linked 
glycosylation site on its extracellular domain at position 36.   This N-linked glycosylation 
site appears to be dispensable for the apical targeting of Crb3 however (170).    Galectin-
3 has been identified as a possible apical sorting protein in polarized epithelial cells (49, 
50). Since N-linked glycosylation of Crb3a is not necessary for apical targeting it seems 
unlikely Galectin-3 is responsible for Crb3a localization along the apical membrane at 
least in recognition of asparagine 36.  The exocyst complex has also been shown to 
regulate ciliogenesis, however in exocyst mutants the tight junctions remained intact 
again suggesting that the exocyst may not be responsible for the trafficking of Crb3a, at 
least to the apical surface and the tight junction (305).    Since Crb3a has three different 
subcellular localizations it is quite likely that there is more than one mechanism that 
directs transmembrane proteins to the apical surface.   
Studies by in 3-dimenstional systems have given insight into the role of Crb3a in 
apical membrane formation however (141, 176).  Using lumen formation models, it has 
been demonstrated that the formation and delineation of both the apical and basolateral 
surfaces are a result of coordinated endo- and exocytitic events.  In these models, proteins 
destined for the apical membrane first appear on the plasma membrane in a one cell, 
unpolarized stage.  Upon the initiation of cell division, apical membrane proteins are 
endocytosed and trafficked to the eventual site of the apical membrane.  It is at this point 
where apical membrane proteins accumulate and begin to 1.) Form the apical surface by 
exclusion of basolateral proteins, 2.) Establish a lumen, and 3.) Begin the formation of 
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the tight junction.  Although this model is in its infancy, it illustrates the exocytic events 
that may lead to the maintenance of the apical membrane during steady state.   
Schluter et al. illustrated that Crb3 trafficking to the apical surface is essential for 
lumen formation during the first cell division and this movement is not only dependent on 
Rab11a activity but also sets the basis for aPKCζ localization (246).  Concurrently, the 
role of Rab11 in dCrumbs trafficking was confirmed in Drosophilia as Rab11 insult 
caused a defect in apical surface integrity (234).  Both the previously mentioned studies 
were concerned with the exocystosis of dCrumbs, but perhaps the most striking evidence 
for the role of dCrumbs in epithelial homeostasis is a dissection of endocytic events.  In 
Drosophila deletion of avalanche, the fly equivalent of Syntaxin-7, gives an overgrowth 
phenotype quite similar to Crb3a overexpression and neoplastic tumor growth (167).  
Similarly, in flies knockdown or mutation of the gene erupted (ept, mammalian TSG101) 
again leads to cell overgrowth and apical expansion (92, 192).  TSG101 is a member of 
the ESCRT-I complex (endosomal-sorting-complex- required for-transport-I) and an 
identified neoplastic tumor suppressor linked to cell polarity (18).   In mammals, the role 
of TSG101 as a tumor suppressor is still debatable and seems to be tissue specific, but it 
is known that TSG101 is involved in multitude of functions including the entry into the 
endocytic MVB pathway to internalize transmembrane proteins for degradation either 
through fusion with the lysosome or inclusion of proteins in exosomes (250).  Taking into 
consideration the evidence in Drosophila it can by hypothesized that endocytosis of 
Crb3a is essential for controlling epithelial growth and development in mammals.  There 





Figure 1-4:  Identified regulators of Crumbs in Drosophila and 
mammalian systems.  The cytoplasmic domains of dCrumbs and 
mammalian Crb3a are highly conserved, however, binding partners of the 
FERM binding domain have only been readily identified and studied in 
Drosophila and have been shown to regulate epithelial growth and 
morphology.  Idenitifcation of FERM binding domain partners for 





mammalian renal system, however the urinary exosome proteome includes numerous 
polarity proteins, including Crb3a (82).  
A body of recent evidence also in Drosophila suggests that dCrumbs could 
possibly act as an upstream member of one arm of the conserved Hippo signaling cascade 
(Figure 1-4 and (88, 160, 233)).  In flies and mammals, the Hippo pathway controls the 
exit from the cell cycle and controls apoptosis by nuclear shuttling of the transcription 
factor Yorkie/Yap (87).  Fly knockouts of Hippo members result in an enlargement of the 
apical surface, although this is independent of Yorkie/Yap activity and has been suggested 
to be a result of impaired endocytosis (77, 90).  These findings are significant in that they 
provide a functional link to the amount of dCrumbs localized to the apical surface and the 
ability of the cell to control tissue growth and proliferation.  Additionally, recent data 
suggest that dCrumbs overexpression leads to tissue overgrowth by binding the protein 
Expanded, with Expanded being a negative regulator of Yorkie/Yap activity (88, 233).  It 
will be interesting to confirm these results in mammalian systems to further understand 
how Crb3a controls cellular growth. 
 
1.4.3 Renal Apico-Basal Epithelial Polarity in Context:  A Link to Nephropathies, 
Planar Cell Polarity, and Renal Cilia 
 
There is an established link between some of the most well studied nephropathies 
and the basic molecular mechanisms governing renal epithelial cell polarity.  In the 
establishment of apico-basal polarity in the developing renal tubule network we must 
keep in mind the context in which individual cells exist.  Individual renal epithelial cells 
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are single functional units in a continuous three-dimensional epithelial sheet that must 
maintain its integrity while undergoing cell division and apoptosis.  The ability for 
epithelial cells to form a cohesive polarized functional sheet is facilitated by the 
relationship between apical-basal cell polarity and planar cell polarity (PCP).   PCP 
involves spatio-temporal control over symmetry perpendicular to the apical-basal axis 
based on mitotic organization and is a result of the formation and function of the primary 
renal cilium (131, 185).  In the development of kidney tubules PCP is controlled through 
both canonical and non-canonical Wnt-signaling pathways (131, 185).  The formation of 
the primary cilium is an essential step of developmental epithelial polarization, 
orientating the cell in space during development and providing signal transduction (80).  
Defects in vertebrate cilia and ciliogenesis, referred to as ciliopathies, result in abnormal 
PCP (68).  Ciliopathies may be a result of failure for the primary cilium to form or 
defects in cilia trafficking, known as intraflaggelar transport (IFT, reviewed in (224)).  In 
these scenarios, there is a failure of proteins to traffic either in or out of the cilia, resulting 
in decreased signaling.  The primary monocilium of renal epithelia arises from the basal 
body, a structure associated with the mother centriole orientated in space above the 
nucleus.  Failure of the basal body and centrioles to be correctly oriented results in 
defects in ciliogenesis and cell division.  Lack of a primary cilium in polarized epithelia 
leads to loss of sensory function, as the primary cilium in renal epithelia is host a number 
of receptors and channels that are essential to cellular function.   
There is an established link between PCP and apico-basal polarity as PCP affects 
many polarity proteins.  The conserved polarity protein SCRIB is considered a PCP 
protein, where mutation in the protein causes aberrant PCP (193).  Congenital renal 
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defects have given insight to the relationship between renal physiology, apical-basal 
polarity and PCP.  The congenital, autosomal dominant disease Von Hippel-Lindau is a 
result of the loss of function of the tumor suppressor von Hippel-Lindau (VHL) 
potentially resulting in renal cell carcinoma (RCC) and loss of PCP.  VHL controls EMT 
via HIF1-α where VHL loss of function results in an upregulation of Snail resulting in the 
Snail mediated repression of the genes which encode Occludin and Claudin-1, both 
components of the tight junction (32, 93, 113).   The VHL protein additionally has been 
identified as a binding partner of the Par polarity complex and shown to be necessary for 
the growth of the primary renal cilium and ubiquitination of aPKC isoforms (118, 216, 
244).   
Polycystic Kidney Disease (PKD) is another well-studied example of aberrant 
PCP in renal epithelia.  The PKD proteins polycystin 1 (PC1) and polycystin 2 (PC2) 
localize to the lateral membranes and the primary cilium of polarized renal epithelium 
(107, 263).  Traditionally, PC1 and PC2 are seen as intricate members of primary cilium 
formation and cilium signaling through the IFT system (reviewed in (224)).  The loss of 
functional Polycystins leads to aberrant cell cycle progression and hyperproliferation, 
hallmarks of not only cyst formation but of the EMT phenotype.  However, Polycystins 
also may be involved with the establishment of apico-basal polarity in renal epithelia.  
PC1 in part seems to regulate the formation of E-cadherin positive adherens junctions in 
MDCK cells (107, 263).  Additionally, overexpression of the exocyst protein Sec10 has 
been shown to lead the a cystic phenotype and this phenotype has been linked to 
expression of Par3, since Par3 can localized to the primary cilium and both knockdown 
of Sec10 and Par3 give a strikingly similar phenotype (249, 305).  
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Nephronophthisis (NPHP) is a ciliopathy involving the well-defined nephrocystin 
gene family.  NPHP the gene products localize to the primary cilium and/or basal body 
(95).  Co-immunoprecipitation experiments show a physical interaction between PALS1 
and nephrocystins 1 and 4 and these interactions suggest that PALS1 and the 
nephrocystins contribute to overall cell morphology.  Nephrocystin-1 and Nephrocystin-4 
knockdown cells exhibit a similar phenotype to PALS1 knockdowns (51).  An established 
link between PALS1 and Nephrocystin-1 and Nephrocystin-4 and their effect on cell 
morphology links the molecular mechanisms of apical-basal cell polarity with the 
aberrant cilia physiology associated with NPHP.  Interestingly, the known NPHP patient 
mutation p.L180P results in a mutation of the Nephrocystin-1 when this mutation is 
recapitulated in vitro the interaction of Nephrocystin-1 and PALS1 is severely decreased 
(51).  As mentioned above, the protein Lin-7 contributes to the stability of PALS1 and 
when Lin-7 is knocked out in mice, the mice also exhibit a cystic kidney phenotype 
(217).  Continued study of how nephropathies are related to the core polarity complex 
proteins will only strengthen these models and provide further areas for study. 
 
1.5 Concluding Remarks 
 
The molecular mechanisms underlying the development of basic renal epithelial 
polarity are numerous.  Although many protein-protein interactions have been mapped, 
we are only now beginning to understand the complexity of these interactions.  
Considering that most of our understanding of the basic molecular mechanisms of 
epithelial polarity have only been discovered and studied in the last twenty years, it will 
be interesting to see what the next twenty will bring.  Now that functional interactions 
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have been mapped, as a research community we will have to evolve to understanding 
how polarity is controlled both spatially and temporally.  Although answers to these 
questions will undoubtedly be complex, they are important questions to ask, as they will 
only further our understanding of development and disease. 
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Chapter 2  
 





Polarization of mammalian epithelia is characterized by the asymmetrical 
partitioning of proteins to specific membrane domains.  The cellular boundary of the 
apical and basolateral membranes in polarized epithelia is demarcated by the tight 
junction that forms a fence between the two membrane compartments.  Junctions within 
and between cells are defined by the localization of, and interactions between, specific 
protein complexes.  The interaction of these proteins is mediated by evolutionarily 
conserved protein-protein interaction domains. Many studies have shown an important 
role for PDS-95/Discs large/ZO-1 (PDZ) domain-containing proteins in tight junctions 
and the polarized localization of proteins (65, 238).  One of the earliest studies to show 
this relationship was the work of Kim and co-workers that demonstrated an important 
role for the Lin-2, Lin-7, and Lin-10 proteins in the basolateral targeting of the 
Caenorhabditis elegans epidermal growth factor receptor (127, 256).  Mutation in any 
one of these genes led to a vulva-less phenotype, presumably due to mistargeting of the 
epidermal growth factor receptor (127, 256).  Lin-2, Lin-7, and Lin-10 all contain PDZ 
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domains and form a conserved heterotrimeric protein complex (25, 31, 127).  Mammalian 
Lin-7 (also known as vertebrate Lin-7 (VELI) or MALS) is a small protein (~197 amino 
acids), and in the worm its PDZ domain directly binds the epidermal growth factor 
receptor (25, 31, 114, 124, 256).  Lin-2 is a member of the membrane-associated 
guanylate kinase (MAGUK) family of proteins, whereas Lin-10 is a multidomain scaffold 
protein (25, 31, 54) (105, 127) (151).  Lin-7 binds to Lin-2 via an L27 domain; however, 
it is important to note that Lin-10 is not associated with Lin-2 and Lin-7 in mammalian 
epithelial cells (55, 260). 
Recent work in mammalian cells as well as Drosophila has identified additional 
binding partners for the Lin-7 L27 domain.  The L27 domain of Lin-7 has been 
demonstrated to bind a family of MAGUK proteins highly related to Lin-2, collectively 
referred to as PALS or Proteins Associated with Lin-Seven (129).  The archetype for 
these proteins is known as PALS1 in mammalian cells and Stardust in Drosophila.  
PALS1/Stardust contains several protein interaction motifs, including two adjacent L27 
domains, and binds to Lin-7 via the L27 domain nearer its carboxyl terminus (L27C) 
(236).  The amino-terminal L27 domain (L27N) of PALS1/Stardust binds to the polarity 
protein PATJ (229).  Additionally, the PDZ domain of PALS1/Stardust binds to the 
carboxyl terminus of Crumbs, an apical transmembrane protein (12, 100, 170).  Studies in 
mammalian and invertebrate systems have shown an important role for the Crumbs-
PALS1-PATJ complex in polarity determination in epithelial cells (253).  In turn, these 
proteins bind to the highly evolutionarily conserved Par3-Par6-atypical protein kinase C 
polarity effector complex via an interaction between PALS1 and Crumbs with Par6 (110, 
153).  In mammalian cells, the loss of PATJ or PALS1 via RNA interference knock down 
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leads to loss of polarization of epithelial cells under certain experimental conditions (254, 
262).  In addition, the loss of these proteins results in defects in tight junction formation. 
Although PALS1 binds to Lin-7, the exact role of Lin-7 in tight junction formation and 
polarity determination by these proteins remains unclear.  As mentioned, Lin-7 also binds 
to other MAGUK proteins related to Lin-2 and PALS1, including PALS2, DLG2, and 
DLG3 (129).  The role of these other Lin-7 binding partners in protein targeting and 
epithelial polarization is still unclear, although some clues have been provided by studies 
of invertebrate systems (13, 143).  
It is not clear at this time why Lin-7 binds to several mammalian MAGUK 
proteins.  Recent reports of Lin-7 knock-out mice indicate Lin-7 might not be crucial for 
epithelial morphogenesis (219).  Accordingly, further work on the exact roles of Lin-7 is 
indicated.  In this study, we examined the role of Lin-7 in Madin-Darby canine kidney 
(MDCK) cells.  After stable transfection of the mammalian epithelial cell line MDCKII 
with Lin-7 small hairpin RNA (shRNA), we found that the resulting loss of Lin-7 
correlated with the loss of expression of several Lin-7-binding proteins, including 
PALS1.  The loss of these polarity proteins resulted in defects in tight junction formation 
in the Lin-7 knockdown cell lines.  From these data, we hypothesize that Lin-7 is 
essential for the stable expression of several MAGUK family members that are in turn 
required for proper formation of tight junctions in mammalian epithelial cells. 
 
2.2 Materials and Methods 
2.2.1 DNA Constructs 
To create the shRNA constructs, two 19-base pair sites within canine Lin-7C were 
chosen, and pairs of complementary oligonucleotides were synthesized by Invitrogen 
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custom primers.  These oligonucleotides contained the following target sequences: 5`-
GGCTCGGTGAAGCTGGTGG-3`, corresponding to the amino acids NH3-GSVKLV-
COOH, and 5`-GGCCACAGTGGCAGCCTTC-3’, corresponding to the amino acids 
NH3-ATVAAF-COOH.  These sequences were checked for significant homology to other 
genes in the canine genome database, and none was found.  The sense and antisense 
sequences were separated by a 9-base pair loop region, and each oligonucleotide was 
terminated with restriction endonuclease half-sites.  After annealing the complementary 
oligonucleotides, the dimers were ligated into the pre-cut pSilencer 2.0-U6/neomycin 
plasmid (Ambion, Austin, TX) as directed by the manufacturer, followed by amplification 
of the resulting plasmids.  All plasmid sequences were verified by automated sequencing 
at the University of Michigan DNA Sequencing Core.   
The various rescue plasmids used in this study express Myc-tagged constructs 
from a cytomegalovirus promoter in the plasmid pRK5-myc and contain the human or 
murine gene indicated in the text and figures.  These constructs, mycLin-7FL, mycLin-
7N (amino acids 1–97), mycLin-7PDZ (amino acids 89–197), mycPALS1, mycLin-2, 
mycPALS2, and mycDlg2, have been previously published (25, 170, 236, 260).  In the 
case of the murine Lin-7 constructs, these contained such significant differences in their 
RNA sequence as to be unaffected by the canine Lin-7-targeted shRNA constructs.   
 
2.2.2 Cell Culture and Transfection 
MDCKII cells were cultured in Dulbecco’s modified Eagle’s medium plus 10% 
fetal bovine serum supplemented with penicillin, streptomycin, and L-glutamine.  All cell 
culture media and supplements were purchased from Invitrogen. To create the cell lines 
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stably expressing shRNA constructs, MDCKII cells were transfected with 5µg of plasmid 
DNA using FuGENE 6 reagent (Roche Applied Science).  Cells were transfected with 
either construct individually or with a mixture of the two constructs to create cell lines. 
After selection with 500 µg of active G418/ml (Invitrogen) for 14 days, surviving clones 
were isolated for the generation of cell lines. These lines were screened for loss of Lin-7 
expression by both immunostaining and Western blot analysis using affinity purified anti-
Lin-7 sera.   
Rescue clones were created by co-transfection of the C19 and C20 shRNA Lin-7 
lines with 5 µg of the Myc-tagged rescue plasmid and 0.5 µg of zeocin resistance 
plasmid, followed by selection with 200 µg of zeocin/ml (Invitrogen) for 14 days and the 
isolation of cell lines. Clones were screened for the expression of the Myc-tagged protein 
and the maintained loss of endogenous Lin-7 expression using both immunostaining and 
Western blot analysis.  For immunostaining or calcium switch assays, MDCKII cell lines 
were seeded at confluence onto 12- or 24-mm Transwell clear polyester filters (Corning 
Inc.; Corning, NY) in low calcium medium (with 5% dialyzed fetal bovine serum, 5 µM 
Ca2+).  After allowing the cells to adhere to the substrate overnight, the non-adherent cells 
were removed by gently washing with PBS and the medium was replaced with normal 
growth medium. The cells were then grown at least 72 h so that a tightly packed 
columnar epithelial monolayer was formed. 
 
2.2.3 Calcium Switch Assay and Transepithelial Electrical Resistance Measurement 
MDCKII cell lines were grown to confluence on 24-mm Transwell filters and 
were then washed extensively with PBS and grown in low calcium medium overnight to 
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dissociate cell-cell contacts.  The low calcium medium was replaced the next day with 
normal growth medium (containing1.8 µM Ca2+), and the cells were prepared for 
immunostaining at various times afterward (typically 0, 3, 6, or 29 h).   
To measure the transepithelial electrical resistance (TER) a similar experiment 
was performed using 12-mm Transwell filters.  The TER was determined with a 
Millicell-ERS volt-ohm meter (Millipore, Billerica, MA) immediately after the addition 
of normal growth medium (time=0) and at 30–60-min intervals for up to 48 h.  Prior to 
each measurement, the Millicell was “zeroed” according to the manufacturer’s directions 
and the background resistance was determined using cell-free filters.  Each cell line was 
measured in triplicate, background was subtracted, and the means and the S.D. from the 
means (n=3) for each time point were plotted using Microsoft Excel. 
 
2.2.4 Antibodies 
Lin-7 (UM199)-, Lin-2 (UM195 and UM196)-, PALS1 (UM349)-, PATJ 
(UM356)-, and CRB3 (UM369)-specific antisera were generated in rabbits and affinity 
purified as previously described (25, 170, 236, 260).  Mouse anti-Myc antibody was 
purified from hybridoma clone 9E10 ascites fluid obtained from the University of 
Michigan Hybridoma Core.  Antibodies directed against ZO-1, occludin, claudin-1, and 
claudin-4 were purchased from Zymed Laboratories Inc. (San Francisco, CA).  
Antibodies to E-cadherin and actin were purchased from Sigma.  Antibodies to Par3 and 
protein kinase C ζ were obtained from Upstate (Lake Placid, NY).  Fluorochrome-
conjugated antibodies used for immunofluorescence were purchased from Molecular 
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Probes (Eugene, OR).  Horseradish peroxidase-conjugated antibodies used in 
immunoblotting were obtained from Amersham Biosciences. 
 
2.2.5 Immunoprecipitation and Immunoblotting 
MDCKII cell lysates were prepared from confluent 15-cm dishes with 1 ml of ice-
cold lysis buffer (50 mM Tris-HCl, pH 7.4, 150 mM NaCl, 10% glycerol, 1% Triton X-
100, 1.5 mM MgCl2, 1 mM EGTA, 1mM phenylmethylsulfonyl fluoride, 10 µg/ml 
leupeptin, 20 µg/ml aprotinin, and phosphatase inhibitor mixture) (Sigma) and cleared by 
centrifugation at 14,000 x g for 20 min at 4 °C.  A portion of the lysate was reserved, 
mixed with LDS loading buffer (Invitrogen), and used as input.  For 
immunoprecipitation, 1–5 µl of antibody was mixed with 200 µl of lysate and 50 µl of 
50% slurry of protein A-Sepharose beads (Zymed Laboratories Inc.; San Francisco, CA) 
and incubated overnight at 4 °C.  The beads were washed three times with ice-cold 
HNTG and resuspended in LDS loading buffer.  Samples were separated on 4–12% 
NuPAGE NOVEX gels (Invitrogen) in MOPS-SDS running buffer and transferred to 
nitrocellulose membranes in Bicine-MeOH.  The transfer efficiency was assessed by 
staining with 0.5% Ponceau S red in 10% acetic acid, and then the membranes were 
blocked by incubation in 5% bovine serum albumin (Calbiochem; San Diego, CA) in 
Tris-buffered saline (TBS).  The membranes were incubated with primary antibody in 5% 
bovine serum albumin/TBS for 2 hr. at room temperature and then washed with 0.1% 
Triton X-100/TBS.  Membranes were incubated with horseradish peroxidase-conjugated 
secondary antibody in 5% skimmed milk/TBS for 1 hr. at room temperature and then 
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washed with 0.1% TritonX-100/TBS.  Protein bands were visualized using ECL reagent 
(PerkinElmer Life Sciences). 
 
2.2.6 CRB3 Peptide Beads 
CRB3 peptide-coupled agarose beads were created using the SulfoLink Coupling 
gel kit (Pierce Biotechnology, Rockford, IL) and were linked via a terminal cysteine 
residue added to a peptide corresponding to the carboxyl-terminal 18 amino acids of 
CRB3 (wild type, NH3-CARVPPTPNLKLPPEERLI-COOH) or the same sequence 
missing the terminal ERLI.  The CRB3 peptides were synthesized at the University of 
Michigan Protein Structure Facility.  For the CRB3 peptide bead pulldown assays, 20 µl 
of 50% slurry of CRB3 peptide beads were added to 200 µl of cell lysate and incubated 
overnight at 4 °C.  The beads were washed three times with ice-cold HNTG (50 mM 
HEPES, pH 7.5, 150 mM NaCl, 0.1% Triton X-100, and 10% glycerol) and resuspended 
in LDS loading buffer.  Samples were separated on 4–12% NuPAGE NOVEX gels, 
transferred to nitrocellulose, and processed for Western blotting as described above for 
immunoprecipitations.   
 
2.2.7 Pulse-Chase Labeling 
The rate of degradation of PALS1protein was determined using a pulse-chase 
protocol.  MDCKII cell lines grown to confluence on 15-cm dishes were incubated for 2 
hr. in methionine-free Dulbecco’s modified Eagle’s medium (Invitrogen) supplemented 
with 10% dialyzed fetal bovine serum.  Cells were then pulse labeled for 1 h at 37°C by 
the addition of 250 mCi/ml 35S-Easytag Express label (PerkinElmer).  Unincorporated 
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label was washed away, and cells were incubated at 37°C for 0–12 h in complete growth 
medium. Cell lysates were collected and utilized as described above for 
immunoprecipitation.  The precipitated proteins were separated by SDS-PAGE, and the 
gel was fixed in 30% methanol/10% acetic acid, soaked for 30 min in Amplify 
(AmershamBiosciences), and dried.  Densitometry was performed using a Molecular 
Dynamics laser scanner, model STORM860, and ImageQuant software (GE Healthcare). 
Each sample was prepared in triplicate (n =3) so that the standard deviation from the 
means could be determined. 
 
2.2.8 Immunostaining and Confocal Microscopy 
Cells grown on Transwell filters were cut from the support with a scalpel, washed 
with PBS, and fixed with 4% paraformaldehyde/PBS for 30 min, permeabilized with 
either 0.1% Triton X-100/PBS or 1% SDS/PBS for 15 min, and then blocked with 2% 
goat serum/PBS for 1 hr.  The filters were then incubated with primary antibodies in goat 
serum/PBS for overnight at 30 °C in a humidified chamber.  After washing extensively 
with goat serum/PBS, fluorochrome-conjugated secondary antibodies in goat serum/PBS 
were added overnight at 4 °C.   Finally, filters were washed with PBS and mounted onto 
glass slides using ProLong antifade reagent (Molecular Probes, Eugene, OR). All images 
were obtained using an Olympus FluoView 500 confocal laser-scanning confocal 
microscope at the Morphology and Image Analysis Core of the Michigan Diabetes 
Research and Training Center.   Samples were scanned with appropriate lasers and filter 
sets, and images were collected at 0.5-µm intervals on an Olympus IX-71 inverted 
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microscope using an x100 oil objective.  FluoView v4.3 software was used to collect 
images, and subsequent preparation was performed using Adobe Creative Suite software. 
 
2.2.9 Quantitative Real-time PCR 
Messenger RNA from cell lines was isolated following the manufacturer’s 
protocol found in the RNeasy kit (Qiagen). cDNA was reversed transcribed from isolated 
mRNA by Superscript III First-Strand Synthesis Supermix (Invitrogen) according to the 
published protocol.  Real-time PCR was performed using Platinum SYBR Green qPCR 
Supermix UDG with Rox (Invitrogen) in an Applied Biosystem 7300 real-time PCR 
system with the following parameters: 50 °C (2 min), 95 °C (10 min), 40 cycles of 95 °C 
(15 s), 54 °C (30 s), 72 °C (1 min), followed by a dissociation cycle to verify one product 
by melting curve analysis. Primers to desired amplicons were designed using PerlPrimer 
software (174) and are as follows: Canis familiaris Lin-7C (5`-
GCCTTACAAAGAGTCCTTCA-3` (forward)), (5`-TGATGTCCACAGTCTCATAG-3` 
(reverse)); C. familiaris PALS1 (5`-TAGAACCCTTTACAGATGAGAG-3`(forward)), 
(5`-ACTATCCGACTAATGATGACA G-3` (reverse)); C. familiaris glyceraldehyde- 
3-phosphate dehydrogenase (5`-ATTCTATCCACGGCAAATCC-3` (forward)), (5`-
GGACTCCACAACATACTCAG-3`(reverse)).  Primer pairs were validated by subjecting 
the quantitative PCR reactions to agarose gel electrophoresis to confirm the presence of 
single products at the expected size.  In addition, each amplicon was sequenced to verify 
its identity.  Experimental samples were performed in duplicate. Results were compiled 




2.3.1 Lin-7 shRNA affects the formation of tight junctions  
Previous work from our group had shown that MDCKII cells, a canine kidney-
derived epithelial cell line, express only one of the three Lin-7 genes, Lin-7C (260).  Lin-
7B is not expressed in the kidney tubule; and Lin-7A is larger than Lin-7C and this size is 
not seen on Western blotting of MDCKII cell lysates with anti-Lin-7 antibodies (220, 
260).  We generated shRNA expression plasmids to specifically target the canine Lin-7C 
sequence (Figure 2-1A) based on the genomic information available in the public 
database.  These shRNA constructs had several mismatches with mouse Lin-7C allowing 
for eventual rescue of the phenotype using murine Lin-7 constructs (Figure 2-1A).  We 
chose two different shRNA constructs (shRNA 1 and shRNA 2, respectively) and 
transfected them into MDCKII cells separately and in combination in order to 
knockdown the endogenous expression of Lin-7.  We isolated several stable cell lines, 
including both controls, that exhibited little or no knockdown (clones 1, 12 and 21), and 
Lin-7 knockdown clones that had greatly reduced expression of Lin-7 (Figure 2-1B, 
clones 6, 10, 17, 19, and 20).   Immunostaining with affinity-purified anti-Lin-7 
antibodies confirmed markedly reduced Lin-7 at cell-cell junctions (Figure 2-2).  In 
contrast, E-cadherin was correctly localized to lateral cell-cell junctions (Figure 2-2), 
suggesting that Lin-7 shRNA had little or no effect on the integrity of adherens junctions.  
We next tested the MDCKII cell lines for the formation of tight junctions using a calcium 
switch assay, in which cells were placed in low calcium medium overnight to dissociate 
the cells by breaking adherens junctions, followed by the readdition of calcium to allow 
the MDCKII cells to form junctions.  Tight junction function was measured by the 
establishment of TER.   
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Figure 2-1:  Lin-7 shRNA clones.  (A) Sequences of canine Lin-7 short 
hairpin RNAs (shRNAs) compared to the murine Lin-7 sequence used for 
rescue experiments. Differences are indicated in bold.  (B) Western blots 
of Lin-7 shRNA MDCKII cells.  The shRNAs used are indicated above.  
Clones 19, 20 were used for future experiments and clone 21 was used as 





Figure 2-2:  Immunofluorescence (IF) staining of Lin-7 shRNA clones 19, 
20, and 21.  Knockdown of Lin-7 reduced cellular levels of Lin-7 but had 














Figure 2-3:  Knockdown of Lin-7 effects tight junction formation but not 
expression of tight junction structural proteins.  (A) Trans-epithelial resistance 
(TER) of Lin-7 shRNA clones.  Control clones (dashed lines with open shapes) 
show normal TER profiles while Lin-7 knockdown clones (solid lines with closed 
shapes) have reduced TER profiles indicating defects in tight junction formation.  
(B) Western blots of tight junction structural proteins in Lin-7 shRNA clones.  




Cell lines in which Lin-7 had been knocked down had markedly abnormal TER profiles 
(Figure 2-3A, solid lines) compared with wild-type and control cells (Figure 2-3A, 
dashed lines).  However, western blotting indicated no change in expression of several 
tight junction component proteins including claudin-1, claudin-4 and occludin in cells 
with or without Lin-7 (Figure 2-3B).  Furthermore, immunostaining of the MDCKII cells 
that had been grown on filters for 7 days showed that the tight junction marker proteins 
claudin-1 and ZO-1 were similarly localized in both control and Lin-7 knockdown cell 
lines (results not shown).  However, using the calcium switch assay, abnormal, 
incomplete localization of ZO-1 was observed in the Lin-7 knockdown cells (Figure 2-4) 
in contrast to control cells.  In conjunction with the TER data, this suggests that Lin-7 
plays a role in the formation of tight junctions and the loss of Lin-7 expression results in 
a delay in tight junction formation during polarization. 
 
2.3.2 Lin-7 shRNA affects expression of MAGUK family members 
We have previously demonstrated that Far-Western blotting with a radiolabeled 
Lin-7 probe could reveal multiple MAGUK proteins that bind to Lin-7 (129).  These 
include Lin-2/CASK, PALS1/MPP5, PALS2/Vam-1, Dlg2/MMP2, and Dlg3/MPP3.  In 
the Lin-7 knockdown cells the expression of these MAGUKs, except for Lin-2, was 
significantly reduced (Figure 2-5A).  Of the MAGUK family members with reduced 
expression, we chose to focus our study on PALS1 because of its known roles in polarity 
and tight junction formation, which had been previously demonstrated, by our laboratory 
and others (12, 100, 235, 237, 239, 262).   The PDZ domain of PALS1 binds to the 




Figure 2-4:  Lin-7 shRNA causes defects in tight junction formation 
during cell polarization.  In cell polarization assays (calcium switch) Lin-7 
shRNA cells fail to form complete tight junctions compared to wild type 
cells as indicated by ZO-1 staining.  (A-C) Wild type MDCKII cells 24 hr. 
post calcium switch.  (D-F) Lin-7 shRNA clone 20 24 hr. post calcium 
switch.  (G) Zoom in of panel F illustrating that complete tight junctions 













complex with PATJ (12, 100, 152, 236).  Using a Sepharose bead coated with a peptide 
corresponding to the carboxyl-terminus of Crumbs3 (CRB3) we are able to precipitate 
PALS1 and PATJ from MDCKII cell lysates.  In accord with Figure 2-5B, Crumbs beads 
precipitated PALS1 from control cells, but not from cells where Lin-7 was knocked 
down.  PATJ expression was also reduced in the Lin-7 knockdown cells, although CRB3 
expression was similar in control and wild type cells (Figure 2-6A).  This agrees with our 
previously published result that PATJ protein levels are reduced when PALS1 expression 
is knocked down (262).  However, the knockdown of Lin-7 did not affect expression of 
Par3 or aPKCζ (Figure 2-6B). 
 
2.3.3 The L27 domain of Lin-7C is essential for correct tight junction formation 
To determine whether these effects were specific to the loss of Lin-7, we rescued 
the Lin-7 shRNA MDCKII cells using mouse Lin-7C constructs.  Murine Lin-7C is 
resistant to the effect of the shRNA constructs we used to knockdown canine Lin-7 due to 
nucleotide sequence differences between species (Figure 2-1A).  We transfected Lin-7 
knockdown cell lines with Myc-tagged mouse Lin-7C constructs: full length Lin-7C 
(mycLin-7FL), the amino-terminus containing the L27 domain (amino acids1-97; 
mycLin-7N) and the carboxyl-terminus containing the PDZ domain (amino acids 89-197; 
mycLin-7PDZ).  Several MDCKII cell clones expressing Zeocin only were also selected 
as controls.  Full length murine Lin-7 and the amino-terminal/L27 domain construct 
rescued the expression of the MAGUK proteins, including PALS1, as determined by Far-
western blotting with radiolabeled GST-Lin-7 (Figure 2-7).  In contrast, the carboxyl-
terminus/PDZ domain construct and Zeocin alone did not rescue MAGUK expression  
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Figure 2-5:  Lin-7 shRNA reduces expression of MAGUK family 
members.  (A) Far Western blot of MAGUK family members that bind 
Lin-7.  Knockdown of Lin-7 effects expression of PALS1, Dlg2, Dlg3, and 
PALS2 but not Lin-2.  (B) Crb3 bead pull-down of PALS1 demonstrates 
that knockdown of Lin-7 correlates to reduced binding and expression of 




Figure 2-6:  Lin-7 shRNA effects expression of PATJ, but not Crb3 or Par 
polarity complex proteins.  (A) Lin-7 shRNA correlates to reduced 
expression in PATJ.  (B) Lin-7 shRNA does not effect expression of Par3 














(Figure 2-7).  PATJ protein expression was also rescued by the Myc-Lin-7FL and Myc-
Lin-7N constructs (Figure 2-7).  Both the Myc-Lin-7FL and Myc-Lin-7N constructs also 
rescued the TER after calcium switch (Figure 2-8, dashed lines and open shapes).  
Additionally, immunostaining for ZO-1 after calcium switch illustrated that Myc-Lin-7FL 
and Myc-Lin-7N constructs rescued normal tight junction formation (Figure 2-9).  Thus, 
these experiments indicate that the L27 domain, but not the PDZ domain, of Lin-7 is 
required to rescue the Lin-7 knockdown phenotype.   
 
2.3.4 Reexpression of PALS1 can reverse the tight junction defect seen in Lin-7 
knockdown cells 
 
Next, we wanted to determine if loss of the MAGUK proteins could explain the 
tight junction defects.  In particular, we suspected that loss of PALS1 was responsible for 
the tight junction defects in that PALS1 is required for tight junction formation (262).  To 
this end, the Lin-7 knockdown cell lines were transfected with a vector expressing 
mycPALS1 and stable cell lines were selected.  Two Lin-7 shRNA cell lines 
overexpressing mycPALS1 were chosen for further study.  In these cell lines, mycPALS1 
rescued the expression of endogenous PATJ (Figure 2-10A).  Endogenous Lin-7 protein 
was still low to undetectable in these PALS1 rescue clones (Figure 2-10B).  mycPALS1 
targeted correctly to the tight junction in the absence of endogenous Lin-7 (Figure 2-10B) 
and was also able to partially rescue the TER after calcium switch (Figure 2-11, dashed 
lines).   In contrast, expression of Myc-tagged PALS2, Dlg2 or overexpressing Lin-2 







Figure 2-7:  Rescue of protein expression with murine mycLin-7 FL and 
mycLin-7N in Lin-7 shRNA cell lines.  Introduction of either full length 
(FL) or the N-terminal half (the L27 domain) of murine Lin-7 can rescue 












Figure 2-8:  TER of murine mycLin-7 rescue constructs.  Both mycLin-
7FL and mycLin-7N (dashed lines with open shapes) can rescue tight 
junction formation but mycLin-7PDZ or control cells (solid lines with 




Figure 2-9:  IF of murine Lin-7 rescues.  Full-length (FL) and N-terminal 
(N) mycLin-7 can rescue the defect in tight junction formation 24 hr. post 
calcium switch.  A mycLin-7 PDZ construct corresponding to the C-












Figure 2-10:  Rescue of Lin-7 shRNA cells with mycPALS1.  (A) 
Expression of mycPALS1 in Lin-7 shRNA cells can rescue protein 
expression of PATJ.  (B) IF of mycPALS1 rescue.  PALS1 correctly 





Figure 2-11:  Expression of mycPALS1 can partially rescue TER profiles 
of Lin-7 shRNA cells.  Overexpression of mycPALS1 in Lin-7 shRNA 
cells (dashed lines with open shapes) partially rescues tight junction 





Figure 2-12:  Other Lin-7 L27 domain binding partners cannot rescue Lin-
7 shRNA tight junction defects.  (A) Far Western blot using GST-Lin-7 on 
Lin-7 shRNA cells overexpressing other Lin-7 binding partners. (B) TER 




shRNA cells (Figure 2-12A-B).  These results indicate that the defects we observed in 
Lin-7 knockdown cells were primarily due to the loss of PALS1. 
 
2.3.5 Lin-7 expression affects stability of PALS1 in polarized MDCKII cells 
Finally we sought to determine the manner by which PALS1 expression was 
reduced in Lin-7 shRNA cells: The loss of Lin-7 might be affecting the PALS1 mRNA or 
the expression and stability of the PALS1 protein.  We performed quantitative reverse 
transcripiton-PCR to measure PALS1 transcripts in both Lin-7 shRNA and a previously 
published PALS1 shRNA cell line (262).  We found no difference in the mRNA levels 
between control and Lin-7 knockdown cells (Figure 2-13A) suggesting PALS1 mRNA 
levels are not altered in Lin-7 shRNA cells.  Control PALS1 knockdown cells illustrate 
our primer pairs were specific for the PALS1 transcript.  Subsequently, we undertook 
pulse-chase radiolabeling to examine the degradation rate of the PALS1 protein.  Our 
antibodies do not immunoprecipitate PALS1, so instead we examined wild type cells and 
Lin-7 shRNA cells transfected with mycPALS1.  Thus we were able to 
immunoprecipitate tagged PALS1 and follow its half-life in the presence and absence of 
Lin-7.  The pulse-chase assay found that the half life of PALS1 was much shorter in the 
Lin-7 knockdown cells in comparison to controls, with only 1.7-3.9% of radiolabeled 
mycPALS1 protein remaining in Lin-7 knockdown cell lines after 12 hours, compared to 
18.7% in control cells (Figure 2-13B and C).  These data indicate that Lin-7 stabilizes the 




Figure 2-13:  PALS1 protein degradation is increase in Lin-7 knockdown 
cells.  (A) Quantitative real-time PCR of Lin-7 and PALS1 transcripts. (B) 
Pulse chase labeling of PATJ and mycPALS1 in Lin-7 shRNA cells. (B) 





Lin-7, a small PDZ domain-containing protein has been shown to play a role in 
the polarized localization of proteins in both invertebrates and mammals.  Here we show 
that Lin-7 regulates the expression of many other MAGUK family proteins, most notably 
PALS1, in polarized mammalian kidney cells.  To study the role of Lin-7 in mammalian 
epithelia, we generated stable Lin-7 shRNA MDCKII and control cell lines.  Lin-7 
knockdown cell lines showed a specific reduction in endogenous Lin-7C and, under static 
conditions, cell-cell junction integrity appeared normal.  However, when subjected to 
calcium switch, where we could monitor phenotypes under polarizing conditions, 
transepithelial electrical resistance and immunostaining data clearly demonstrated that 
Lin-7 shRNA cells were unable to efficiently form tight junctions, suggesting that Lin-7 
affects the formation of tight junctions in polarizing epithelial cells by delaying their 
formation.  
Lin-7 knockdown reduced the expression of MAGUK family proteins that are 
known binding partners of the L27 domain of Lin-7.  The cause for the reduction in 
expression of the MAGUK PALS1 was due to a reduced half-life as seen by pulse chase 
experiments with no difference seen in mRNA levels.  The reduced expression of PALS1 
and other MAGUKs was rescued by expression of the L27 domain of Lin-7 but not by 
expression of the Lin-7 PDZ domain.  It is likely that the binding of the Lin-7 L27 
domain to the PALS1 L27 domain stabilizes the fold of the PALS1 protein making it 
more stable.  As L27 domains interact via large hydrophobic surfaces, it is not hard to 
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understand how L27 domain interactions would stabilize folding of proteins containing 
this domain (66, 156) (229).   
Knockdown of PALS1 leads to a loss of PATJ expression and loss of PATJ was 
also seen in cells missing Lin-7 (262).  This was due to the lack of PALS1 as re-
expression of PALS1, even in the absence of Lin-7, restored PATJ expression.  PALS1 
also binds to PATJ via an L27 domain interaction involving a single L27 domain in the 
amino-terminus of PATJ.  Again it is possible that an unliganded L27 domain in PATJ 
leads to protein misfolding, instability and reduced expression in cells missing PALS1.  It 
is interesting to note however that PALS1 expression in PATJ knockdown cells is only 
moderately affected (254).  This suggests the relationship between L27 domain binding 
and protein stability is complex.  Similarly the expression of the MAGUK protein, Lin-
2/CASK, appeared unaffected by the Lin-7 knockdown although it binds Lin-7 like 
PALS1.  It is interesting to note however that Lin-2/CASK expression was reduced in the 
brains of Lin-7 knockout mice (219).  The differential effects of L27 binding on MAGUK 
stability may point to simple structural differences amongst the proteins or might suggest 
that the L27 domains of these MAGUKs have alternate binding partners. 
The effects we saw with Lin-7 were due to loss of the L27 domain and not the 
PDZ domain.  The role of the PDZ domain of Lin-7 was best described in worms where it 
targets the epidermal growth factor receptor to the lateral surface (256).  Several binding 
partners for the PDZ domain of mammalian Lin-7 have been described.  One binding 
partner is β-catenin although we saw no defects in cadherin staining in cells missing Lin-
7 (227).  Defects in other Lin-7 binding partners such as potassium channels or other 
transporters would not be detected in our studies (218, 228).  It has been found that 
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mammalian epidermal growth factor receptor family members can bind to the first 13 
amino acids of Lin-7C in a region N terminal to the PDZ domain, however deleting this 
region in mouse Lin-7C had no effect on the ability of this Lin-7 to rescue knockdown 
MDCK cells ((251) and S. Straight and B. Margolis, unpublished observations). 
We demonstrated that the tight junction defect of Lin-7 shRNA was due to the 
reduction in endogenous PALS1.   Even without Lin-7, exogenously expressed PALS1 
still trafficked properly to the tight junction and partially rescued tight junction 
formation.  Its inability to completely rescue TER measurements (Figure 2-11) could 
have been due to the presence of the Myc tag or the expression level of the mycPALS1 
protein.  Another possibility could be the loss of other Lin-7 binding MAGUK proteins 
such as DLG2, DLG3 or PALS2 whose function in epithelia is unclear.  Again further 
studies in the Lin-7 knockout mice may be instructive.  These mice with all Lin-7 genes 
removed die shortly after birth due to respiratory failure (219).  These studies indicate no 
gross defects in tissue morphogenesis suggesting epithelial polarity is not overtly 
perturbed.  Defects in tight junctions may not appear until later in knockout animals 
where they manifest as deficiencies in the skin barrier (70).  Although it is likely that 
PALS1 is reduced in these Lin-7 knockout animals, they may have sufficient PALS1 to 
mediate epithelial polarity.  In summary, our results show an expanding role for Lin-7 in 
epithelial function by stabilizing a large number of MAGUK proteins.  Further studies of 
defects in knockout mice will reveal if the defects we observed in tissue culture cells 
extends to the whole animal. 
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Chapter 3  
 





The epithelial monolayer is formed by a combination of timed transcription events 
and protein-protein interactions to facilitate the formation of two biochemically distinct 
membrane domains.  These are the apical domain that faces the lumen, and the 
basolateral domain that faces neighboring cells and the basement membrane.  Protein 
complexes, containing a subset of conserved proteins from invertebrates to higher 
mammals, control segregation of epithelial cells into distinct apical versus basolateral 
domains by the formation of tight junctions.  The Crumbs polarity complex consisting of 
Crumbs3a, Protein associated with Lin-7 1, and PALS1 associated tight junction protein 
(Crb3-PALS1-PATJ) controls tight junction formation (235).  Knockdown of either 
PALS1 or PATJ in epithelia causes a delay in tight junction formation (254) (262). Cells 
deficient in Crb3 fail to form tight junctions and do not polarize properly (133, 294). 
Both Crb3 and PALS1 interact with Par6, a member of the Par complex (110, 153).  In 
addition to Par6, the Par complex contains the proteins Par3 and atypical Protein Kinase 
C isoform zeta (aPKCζ).  The Par complex also interacts with Lethal Giant Larvae (Lgl), 
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a member of the SCRIB-Lgl-Discs large (Dlg) protein complex (300).  The Crumbs 
complex confirms the formation of the apical domain, while the Scribble complex 
modulates the formation of the lateral membrane.  The function of the Par complex is to 
maintain the balance between membranous surfaces (10, 38). 
Maintenance of epithelial membrane surfaces is essential to maintain epithelial 
morphology.  The epithelial to mesenchymal transition (EMT) is the genetic 
rearrangement of epithelial cells resulting in loss of polarity with increased invasion, lack 
of contact inhibition, and resistance to apoptosis (197). The reciprocal process, 
mesenchymal to epithelial transition (MET) has also been extensively characterized. 
Maintaining EMT/MET balance is essential in development and wound healing while the 
loss of the EMT/MET balance manifests in fibrotic disease and cancers of epithelial 
origin (165, 274, 275).  In cancer or fibrotic disease EMT has been shown to cause a 
drastic and prolonged repression of proteins essential for maintaining polarity (108, 188).  
During EMT/MET there is also a rearrangement of the cytoskeleton and an acquisition of 
invasive properties such as expression of the intermediate filament vimentin, an increase 
in smooth-muscle actin, and migration of the microtubule organizing center (302).  
Activation of signaling pathways results in upregulation of transcriptional repressors 
responsible for the genetic rearrangements associated with EMT (303).   
One family of transcription factors implicated in EMT is the zinc-finger 
transcription factors Snail (Snai1) and Slug (Snai2).  Snail and Slug bind E-box motifs in 
the promoters of genes necessary for maintaining epithelial integrity including Cdh1, the 
gene for E-cadherin, and the major epithelial cell adhesion protein (24, 33, 89).  It 
appears that Snail and Slug, although related, may have divergent targets suggesting a 
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level of specificity (196).  Slug was identified as an EMT factor in the neural crest of the 
migrating mesoderm of chick embryos and has subsequently been described in numerous 
cancers (6, 208).  Validated targets of Slug include tight junction structural proteins of the 
claudin and occuldin families (177, 243, 291).  Slug has also been shown to block 
transcription in a transient capacity, allowing for EMT at the leading edge of cutaneous 
wounding to faciltate wound closure (242). 
Epithelial tissues must polarize to function properly.  For example, thyroid 
follicular epithelial cells (thyrocytes) require a defined apical membrane and tight 
junction to secrete thyroglobulin into the follicular lumen for iodination and storage.  
Some cultured thyroid follicular epithelial cells lack tight junctions, and these cells can be 
used to identify factors in tight junction biogenesis.  FRTL5 cells exhibit little apico-basal 
polarity and fail to form proper tight junctions, yet do not exhibit markedly increased 
invasiveness (9, 306).  FRT cells have normal apico-basal polarity and form proper tight 
junctions (74) (209).  Although FRT cells remain fully polarized, they have lost the 
ability to synthesize thyroglobulin and concentrate iodine therefore they cannot be 
utilized to study polarized trafficking (7).  Non-polarized FRTL5 cells lack tight junctions 
and apical membranes but synthesize high levels of thyroglobulin making them valuable 
for the study of polarized trafficking (306).  Due to production of large amounts of 
secreted protein and to study cellular phenomenon such as polarization and polarized 
trafficking, it would be beneficial to understand why FRTL5 cells do not possess tight 
junctions and polarity.  Since FRTL5 cells lack discernable tight junctions yet are 
minimally invasive, FRTL5 cells may also effectively mimic transient EMT found in both 
development and wound healing.  Through genomic studies of transient EMT states we 
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can potentially elucidate genetic rearrangements that underscore the factors governing 
tight junction biogenesis.   
For this study we chose to ask the question as to what genes of unpolarized 
FRTL5 thyroid cells experience reduced expression in order to keep FRTL5 cells devoid 
of tight junctions as compared to polarized FRT cells.  We preformed a screen for 
components of the conserved polarity complex proteins known to establish tight junctions 
and revealed drastically different protein profiles between FRT and FRTL5 cells.  A 
microarray analysis illustrated significant differences in gene expression of tight junction 
proteins between these two cell lines.  Additionally, the unpolarized phenotype of FRTL5 
cells seems to be a result of the endogenous expression of the oncogene and EMT 
transcriptional repressor Slug (Snai2). To confirm the role of Slug in repressing cell 
polarity, we overexpressed Slug in a normally polarized Madin-Darby canine kidney cells 
(MDCKII cells) and found Slug directly inhibits polarity by binding the promoter of 
Crb3.  
 
3.2 Materials and Methods 
3.2.1 Cell lines 
Wild-type FRT, FRTL5, and PCCL3 cells were a gift obtained from P. Arvan 
(University of Michigan).  FRT cells were maintained in F-12 Coon’s Modified Ham’s 
Medium (Sigma-Aldrich, St. Louis, MO) supplemented with 2.68 g/L sodium 
bicarbonate (Sigma-Aldrich), 10% Fetal Bovine Serum (FBS), Gibco-Invitrogen)), and 
1% Penicillin/L-Glutamine/Streptomycin (Gibco-Invitrogen).  FRTL5 and PCCL3 cells 
were maintained in F-12 Coon’s Modified Ham’s Medium (Sigma-Aldrich) 
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supplemented with 2.68 g/L sodium bicarbonate and 5% Fetal Calf Serum (FCS), Gibco-
Invitrogen)), 1% Penicillin/Glutamine/Streptomycin (Gibco-Invitrogen) and a hormone 
cocktail including: thyroid stimulating hormone (TSH), 1 µg/mL insulin, 5 µg/mL apo-
transferrin, and 1 nM hydrocortisone.  All hormones were purchased from Sigma-Aldrich 
and dissolved in MOSH buffer (1% BSA, 1x Hank’s Buffered Saline (Gibco-Invitrogen)) 
in the appropriate amounts, filter sterilized in 1000x concentrations, and stored at -20 C 
prior to single use.  MDCKI and MDCKII cells were maintained in DMEM (Gibco-
Invitrogen) with 10% FBS and 1% Penicillin/L-Glutamine/Streptomycin (Gibco-
Invitrogen).  For retroviral transduction, 293T cells were transfected with 1 µg pGag-Pol, 
1 µg pVSV, and 1 µg of the either expression plasmid or vector control plasmid using 
FuGene6 (Roche Applied Sciences, Madison, WI).  24 hr. post transfection, viral 
supernatants were collected, sterile filtered, diluted 2-fold with complete media 
containing 8 ng/mL polybrene, and placed directly on MDCKII cells.  2 days post 
infection; MDCKII cells were trypsinized and plated in selection media.  For MDCKII 
cells expressing Slug-V5 selection medium containing 200 µg/mL hygromycin was used.   
MDCKI cells constitutively expressing Snail-Flag used as controls were a gift from E. 
Fearon (University of Michigan). 
 
3.2.2 DNA Constructs 
Plasmid cDNA containing the H.s. Slug and was a kind gift from the E. Fearon 
(University of Michigan) as published in Hajra, et al., 2002 (89).  H.s. Slug was PCR 
amplified using the Roche High Fidelity PCR Kit via manufacturers protocol and a V5-
tag was added to the C-terminus of the products via this PCR step.  The primer sequences 
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are as follows:  Forward (5`-TTATTGGATCCCCACCATGCCGCGCTCCTTCCTG- 
GTC-3`) and Reverse (5`-TTAATTGGATCCTCAAGTTGAATCCAATCCCAACAA- 
TGGGTTTGGGATTGGCTTTCCTCCTCCGTGTGCTACACAGCAGCCAGATTC-3`).  
PCR products were ligated into pQCXIH  (Clonetech).   The University of Michigan 
Automated DNA Sequencing Core confirmed sequences. 
 
3.2.3 Antibodies and Immunostaining 
Antibodies against Crb3a (UM-369), PALS1 (UM-349), and PATJ (UM-356) 
were affinity purified and used as described previously (170, 236).  An anti-V5 antibody 
was purchased from Bethyl Labs.  The anti-actin and anti-E-cadherin antibodies were 
purchased from Sigma.  Anti-mouse and anti-rabbit secondary were used at 1:20,000 in 
5% fat-free milk and purchased from Molecular Probes.  For immunostaing, cells were 
seeded on Transwell filters (Corning, Corning, NY) and allowed to polarize over 4 days.  
Filters were excised, washed twice with PBS, fixed for 20 min. with 4% 
paraformaldehyde and permiablized with 0.1% SDS/PBS for 5 min.  Filters were then 
washed twice with PBS and blocked in PBS supplemented with 2% goat serum (PBSG) 
for 2 – 24 hrs.  Primary and fluorophore-conjugated secondary antibodies (Molecular 
Probes) were diluted in PBSG to appropriate concentrations. All images were obtained 
using an Olympus FluoView 500 confocal laser-scanning confocal microscope at the 
Morphology and Image Analysis Core of the Michigan Diabetes Research and Training 
Center.   Samples were scanned with appropriate lasers and filter sets, and images were 
collected on an Olympus IX-71 inverted microscope using an 100x oil objective.  
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FluoView v4.3 software was used to collect images, and subsequent preparation was 
performed using Adobe Creative Suite software. 
 
3.2.4 Microarray and Statistics 
All microarray analysis and statistics were performed at the University of 
Michigan Microarray Core using GeneChip Rat Gene 1.0 ST Array (Affymetrix, Cat.#  
901172).  Total cytoplasmic RNA was extracted from FRT and FRTL5 cells using the 
RNeasy kit from Qiagen according to the manufacturer’s protocol for isolation of total 
cytoplasmic mRNA.   Gene arrays were completed in duplicate.  Quality control steps 
were done to ensure accuracy.  In brief, perfect match (PM), robust mulit-array average 
(RMA), and principal component analysis (PCA), were completed to ensure quality of 
the datasets (115).  Data was analyzed by filtering the probe set for those with a variance 
less than 0.05 and then fit to a linear model of microarray analysis (257).  Probesets were 
then selected using an adjusted p-value of 0.05%, adjusted for a false discovery rate, and 
a 4-fold difference (232).  Analysis was done using the affy and limma packages of 
Bioconductor.  Outputs were presented using Microsoft Excel.  Relative differences in 
gene expression were determined by the t-statistic, where positive values represent genes 
highly expressed in FRT cells relative to FRTL5 cells and negative values represent genes 
highly expressed in FRTL5 cells relative to FRT cells. 
 
3.2.5 qRT-PCR  
Quantitative real-time PCR experiments were performed as described (261).  
Primer pairs used are as follows:  R.n. Snai2 - (Forward: 5'- CTTCAAGGACACATT- 
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AGAACAC 3' Reverse: 5' GGTATTTCTTTACATCAGAGTGGG 3'), R.n. GAPDH- 
(Forward: 5'-GCCATATTCATTGTCATACCAG-3' Reverse: 5'-ATTCTTCCACCTTT-
GATGCT-3'), R.n. Cdh1- (Forward: 5'-AGAAGCCATTGACAAGTACCT-3' Reverse: 5'-
ACAGATCCCTCAAAGACCTC-3').  R.n Crb3- (Forward: 5`- 
GAGACAACAGCCTCTGATGA-3`) Reverse: 5`- GGTCACAGTAGGAGACACAG-
3`).  For end point PCR, qPCR primers were used to amplify target genes from cDNA 
isolated for qRT-PCR experiments using Taq polymerase (Invitrogen).  To verify the 
identity of PCR products, bands were excised from agarose gels and cloned into the 
pGem-Teasy vector system (Roche) and submitted for automated sequencing.   
 
3.2.6 ChIP Assays 
ChIP was performed in duplicate exactly as described (223) except 
for minor modifications in the sonication procedure. In brief, control MDCK cells and 
MDCK cells overexpressing V5 tagged-slug were fixed for 10 min at 25°C with 
1% formaldehyde in culture medium. Crosslinking was stopped by the addition of 
glycine to 0.125 M. Cells were washed twice with ice cold PBS, scraped, and harvested 
by centrifugation. The cell pellet was washed in PBS, resuspended in cell lysis buffer (5 
mM PIPES [pH 8.0], 85 mM KCl, 0.5% NP40, and protease inhibitors), incubated at 4°C 
for 5 min, and centrifuged for 5 min at 3000 g. The nuclei were resuspended in nuclei 
lysis buffer (50 mM Tris-HCl [pH 8.1], 10 mM EDTA, 1% SDS, protease inhibitors) and 
were sonicated on ice with five 20 s pulses using a microtip probe sonicator (Branson 
Sonifier 250) with output control set to 2.5. Sonicated lysates were clarified by 
centrifugation at 4o°C for 15 min. Fifteen micrograms of chromatin was diluted in IP 
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dilution buffer (0.01% SDS, 1.1% Triton X-100, 1.2 mM EDTA, 16.7 mM Tris-HCl [pH 
8.1], and 167 mM NaCl) and preclarified with 40 µl protein A-agarose (Invitrogen). Each 
immunoprecipitation was performed with 5 µg antibodies. After overnight incubation at 
4°C, 40 µl protein A-agarose beads were added and the incubation was continued for 1 hr. 
The beads were sequentially washed once in IP dilution buffer, once in TSE-500 wash 
buffer (0.1% SDS, 1% Trition X-100, 2mM EDTA, 20 mM Tris-HCl [pH 8.1], 500 mM 
NaCl), once in LiCl buffer (100 mM Tris-HCl [pH 8.1], 500 mM LiCl, 1% NP-40, 1% 
Na deoxycholate), and finally two times in Tris-EDTA. Bound complexes were eluted by 
vortexing beads twice for 15 min at 25°C in 250 ul of elution buffer (100 mM Na 
bicarbonate and 1% SDS). NaCl (5 M) was added to a final concentration of 0.2 M to the 
pooled eluates, and crosslinks were reversed by incubating samples at 65oC overnight. 
The samples were digested with proteinase K for 1 hr at 56oC, and phenol-chloroform 
extracted. DNA was precipitated and reconstituted in sterile water. Real-time PCR 
quantitation of precipitated genomic DNA relative to inputs was performed in triplicate 
using IQ SYBR GREEN with ROX mastermix (Bio-rad) in a Real Time PCR machine 
from Applied Biosystems as described (223). 
Primer sequences for amplification are as follows (294): 
Canis familiaris Crumbs3 promoter 5’-CGG TAA TGT CTC CAC ACT AA-3’ 
(forward) 5’-CCC AAT TCT ATA ATA CGG AAG AG-3’ (reverse) Canis familiaris 
Crumbs3 “- 10 Kb” 5’-GTA TAT CGC ACA CGA TTT CCC-3’ (forward) 5’-CAC ACG 
CAT ACA TAG ATA CGA-3’ (reverse) Canis familiaris GAPDH promoter 5’- 
CAT TAC CCA TTT AGC CAA TTC C-3’ (forward) 5’-TGA AAC AAC TGA GCA 




3.3.1 FRTL5 thyroid epithelial cells are lacking polarized epithelial markers 
Previous studies on FRTL5 thyroid epithelial cell have illustrated that although 
FRTL5 cells express the genes required for production of thyroid hormones such as 
thyroglobulin, they lack the ability to exocytose thyroglobulin in a directed manner 
through the apical membrane (7, 8).  Presumably, the lack of polarization of FRTL5 cells 
is the cause of the lack of targeted secretion of thyroglobulin.  We therefore initially 
chose to survey FRTL5 cells for their expression of key polarity proteins that have been 
shown to lead to the formation of suitable tight junctions and therefore a correct columnar 
epithelial phenotype. For controls, another non-polarized thyroid epithelial cell line, 
PCCL3, was included as well as fully polarized MDCKI cells and non-polarized MDCKI 
cells overexpressing the EMT factor Snail. Initial Western blot experiments indicate that 
FRTL5 cells are lacking in the essential polarity markers including Crb3 and E-cadherin 
(Figure 3-1A).  Additionally, the tight junction proteins PALS1, PATJ, and Par3 appear to 
be altered in both protein level and expression of isoforms in FRTL5 cells when 
compared to fully polarized FRT cells (Figure 3-1A).   The protein expression profile of 
FRTL5 cells when compared to FRT cells was curiously similar to the protein expression 
profile of an epithelial cell that had undergone epithelial to mesenchymal transition 
(EMT) by overexpression of the transcription factor Snail (294).  We therefore chose to 
test FRTL5 cells for the presence of EMT markers to see if FRTL5 had similar  
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Figure 3-1:  Altered expression of conserved polarity proteins and tight 
juction structural protines in wild type FRTL5 thyrocytes.  (A). Western 
blots of polarity and tight junction proteins. (B) FRTL5 cells are lacking 
tight junctions compared to FRT cells.  (C) Immunofluorescent staining of 
polarity proteins in FRT and FRTL5 cells. 
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characteristics as cells that have undergone EMT.   In FRTL5 cells we see an introduction 
of an alternate cadherin species; presumably N-cadherin.  This “cadherin switch” is often 
indicative that a cell has undergone some stages of EMT (Figure 3-1A).  
Immunofluorescence staining of both FRT and FRTL5 cells argeed with our 
Western blotting data.  Control FRT cells show the presence of a normal tight junction  
structure and correct subcellular localization of the tight junction markers Claudin-4 and 
ZO-1 while Claudin-4 and ZO-1 staining in FRTL5 cells shows that these cells lack a 
proper tight junction (Figure 3-1B).   Also PALS1, normally associated with the tight 
junction in the cortical region of cells is now in the cytosol in FRTL5 cells.  In addition to 
tight junction markers, FRTL5 cells lack cortical staining of endogenous E-cadherin, the 
major epithelial adhesion molecule while FRT cells express E-cadherin along their lateral 
membrane (Figure 3-1C).   
 
3.3.2 Altered transcription of junction components in FRTL5 cells 
We next chose to study global gene expression differences between FRT cells and 
FRTL5 cells to more fully understand which genes are involved in the loss of polarity in 
FRTL5 cells. We preformed a microarray analysis comparing mRNA expression levels 
between wild type FRT and wild type FRTL5 cells to determine differences in gene 
expression that could possibly explain why FRTL5 cells lack tight junctions.  The full 
output of our microarray is included in Appendix A.  Searching our data set for polarity 
proteins, we discovered that not only were FRTL5 cells were not expressing the key 
polarity genes Cdh1 and Crb3, but they were also reduced in expression of genes 




Symbol Description t-statistic Fold Change 
Sdc2 syndecan 2 -64.02 -9.09 
Cdh1 cadherin 1 62.82 8.57 
Cldn8 claudin 8 57.71 8.64 
Icam1 intercellular adhesion molecule 1 -42.2 -5.83 
Cldn4 claudin 4 41.83 7.49 
Cldn1 claudin 1 38.68 5.36 
Crb3 crumbs homolog 3 (Drosophila) 37.45 5.23 
Dsc2 desmocollin 2 -37.38 -5.46 
Gjb5 
gap junction membrane channel 
protein beta 5 31.44 4.88 
LOC304000 cell adhesion molecule JCAM 30.3 4.5 
Cldn7 claudin 7 27.23 6.03 
Cdh2 cadherin 2 -25.08 -3.7 
Jam3 junctional adhesion molecule 3 -24.65 -3.38 
Cldn6_predicted claudin 6 (predicted) 23.48 3.97 
Cldn3 claudin 3 23.4 4.01 
Dsp desmoplakin 22.22 5.05 
Gjb3 
gap junction membrane channel 
protein beta 3 22.02 4.07 
Fgfr1 Fibroblast growth factor receptor 1 -21.61 -4.28 
Sdc1 syndecan 1 21.35 5.13 
Prkch protein kinase C, eta 20.87 2.82 
Plcb4 phospholipase C, beta 4 -20.46 -4.06 
Itga6 integrin, alpha 6 -19.68 -2.67 
Gja4 
gap junction membrane channel 
protein alpha 4 17.79 3.01 
Prkch protein kinase C, eta 17.47 2.43 
Prkcz protein kinase C, zeta -17.31 -2.59 
Cdh23 cadherin 23 (otocadherin) 16.96 2.57 
Table 3-1:  Polarity proteins differentially regulated in FRT cells relative 
to FRTL5 cells.  The table represents 25 genes known to influence cell 
polarity with the largest differences in expression. Genes upregulated in 
FRT cells are in white and have positive values.  Genes upregulated in 
FRTL5 cells are shaded in gray and have negative values.  The absolute 
value of the t-statistic represents the relative level of difference where a 
greater absolute value represents greater difference in gene expression 
















Symbol Description t-statistic Fold Change 
Tg thyroglobulin -58.84 -8.88 
Thrsp thyroid hormone responsive protein -42.24 -7.99 
Titf1 thyroid transcription factor 1 -32.73 -4.91 
Tpo thyroid peroxidase -31.72 -6.83 
Foxe1 
forkhead box E1 (thyroid transcription 
factor 2) -21.51 -4.18 
Tshr thyroid stimulating hormone receptor -20.01 -4.88 
Table 3-2:  Thyroid horome specific genes upregulated only in FRTL5 














(Table 3-1.  Notably, the Cdh2 gene, which codes for N-cadherin was upregulated in 
FRTL5 cells further confirming the presence of the “cadherin switch” in FRTL5 cells 
(Table 3-1). For controls of we looked at a subset of genes that are only expressed in 
FRTL5 cells and are involved in the synthesis of thyroid hormones (Table 3-2).  The 
genes for thyroglobulin (Tg), thyroid hormone responsive protein (Thrsp) thyroid 
transcription factor 1 (Titf1), thyroid peroxidase (Tpo), forkhead box E1 (thyroid 
transcription factor 2; FoxE1), and thyroid stimulating hormone receptor (Thsr) were all 
specifically upregulated in FRTL5 cells indicative of TSH sensitivity and the ability to 
produce and process thyroglobulin.   
  
3.3.3 Snai2 is upregulated in FRTL5 cells 
Lack of expression of genes coding for polarity and tight junction proteins 
indicated that FRTL5 cells might be exhibiting some of the characteristics of EMT 
including lack of proper junctions, lack of contact inhibition, and genetic rearrangement 
(149).  To investigate if FRTL5 cells had undergone EMT, we searched our microarray 
for known inducers of EMT that may cause loss of apico-basal polarity.  The first 
indication that FRTL5 cells had undergone EMT was the alteration of expression in genes 
of the transforming growth factor Beta/bone morphogenic protein (TGF-β/BMP) 
pathways (See Appendix A). TGF-β has previously been demonstrated to upregulate 
endogenous expression of EMT transcription factors such as Snail (reviewed in (287, 
303)).   According to microarray data, FRTL5 cells were expressing increased levels of 
the TGF-β pathway (pro-EMT) genes including Connective Tissue Growth Factor 
(CTGF), Id4, and Smad3 (287). Conversely, FRT cells were expressing genes involved 
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with BMP signaling (anti-EMT) such as Gata3, Id2, and Gata4 (287). Upon analysis of 
the microarray data, we found annotated genes encoding the EMT transcription factors 
Snail (Snai1), Twist (Twist1), Transcription Factor 8 (ZEB1, Tcf8), and FoxC2 (FoxC2).  
All genes coding for these EMT transcription factors were not significantly different 
according to our microarray statistical breakdown (Table 3-3).  However, one notable 
omission from microarray chip was the gene Snai2, which codes for the EMT 
transcription factor Slug.  Slug has been previously shown to downregulate the Cdh1 
gene and lead to an EMT phenotype (24).  Since our array did not contain the Snai2 gene, 
we screend for the presence of Snai2 transcript via PCR.  Using primers designed 
specifically for rat Snai2, we were able to amplify a 127 base pair fragment of Slug 
FRTL5 cDNA reverse transcribed from total FRTL5 cytoplasmic mRNAs but not from 
cDNA derived by the same method from FRT cells.   qRT-PCR experiments verified that 
there is a 60% increase in endogenous Snai2 in FRTL5 cells compared to FRT cells. 
 
3.3.4 Slug expression leads to polarity defects in MDCKII cells 
 To further elucidate the role of Slug in the repression of genes responsible for 
proper epithelial morphology, we chose to exogenously express Slug in Madin-Darby 
canine kidney cells (MDCKII cells).  A V5-epitope tagged version of human Slug was 
stably transduced into MDCKII cells.  Overexpression of Slug in MDCKII cells lead to a 
change in epithelial morphology including loss of ZO-1 staining at the tight junctions in 
Slug-V5 cells when compared to control cells (Figure 3-3A).  Also, staining for E-
cadherin shows a loss of E-cadherin at the cortical membrane in Slug-V5 cells (Figure 






  Expression Values 
Symbol Description FRT-A FRT-B FRTL5-A FRTL5-B 
Snai1 snail homolog 1 (Drosophila) 6.74780035 6.848649 6.614032 6.72288 
Twist1 
twist gene homolog 1 
(Drosophila) 4.47924204 4.457792 4.300423 4.34056 
Tcf8 
(ZEB1) transcription factor 8 6.59271 6.613233 8.521425 8.541948 
Foxc2 forkhead box C2 5.225509 4.869783 4.734558 4.740721 
Table 3-3: Annotated genes for EMT trancription factors in FRT cells 

















Figure 3-2:  PCR of Snai2 (Slug) transcripts from wild type FRTL5 cells.  
(A) End point PCR from cDNA derived from total cytoplasmic mRNA of 
FRT and FRTL5 cells.  (B) qPCR of transcripts for Crb3 and Snai2 in wild 





Figure 3-3:  Slug overexpression leads to EMT in MDCKII cells.  (A) 
Slug-V5 expression leads to morphology changes and reduction of tight 
junction ZO-1 and adherens junction E-cadherin.  (B) Differential lysis of 
MDCKII cells expression Slug-V5.  Cells were lysed in an SDS soluble 
fraction (lanes 1 and 2) and a Triton-X soluble fraction (lanes 3 and 4)  to 
determine if Slug-V5 expression results in loss of protein or change in 





cells did not grow in a into a nice cobblestone monolayer typical of vector only control 
cells (Figure 3-3A).  These morphological changes are indicative of cells that have gone 
through EMT.   
Expression of Slug resulted in morphological changes of MDCKII cells; therefore 
we tested the affect of Slug on expression on the levels of Crb3 and E-cadherin proteins. 
Using Western blot analysis we discovered that exogenous Slug expression leads to a 
reduction in protein of both E-cadherin and Crb3 (Figure 3-3B).  To rule out that 
expression of Slug-V5 was affecting the localization of both E-cadherin and Crb3, we 
used a crude differential lysis to differentiate between a triton-soluble cytosolic fraction 
and an SDS-soluble membrane associated fraction to determine if Slug-V5 expression 
was only causing a change in subcellular localization and not a reduction in Crb3a 
protein.  Using this method, we verified that Slug-V5 expression lead a decrease in E-
cadherin and Crb3 protein levels and not a change in subcellular localization. 
 
3.3.5 Slug-V5 directly represses Crb3 in MDCKII cells 
 Since Slug is a known transcription repressor associated with EMT, and EMT 
involves reduced levels of cellular Crb3a, we wanted to know if Slug could directly 
repress transcription of Crb3 by binding the Crb3 promoter in MDCKII cells.  To test our 
hypothesis, we used chromatin-immunoprecipitation (ChIP) assay to verify the presence 
of Slug on the Crb3 promoter region.  We used V5 antibodies to pulldown crosslinked 




Figure 3-4:  ChIP of Crb3a promoter with Slug-V5.  Slug-V5 binds an E-
box in the Crb3 promoter previously identified as a Snail binding site.  
GAPDH and a 10 kb upstream sequence on the Crb3 promoter were used 
as controls. 
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to effectively pulldown and amplify the promoter of the Crb3 gene (294).  These results 
indicate to us that Slug directly affects polarity at least in part by directly repressing 




 Here we investigated the components that affect an epithelial cells ability to form 
junctions and properly polarize.  We found the expression of conserved polarity proteins 
is different in polarized FRT cells relative to non-polarized FRTL5 cells.  Through 
genomic analysis, we determined a subset of proteins necessary for junction formation, 
including the polarity determinant Crb3.  Furthermore, we show that induction of EMT 
by exogenous expression of the EMT transcription factor Slug specifically targets Crb3 
in epithelial cells.  Reduction in Crb3 protein leads to disruption of morphology and a 
reduction of polarity proteins (133, 294).  During the epithelial to mesenchymal transition 
(EMT) epithelial cells lose their epithelial morphology and take on a mesenchymal 
appearance complete with an increase in cell size, loss of contact inhibition, and 
increased invasiveness (1, 275) (302).  EMT has been shown to be an important process 
in development and wound healing, but also detrimental as illustrated in both cancers of 
epithelial origin and cystic disease (165).  Understanding the factors that contribute to 
EMT has become important to understanding these phenotypes in vivo.  Loss of epithelial 
morphology is concurrent with the dissolution of epithelial tight junctions that delineate 
apical versus basolateral domains (113, 177).  Proteins that control the structure, position, 
and formation of the tight junction therefore have become attractive targets to study the 
phenomenon of EMT. 
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 For this study, we chose to compare polarized FRT cells and non-polarized 
FRTL5 cells.  Both cell lines are derived from the thyroid of Fischer rats.  We found that 
FRTL5 cells, which lack proper tight junctions, have altered protein expression profiles 
of the conserved polarity proteins Crb3, PATJ, and Par3.  Our lab and others have 
previously demonstrated that each of these proteins are essential in the formation and 
maintenance of tight junction in other polarized epithelial cells such as MDCKs 
(reviewed in (10)).  Tight junctions are also comprised of transmembrane scaffolds that 
are necessary for tight junctions structure.  Protein analysis confirmed that structural 
claudin-4 is also missing from FRTL5 cells indicating that FRTL5 cells also have defects 
in tight junction structure.  Additionally, when blotting for the major cell-to-cell adhesion 
molecule E-cadherin, we noticed that FRTL5 cells were deficient in E-cadherin, while at 
the same time we found an increase in Pan-cadherin signal.  We believe that our Pan-
cadherin antibody preferentially blots N-cadherin due to lack of signal in our control cells 
clearly expressing high levels of endogenous E-cadherin.  This presumed increase in N-
cadherin lead us to blot for the EMT marker vimentin, and we found an increase in 
vimentin signal in FRTL5 cells.  These results suggested to us that FRTL5 cells exhibit 
characteristics indicative of EMT. 
Determining the roles of polarity proteins in tight junction formation has involved 
the use of RNA interference to reduce protein levels. FRT and FRTL5 represent 
immortalized mammalian cells of the same tissue that represent vast differences in 
genetic profiles. We exploited these differences in FRT and FRTL5 cells to illustrate the 
genetic rearrangements involved with the EMT and specifically EMT loss of epithelial 
junctions. Using cultured FRT and FRTL5 cells; we used a rat microarray identify a large 
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number of candidate genes that could possibly explain why FRTL5 cells lack epithelial 
polarity relative to the polarized FRT cells.  The data generated by our microarray 
analysis demonstrates that FRTL5 cells lack expression of genes for the tight junction 
structural proteins claudins-1, -3, -4, -6, -7 and -8.  Claudin-1 specifically binds PATJ at 
the tight junction, and this interaction may contribute to the localizaton of the Crumbs 
polarity complex (236).  Screening our microarray for conserved Crumbs complex 
polarity proteins, we find the gene for Crb3 and not the genes for PALS1 or PATJ as 
down regulated in FRTL5 cells.  PALS1 and PATJ transcript levels are partially reduced 
in the presence of a Snail in MDCKII cells, however there is no direct evidence that 
PALS1 and PATJ are under direct repression by Snail in EMT (294).  PATJ has been 
demonstrated to be under specific control by ZEB1, however neither ZEB1 nor PATJ are 
indicated as having significant changes in expression in our microarray (4).  This is 
consistent with previous data that clearly demonstrates PALS1 and PATJ are under post-
translational control in MDCKII cells by stabilization through binding to each other and 
other associated proteins (261, 262).  Crb3, in contrast, has been demonstrated to be 
under direct genetic suppression during Snail and ZEB1-induced EMT in MDCK cells (4, 
294).  Likewise, previous studies have shown that Crb3 protein levels are highly 
regulated in polarized epithelial cells and both over abundance or lack of Crb3a lead to 
defects in epithelial morphology and function (235).  Emerging evidence has suggested 
that Crb3a is essential for the establishment of the apical surface and the maintenance of 
that surface.  Exogenous Crb3a can lead to de novo junctions in MCF10A cells (69).  
Crb3a confirms the establishment of the initial apical lumen in lumen formation assays 
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(246).  Finally, overexpression of Crb3 alone is enough to partially rescue Snail-induced 
EMT (294).  
Crb3 is a known target of Snail and ZEB1 mediated transcriptional repression (4, 
294) yet upon comparison of FRT and FRTL5 cells we found no significant differences in 
expression levels of EMT factors Snail, Twist, ZEB1, or FoxC2.  The transcription factor 
Slug was absent from our array perhaps due to lack of annotation at the time of our 
experiment. We performed a PCR based screen for Slug in FRT and FRTL5 cells and 
found significant levels of the transcript in FRTL5 cells.  Snail and Slug are two highly 
similar zinc-finger transcription factors however, it is not known how closely related 
Snail and Slug in terms of specificity of targets (196).  It has been suggested that Snail 
and Slug have both unique and overlapping targets dependent on cell type and context.  
Snail appears to be a more global transcriptional repressor in terms of affinity for targets 
and duration of activity on targets (24).  Slug, on the other hand, has been hypothesized 
to have less affinity for target promoters lending to a more transient EMT phenotype (24, 
242).  We expressed a V5-epitope tagged version of human Slug in MDCKII cells to 
investigate the activity of Slug on epithelial polarity.  We immediately noticed Slug leads 
to defects in epithelial polarity and junction formation indicative of EMT.  Slug is a 
known repressor of Cdh1 in cultured cells but it is not known if Slug has any affect on the 
gene for Crb3 (89). Using ChIP assays, we were able to detect a direct interaction with 
Snail-V5 and canine Crb3 promoter indicating that Slug directly represses Crb3 in 
MDCKII cells.  This is the first report that Slug is responsible for directly repressing 
Crb3.  
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Our initial inspection of our microarray data illustrated a number of potential 
pathways deregulated during EMT conditions.  TGF-β signaling is increased during 
EMT, and in FRTL5 cells there was a specific increase in TGF-β pathways genes.  
Concurrently, in FRTL5 cells we found significant decrease in the BMP signaling 
pathway, which is known to antagonize TGF-β signaling. We had previously utilized 
TGF-β treatment to stimulate endogenous expression of Snail in MDCKII cells (294).  
Induction of Snail in vitro results in a change in protein levels of tight junction proteins 
similar to the protein profiles found in FRTL5 cells.  There is a body of evidence to 
suggest that TGF-β induction in thyrocytes leads to the onset of EMT In primary porcine 
thyrocytes TGF-β treatment lead to dedifferentiation only when combined with epidermal 
growth factor (EGF) treatment (84).  In our microarray, EGF receptor gene expression 
was only significantly higher in polarized FRT cells and not FRTL5 cells.  A genomic 
analysis of human papillary thyroid carcinomas demonstrated an upregulation of TGF-β 
signaling genes at the invasive front of these tumors (285).   Also in anaplastic thyroid 
carcinoma an increase in TGF-β signaling caused by misregulation of specific 
microRNAs leads to invasive phenotypes (28).  Interestingly, in different tumor types 
such as, lung adenocarcinoma TGF-β treatment lead to full EMT phenotypes, including 
the upregulation of endogenous Snail and Slug, but this effect could be attenuated by 
overexpression of TTF1 resulting in only partial EMT compared to the full complement 
of phenotypes associated with Snail and Slug overexpression (241).  Similarly, we noted 
that FRTL5 cells exhibit what appears to be only a partial EMT and importantly also 
express high levels of TTF1.  Expression of TTF1 in lung cancers has been linked to 
good prognoses due to limited invasive properties of tumors (270).  Taken together with 
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our observations, the data suggest that expression of Slug in FRTL5 cells might cause a 
loss of polarity, but not increased invasion due to high levels of TTF1. Further 
experimentation is needed to verify this hypothesis and this will prove fertile ground for 
further study of transient EMT phenotypes. 
Here we illustrate that the known EMT transcription factor Slug, can repress the 
gene for the epithelial polarity determinant Crb3a.  We successfully used microarray 
analysis to identify a subset of genes required for tight junction biogenesis.  Of these 
genes, the known EMT targets Cdh1 and Crb3 as well as tight junction structural proteins 
from the claudin and occuldin families are clearly necessary for tight junction formation 
and epithelial polarity.  Hopefully, our data set will provide invaluable information for 






Chapter 4  
 





Polarized epithelial cells consist of two biochemically distinct membrane 
subdomains, an apical domain facing the lumen and a basolateral domain facing 
neighboring cells and the underlying tissue.  As a method of establishing distinct 
membrane domains, epithelial cells utilize differential trafficking of transmembrane 
proteins (106, 199, 247). Crumbs3a (Crb3a) is a resident apical domain transmembrane 
protein essential for epithelial polarity and part of the conserved tripartite Crumbs 
polarity complex consisting of Crb3a-PALS1-PATJ (152, 170, 235, 237).  Crb3a interacts 
with the conserved Par polarity complex (Par6-Par3-aPKCζ) to modulate the formation 
of the distinct apical versus basolateral domains in polarized epithelial cells (110, 153).  
Crb3a is a highly regulated protein as both excess of Crb3a or lack of Crb3a lead to 
epithelial morphology defects (235).  Likewise, transcriptional repression of the Crb3 
gene leads to rapid loss of epithelial morphology (133).  These previous results indicate 
that Crb3a is essential in both the establishment and maintenance of polarized 
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monolayers.  However, these studies do not take into consideration the role of Crb3a 
trafficking in the regulation of polarity. 
For signal attenuation and degradation, apical surface proteins can be endocytosed 
into apical early endosomes (AEE) positive for Rab4 and Rab5 (30, 250).  Once 
endocytosed, apical components are either recycled into the ARE or shuttled into an 
endosomal degradation pathway.  Mechanisms uncovering the reciprocal exocytosis and 
endocytosis (apical recycling) of Crb3a in polarized epithelial cells have largely been 
inferred by using genetic modeling in various Drosophila tissues using dCrumbs (the 
Drosophila homologue of Crb3a) as a marker of apical maturation. Deposition of 
dCrumbs on the apical surface is necessary for epithelial polarization (272, 296).  In 
Drosophila disruption of Rab11 by either introduction of a dominant negative version of 
the protein or knockout by introduction of a null allele leads to abnormal distribution of 
dCrumbs in multiple tissues (234).  Decreasing output in the Rab11 gene product in flies 
also leads to a failure in apical dCrumbs deposition and initial apical lumen formation 
(41, 139).  Localization of dCrumbs to the surface appears to be maintained by the 
balance of apical versus basolateral domains (92).  Balance of apical versue basolateral 
surfaces is control by endocytosis and exocytosis and disruption of the endocytic 
syntaxin-7 or Rab5 in Drosophila also leads to epithelial morphology defects associated 
with the accumulation of dCrumbs (167).   
Disrupting Drosophila endocytic degradation through the multi-vesicular body 
pathway (MVB) also leads to apical overgrowth similar to dCrumbs overexpression 
phenotypes (78, 79).  Once endocytosed proteins reach AEE, they can be shuttled to the 
MVB for degradation.  MVB formation and traffic is governed by Endosomal Sorting 
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Complex Required for Transport (ESCRT) protein complexes 0-III.  From AEE, ESCRT 
complex proteins shuttle vesicles sequentially along membranes where vesicles are 
invaginated and budded into the interior of the MVB.  Through this process the MVB can 
be seen as a vesicle containing vesicles.  The resident vesicles of the MVB, now called 
exosomes, contain transmembrane proteins and receptors destined for degradation.  For 
this degradation, MVBs can either fuse with the lysosome or alternatively can fuse with 
the plasma membrane to release exosomes into the luminal space.   
Here we chose to investigate the apical recycling of a mammalian homologue of 
Drosophilla Crumbs, Crb3a, and the relationship between apical recycling and regulation 
of epithelial polarity in polarized MDCKII cells.  Using live cell imaging and tissue 
culture models of the apical recycling of Crb3a, we found that once apical surfaces are 
established, apical recycling of Crb3a is reduced.  Reduction of apical recycling suggests 
that Crb3a is trafficked via an alternate mechanism, and abrogation of multi-vesicular 
body biogenesis results in an increase in cellular levels of Crb3a.  We also utilized an 
inducible Crb3a gene system to assess the approximate half-life of the Crb3a protein in 
both fully polarized and non-polarized conditions to determine if presence of an apical 
surface leads to Crb3a protein stabilization.  Similarly, we also observed that Crb3a 
appears to be a very dynamic protein at both the apical surface and tight junction.  Our 
observations lead us to conclude that Crb3a trafficking through non-recycling mediated 




4.2 Materials and Methods 
4.2.1 Cell Lines and Plasmids 
MDCKII cells were maintained in DMEM supplemented with 10% fetal-bovine 
serum and 1% penicillin-streptomycin-glutamate (all from Gibco, Invitrogen) and 
appropriate selection agent where noted.  H.s. Crb3a was PCR amplified from a human 
kidney cDNA library (Clonetech) and ligated into pRevTRE (Clonetech).  For 
monomeric eGFP-Crb3a (mEGFP-Crb3a) cDNA expression construct, an EcoRV site 
was engineered into the coding sequence of H.s. Crb3a via site-directed mutagenesis 
using Pfu Turbo (Stratagene).  Monomeric eGFP (meGFP) was inserted in frame at the 
EcoRV site.  EcoRV sites were then mutated to the original native sequence via site-
directed mutagenesis (see (246)).  For inducible mEGFP-Crb3a (iGFP-Crb3a) cells, 
cDNA for mEGFP-Crb3a was ligated into pRetroX-Tight-Puro (Clonetech) and 
transduced into MDCKII cells stably expressing pTet-On Advanced (Clonetech).  The 
Dendra2-Crb3a (Den2-Crb3a) construct was created by excision of mEGFP from 
mEGFP-Crb3a via EcoRV restriction digest followed by ligation of Dendra2 in frame and 
subsequent site directed mutagenesis. Functionality of mEGFP-Crb3a and Den2-Crb3a 
were tested by Western blot and confocal microscopy.    
For TSG101 knockdown cell lines, short hairpin sequences were obtained from 
(112) and are as follows: SH-1: top oligo: 5`-GATCCGCCTACTAGTT 
CAATGACTTTCAAGAGAAGTCATTGAACTAGTAGGCTTTTTTACGCGTG-3` 
bottom oligo:  5`-AATTCACGCGTAAAAAAGCCTACTAGTTCAATGACTTCTCTT 
GAAAGTCATTGAACTAGTAGGCG-3`.  Short hairpins were annealed and ligated into 
pSiren-RetroQ-DsRed (Clonetech) and transduced into MDCKII cells.  Clones were 
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picked after selection using epifluorescent microscopy selection for DsRed.  The 
University of Michigan Automated DNA Sequencing Core verified all sequences.   
 
4.2.2 Antibodies and Immunofluorescence Staining 
Primary antibodies against Crb3a (UM510) were obtained from serum derived 
from inoculation of rabbits with a peptide (CARVPPTPNLKLPPEERLI) corresponding 
to the C-terminal sequence of human Crb3a (Cocalico Biologicals Reamstown, PA).  
Antibodies for PALS1 were used as described in (262).  Dendra2 antibody was obtained 
from Evrogen.  Antibodies against GFP, and fluorophore conjugated secondary antibodes 
as well as Wheat-germ aggultinin-594 (WGA-594) were obtained from Molecular 
Probes.  Antibodies against Rab11, TSG101, and EEA1 were obtained from BD 
Biosciences.  E-cadherin antibody was obtained from Zymed.  Antibodies against Par6B 
were from Santa Cruz Biotech.  Antibodies against aPKCζ and Par3 were from Upstate.  
HRP-conjugated secondary antibodies were obtained from Amersham-GE.  For 
immunostaining, cells were grown on glass coverslips or transwell filters.   
 
4.2.3 3-Dimensional Tissue Culture Cyst Assays 
MDCKII cells stably expressing plasmids of interest were dissociated using 
enzyme free cell dissociation buffer (Gibco Invitrogen), spun down, washed twice with 
PBS, and counted. Cells were then resuspended in complete growth media containing 4% 
Geltrex (Gibco Invitrogen) and ~ 25,000 cells were seeded into one well of an 8-well 
chamber slide (Nunc), with each chamber containing a bed of 100% Geltrex.  Cysts were 
allowed to grow in complete growth media with 4% geltrex for days indicated in the 
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figure legends.  Cysts were then fixed for 1 hour with 4% paraformaldhyde and 
permiablized with 0.1% SDS/PBS for 30 minutes followed by blocking for 1 hour in 4% 
goat serum/PBS (PBSG).  After blocking, primary antibodies were diluted in (PBSG) and 
cysts were incubated with primary antibody solution for 24-48 hours at 4 degrees.  After 
three 30 minute washes with PBSG, secondary antibodies were diluted in PBSG and 
incubated with cysts for 24 hours at 4 degrees in the dark.  After three 30 minute washes, 
cysts were placed in PBS and for visualization.   
 
4.2.4 Imaging/Live-cell Imaging/FRAP 
All images were obtained on an Olympus FV500 Confocal Microscope at the 
University of Michigan Diabetes Research and Training Center Morphology and Imaging 
Core.     For FRAP analysis, MDCKII cells constitutively expressing mEGFP-Crb3a were 
seeded on coverslips and allowed to polarize over four days.  Coverslips were then placed 
in a live cell-imaging chamber in Libowitz media as above. Regions of interest were 
photobleached using 3 iterations of the UV laser at 100% intensity and then monitored 
for 250 seconds.  Recovery rates were determined by comparing bleached regions to 
control regions of approximately the same intensity.  Recovery plots and statistical 
analysis were produced using Graphpad Prism software.    Media was added as needed 
over the course of the assay.  Images were adjusted using Adobe Photoshop software 
version 8.0.  
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4.2.5 Cell treatments and Modified Pulse chase experiments 
For modified pulse chase assays iGFP-Crb3a cells were grown on in 60 mm tissue 
culture dishes for 4 days until confluency.  Inducible cells were treated with 50 ng/mL 
doxycycline (Clonetech) for 1 hour at 37 degrees for the pulse.  After 1-hour doxycycline 
incubation, cells were washed three times with complete growth media to remove any 
remaining doxycycline. For the chase, inducible cells were allowed to incubate in 
complete growth media.  Four hours post washout, all samples were washed again three 
times with complete growth media to remove any residual doxycycline. At prescribed 
times, inducible cells were harvested and lysed with denaturing lysis buffer for Western 
blot analysis.  Control induction was obtained by treating samples with vehicle for the 
entire length of the experiment. 
For modified pulse chase assays combined with induction of EMT, iGFP-Crb3a 
cells were grown on transwell filters (Corning) to confluence.  Recombinant TGF-β 
(R&D Biosystems) was added to the lower chamber to a final concentration of 5 ng/mL.  
Cells were treated for 2 days, washed with PBS, and boosted with an additional treatment 
of TGF-β for another 2 days.  After 4 days of treatment with TGF-β cells were began on 
the modified pulse chase assay as above in the presence of TGF-β.   
 
4.2.6 Quantitative Western Blot Analysis 
For quantification of Western blots, 50 ng of total protein lysate were run on a 
10% Bis-Tris/MOPS SDS-PAGE gel and transferred to PVDF.  Transfer efficiency was 
determined by Ponceau S staining.  After transfer, membranes were blocked in 5% non-
fat dry milk/TBS overnight.  Primary antibodies for Crb3a and Actin were diluted for 
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blotting in 5% milk/0.05 Tween-20/TBS and membranes were probed for two hours at 
room temperature with rotation.  After extensive washing with 0.05% Tween-20/TBS, 
far-red conjugated secondary antibodies against rabbit (emission 800 nm) and mouse 
(emission 680nm) (Lycor) were diluted 1:10,000 in 5% milk/0.05 Tween-20/TBS and 
incubated for 1 hour with rotation at room temperature protected from light.  Following 
extensive washing with wash buffer, blots were imaged using the Licor Odyssey System.  
After imaging, data was analyzed using Licor ImageQuant software.  Regions of interest 
(ROI) were determined by selecting the area of the predominant band corresponding to 
the respective antibody signal.  The ROI was copied to maintain the area for subsequent 
analysis.  Arbitrary units for each band corresponding to either Crb3a or actin were 
obtained using the established ROI.   Data output is given as a ratio of the signal of Crb3a 
to actin, back corrected to remove background signal from non-induced samples.  Data 
points were plotted on XY-scatter plots using Microsoft Excel software to determine 
trend lines.  Half-lives were determined by calculating exponential decay from modified 
pulse chase assay ratios. 
 
4.2.7 Biotinylation Assay 
iGFP-Crb3a C36 cells were plated on 10 cm tissue culture plates and grown to 
confluency over 4 days.  Cells were treated with 50 ng/mL doxycycline for 1 hr. then 
chased in regular media for 4 hr. to accumulate surface iGFP-Crb3a.  Cell surface 
biotinylation was done with the Piecre-Thermo Cell Surface Biotinylation Kit.  Briefly, 
after induction, iGFP-Crb3 C36 cells were washed twice with ice-cold PBS and then 
incubated with 0.25 mg/mL Sulfo-NHS-SS-Biotin in cold PBS for 30 min.  After 
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incubation, cells were quenched as directed, washed 3x with ice-cold PBS, and incubated 
with complete growth media at 37 degrees at prescribed time points to facilitate uptake.  
After uptake, cells were washed once with PBS and then 4 x 15 minutes with MesNA 
buffer (50 mM MesNA, 150 mM NaCL, 1 mM EDTA, 0.02% Bovine Serum Albumin, 
20 mM Tris-Cl, pH 8.6) to reduce any non-internalized biotin linkages.  Cells were then 
lysed in and protected biotinylated protein was isolated using NeutrAvidin pulldown as 
directed by manufacturers protocol. 
 
4.3 Results 
4.3.1 Efficient repopulation of Crb3a in polarized MDCKII cells 
 Crb3a is localized to the apical surface of polarized epithelial cells and essential 
for cell polarity (170, 235, 272, 296).  We were interested in monitoring the production 
and trafficking of Crb3a vesicles in an effort to understand how Crb3a helps maintain cell 
polarity.  To visualize Crb3a vesicles in MDCKII cells, we used the irreversibly 
photoswitchable protein Dendra2 (Den2) fused in frame into the Crb3a (Den2-Crb3a) 
extracellular domain. We tested Den2-Crb3a fusion constructs for functionality by 
confocal microscopy and Western blot and determined that Den2-Crb3a functioned and 
localized normally in MDCKII cells (Figure 4-1A).  To monitor movement of Den2-
Crb3a containing vesicles we used the photoswitchable properties of Den2 to monitor the 
accumulation of newly synthesized Den2-Crb3a.  Using live cell imaging, we obtained 
pre-activation micrographs and then photoswitched Den2-Crb3a by activation with UV 
light for 1  
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Figure 4-1:  Expression and tracking of Den2-Crb3a in MDCKII cells.  
(A).  Den2-Crb3a was stabily expressed in MDCKII cells.  (B). XZ image 
series of a single cell expressing Den2-Crb3a.  After 1 minute of activation 
with UV light, newly synthesized Den-Crb3a (green) was followed for 8 





minute.  Micrographs were taken to monitor the appearance of green color by excitation 
at 488nm Den2-Crb3a by taking confocal Z-stacks every 60 minutes.  Theoretically, any 
red signal (excitation 594nm) present at time-0 represents converted Den2-Crb3a, or the 
pool of Den2-Crb3a present in the cell at time of activation.  Conversely, any green signal 
obtained post activation hypothetically represents Den2-Crb3a newly synthesized.  We 
observed significant green Den2-Crb3a signal within 60 minutes post conversion (Figure 
4-1B).  We saw a continuous increase in green signal from Den2-Crb3a, and by 4 hours 
post conversion we observed green signal from newly synthesized Den2-Crb3a had 
localized either at or near the apical surface and was similar intensity to the residual red 
signal.  Although there are technical limitations to monitoring movement of Den2-Crb3a 
(see discussion section 4.4), we were able to conclude that the synthesis and movement of 
Crb3a in MDCKII cells is a rapid event and that MDCKII cells are repopulated with 
Crb3a within 60 minutes. 
 
4.3.2 Inducible GFP-Crb3a system 
To be able to monitor the production of a limited pool of cellular Crb3a in 
MDCKII cells, we constructed MDCKII cells stably expressing a tetracycline inducible 
(Tet-On) version of mEGFP-Crb3a (iGFP-Crb3a).  We stably expressed iGFP-Crb3a in 
MDCKII cells picked clones and based on their ability to produce iGFP-Crb3a when 
treated with doxycycline compared to the same clone induced with vehicle alone.  Of the 
clones picked, clone-36 (iGFP-Crb3a C36) appeared to have the best induction when 
compared to vehicle induced and was used for the majority of experiments. To optimize 
experimental procedures, iGFP-Crb3a C36 was used to titrate both the concentration of 
 116 
doxycycline and the length of time for doxycycline treatment (Figure 4-2A).  
Experimentally, the optimal concentration of doxycycline was determined to be 50 ng/mL 
with a treatment time of 1 hour.  Using these conditions, we performed time course 
studies on both transcript and protein levels of iGFP-Crb3a C36.  
Using quantitative real-time PCR (qRT-PCR) the mRNA specific for of iGFP-
Crb3a rose quickly at 0 hours post induction and declined to nearly background levels at 
6 hours post induction (Figure 4-2C).  The protein levels of iGFP-Crb3a C36 peaked at 4 
to 6 hours post induction and by 24 hours post induction these levels appeared to return to 
baseline.  Additionally, iGFP-Crb3a C36 were visualized using confocal microscopy to 
determine any effect of induction on the morphology of MDCKII cells. Morphology of 
iGFP-Crb3a C36 cells was determined to normal after induction conditions Figure 4-2B).  
We refer to this method as a modified pulse chase assay where iGFP-Crb3a C36 is 
produced in limited quantity to track Crb3a production. 
Western blots show iGFP-Crb3a as a series of 3 distinct bands.  The two bands of 
the highest molecular weight are the major products of iGFP-Crb3a induction and 
appeared as a doublet.  Deglycosylation assays were performed on these cells to 
determine post-translational modifications (PTMs).  The mEGFP-Crb3a doublet is a 
result of multiple N and O-linked glycosylations (Figure 4-3). We could not determine 
the specific identity of these glycosylated forms, however the highest molecular weight 
species of iGFP-Crb3a is the most highly N and O-glycosylated, leading us to believe 
that this band represents the most mature form of the protein, localized on the apical 




Figure 4-2: The iGFP-Crb3a sytem. (A) Western blot time course. (B) IF 







Figure 4-3:  N and O-linked glycosylation of Crb3a.  Both endogenous 









4.3.3 GFP-Crb3a is not recycled in G0 phase MDCKII cells 
Crb3a traverses a Rab11a-postive ARE during exocytosis to the apical surface in 
MDCKII cells (246).  Our previous assays however, do not address the role of 
endocytosis in Crb3a recycling.  In lumen formation studies, Rab11a-DN cells had 
exocytic defects but not defects in endocytosis but clearly mEGFP-Crb3a protein likely 
undergoes recycling during lumen formation. We preformed experiments to determine 
under what conditions apical recycling occurs. Since our previous lumen formation 
experiments (see Appendix B) involved the transition between a non-polarized cell to two 
polarized daughter cells, we examined if the presence of an apical surface and/or mitosis 
influence the recycling of iGFP-Crb3a.  Single MDCKII cells will adhere to glass 
coverslips and since they lack any cell-to-cell contacts they will not form junctions and 
express Crb3a on the entire plasma membrane. To understand what conditions iGFP-
Crb3a is recycled, we preformed modified pulse chase/antibody uptake on sub-confluent 
iGFP-Crb3a C36 cells in the presence or absence of serum.  GFP antibody uptake 
illustrated that in serum free conditions where cell are not actively dividing there is 
limited internalization of surface iGFP-Crb3a, and GFP antibody never reached a Rab11 
positive endosome (Figure 4-4 top). The only instance where we see appreciable 
internalization of the GFP antibody is when subconfluent cells are allowed to divide and 
migrate when incubated in complete growth medium containing the full compliment of 
serum (Figure 4-4 bottom). We also tested whether surface expressed iGFP-Crb3a 
endocytosis and recycling into Rab11 positive compartments was a result of neighboring 
cells forming junctions by performing the same experiment in medium depleted in 
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calcium since by depleting calcium cells will divide but not form junctions (Figure 4-4 
second from bottom).  Similarly, we found that in low calcium media surface GFP 
antibody staining could be seen in a Rab11 positive compartment suggesting that during 
sub-confluency where cells are actively dividing before establishing apical surfaces, does 
Crb3a get efficiently recycled into Rab11 positive endosomes.    
In fully polarized monolayers, MDCKII cells are undergoing minimal mitosis (G0 
phase) similar to single cells in serum free media, however these cells have a fully 
established apical surface. To determine if the presence of an apical membrane affects the 
apical recycling of surface Crb3a once cells have polarized, fully confluent transwell-
filters of iGFP-Crb3a C36 cells were subject to modified pulse chase assay and then 
incubated in media containing antibody against the extracellular GFP-tag as above.   
After allowing for uptake by incubation at 37 degrees for 2 hr., filters were stained 
for internalized and protected GFP-antibody.  At no time did we see any appreciable 
internalization, protection, or recycling of GFP-antibody as evidenced by co-stain with 
pan-Rab11 antibody (Figure 4-5A). To further examine if surface iGFP-Crb3a is 
internalized and recycled we subjected fully polarized monolayers to surface 
biotinylation assay.  Fully polarized iGFP-Crb3a C36 cells were subject to modified pulse 
chase, surface labeled with biotin, and incubated for prescribed times at 37 degrees to 
allow for endocytosis.  Internalized iGFP-Crb3a was analyzed by neutravidin pulldown 
and Western blot.  To our surprise, there was very little protection of biotinylated iGFP-
Crb3a over the course of the experiment (Figure 4-5B).  Additionally, the small amount 




Figure 4-4:  GFP-antibody uptake in single cells.  Single cells were plated 
in on coverslips and incubated with media containing GFP-antibody.  
After 2 hr. incubation cells were fixed and stained for internalized GFP-
antibody.  Only in conditions where cells were allowed to divide (in low 





pulldown appeared to only isolate the upper band of the mEGFP-Crb3a doublet 
confirming our previous observation that the upper band represents the mature surface 
form of the protein.  Combined with our previous results, our data suggests that surface 
Crb3a undergoes altered endocytosis and bypasses the apical recycling pathway once 
epithelial cells have established apical surfaces. 
4.3.4 GFP-Crb3a can be isolated from tissue culture media 
 Transmembrane surface proteins must be endocytosed and then degraded for 
signal attenuation (136).  In the case of Crb3a, protein levels must be carefully controlled 
to prevent overgrowth (235). Since surface labeled Crb3a was not significantly 
internalized and protected via antibody uptake or biotinylation, we asked the question as 
to how the cell is preventing an accumulation of surface Crb3a. To first approach this 
question, we incubated mEGFP-Crb3a expressing cells in with either bafilomycin to 
block lysosome function or MG132 to suppress proteosome function.  Treatments with 
both drugs were able to stabilize Crb3a in cells (Figure 4-6).  It has been reported that 
however, that introduction of pharmacological inhibitors to interrupt proteosome can 
block total protein degradation because an intact proteosome pathway is needed for 
lysosome-mediated degradation (140, 164).  Apical transmembrane proteins may also be 
degraded through the multivesicular body (MVB) pathway.  In this pathway, exosomes 
are expelled into the luminal space of an organ or into the media of cultured cells (48).   
Using iGFP-Crb3a C36 cells, we treated cells in serum free media with doxycycline and 
allowed exosomes to accumulate in the media (Figure 4-7).  Using either 




Figure 4-5:  Endocytosis of iGFP-Crb3a in fully polarized monolayers.  
(A) GFP-antibody uptake experiments on fully formed monolayers 
illustrated no overlap between Rab11 and GFP-antibody indicating iGFP-
Crb3a bypasses the apical recycling system. (B) Biotinylation of iGFP-
Crb3a.  Surface iGFP-Crb3a is not internalized and protected.  
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and in tissue culture supernatant.  These results suggest that Crb3a may be removed from 
polarized MDCKII cells via dispersion into the media or luminal fluid. 
4.3.5 TSG101 knockdown increases Crb3a protein levels 
We next chose to investigate if the MVB pathway has a role in the regulation of Crb3a 
with regards to managing epithelial morphology.  Tumor susceptibility gene 101 
(TSG101, also Vps23) is a member of the ESCRT-I complex and implicated in MVB 
biogenesis (135).  Short hairpin RNAs against TSG101 were transduced into MDCKII 
cells to determine the affect of the MVB pathway on the trafficking of endogenous 
Crb3a.  TSG101 shRNA cells had no obvious defects in epithelial polarization of wild 
type MDCKII cells as they continued to form tight junctions and apical membranes in 
confluent monolayers.  We did find differences in protein expression however.  In 
TSG101 knockdown MDCKII cells we noted an increase in protein levels of the polarity 
proteins Crb3a and Par6B, while a decrease in the protein levels of the polarity kinase 
aPKCζ (Figure 4-8Α).  To rule out the possibility that TSG101 knockdown leads to an 
increase in endogenous Crb3a protein by increased transcription of the Crb3 gene, we 
preformed qRT-PCR experiments to monitor Crb3a mRNA.  Using validated primer sets 
specific for canine Crb3a mRNA we determined the increase in Crb3a protein was not a 
result of increased transcription but most likely due to accumulation of Crb3a protein 
(Figure 4-8B). 
Notably, knockdown of TSG101 did not affect the ability of MDCKII cells to 
form cysts with a solitary hollow lumen.  However, in TSG101 shRNA cells we saw and 





Figure 4-6: Pharmacological inhibition of Crb3a degradation.  Top: Crb3a 
degradation is blocked by the the proteosomal inhibitor MG132.  Bottom: 





Figure 4-7:  iGFP-Crb3a isolated for tissue culture media.  After induction 
with doxycycline, iGFP-Crb3a can be immunoprecipitated from pre-
cleared tissue culture media.  
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cells (Figure 4-9A).    There were no appreciable differences in amount or localization of 
Par6B or aPKCζ however (Figure 4-9A).  These findings were recapitulated in two 
different TSG101 shRNA clones using two different short hairpins. TSG101 knockdown 
also affects number and structure of EEA1 positive AEEs in cells (136).  In our system, 
we also observed and increase in number and size of AEEs suggesting that endosome 
trafficking was disrupted in TSG101 knockdown cells.   Also using three-dimesional 
models we wanted to observe if knockdown of TSG101 affected lumen formation 
through endocytosis.  In the lumen formation assay, TSG101 shRNA cells did not have 
defects in lumen formation.  However, lumens between two TSG101 shRNA cells 
appeared to be larger and there is a larger population of cytosolic Crb3a than in control 
cells (Figure 4-10).  We also chose to investigate the affects of TSG101 knockdown on 
MDCKII cells in 12-day old cysts. It has recently been reported that disruption of 
TSG101 in certain tissues can lead to neoplastic tumor growth due to cellular overgrowth 
(79) (192).  We grew cysts in geltrex for 12 days and stained them for endogenous Crb3a 
and monitored the cysts for overgrowth phenotypes.  To our surprise, TSG101 shRNA 
cells continued to form complete and normal lumens (Figure 4-9A).  When we took our 
short hairpins against TSG101 and infected them into cells expressing low levels of 
mEGFP-Crb3a cells we observed notable differences in cell morphology.  In mEGFP-
Crb3a/Control shRNA monolayers, we relatively flat cells with no discernable 
morphological changes.  When mEGFP-Crb3a/TSG101 shRNA cells were grown as 
monolayers, we observed phenotypes consistent with Crb3a overexpressing including 
doming and expanded apical surfaces.  We also observed the same morphological 
changes in preliminary experiments involving iGFP-Crb3a C36 cells combined with  
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Figure 4-8:  Knockdown of TSG101 is MDCKII cells.  (A) Western blot of 
Crumbs and Par polarity complex proteins in TSG101 shRNA cells. (B) 
qRT-PCR of the Crb3a transcript in TSG101 shRNA cells indicating that 




TSG101 shRNAs (Figure 4-11).  In cysts expressing iGFP-Crb3a with control shRNAs 
we found that when we expressed high levels of iGFP-Crb3a by induction with 
doxycycline, these cysts still maintained single large lumens. However, when we 
combined iGFP-Crb3a C36 cells with TSG101 shRNAs, we found cysts with invaded 
lumens.  It also appeared that the iGFP-Crb3a C36/TSG101 shRNA cells had lost the 
ability to maintain their mitotic plane as perpendicular to the apical membrane.  
Additionally, when monitored by Western blot, overexpession of iGFP-Crb3a was enough 
to overcome TSG101 repression by the introduced shRNAs.  Again, these results are 
preliminary and we are currently verifying these observations. 
 
4.3.6 GFP-Crb3a Half-life is independent of epithelial morphology 
Crb3a is a tightly regulated protein and we had previously determined that the 
trafficking and apical recycling of Crb3a is dependent on the presence of an established 
apical surface, we hypothesized that disruption of the apical surface should affect the 
ability of the cell to regulate Crb3a.  To address this issue we wanted to determine the 
biological half-life of Crb3a in both polarized and non-polarized MDCKII cells to 
determine the relationship between trafficking of Crb3a to an established apical surface 
and the regulation of Crb3a protein.  Due to technical limitations regarding the Crb3a 
protein (see discussion section 4.4), we chose to utilize our iGFP-Crb3a system to 
monitor the half-life of Crb3a protein.  To study the half-life of Crb3a in polarized and 
non-polarized conditions we transduced iGFP-Crb3a C36 cells with the transcription 
factor Snail-Flag (Figure 4-12).  Snail is a potent repressor of the endogenous Crb3 gene  
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Figure 4-9:  6 and 12 day-old TSG101 shRNA 1 cysts.  Note the increase 










Figure 4-10:  2-cell stage of TSG101 shRNA cells.  TSG101 shRNA cells 











Figure 4-11: TSG101 shRNA in mEGFP-Crb3a cells.  TSG101 shRNA-1 
was expressed in MDCKII cells moderately overexpressing mEGFP-
Crb3a.  The combination of TSG101 knockdown with Crb3a 















Figure 4-12:  iGFP-Crb3a cells expressing Snail-Flag.  iGFP-Crb3a cells 
were transduced with Snail-flag to disrupt polarity.  iGFP-Crb3a cells 
continued to express iGFP-Crb3a on the surface. 
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and expression of Snail will cause a loss of epithelial phenotypes including formation of 
distinct apical surfaces through epithelial to mesenchymal transition (294).  Additionally, 
Snail expression would not affect our exogenous iGFP-Crb3a promoter allowing us to 
monitor the cells ability to degrade protein in a non-polarized cell (Figure 4-13A).  When 
we used a modified pulse chase assay with iGFP-Crb3a C36/control vector and iGFP-
Crb3a C36/Snail-Flag cells we surprisingly discovered no difference in iGFP-Crb3a 
protein levels between experimental and control cells, and the half-life of iGFP-Crb3a 
protein in both conditions was 3 - 5 hours (Figure 4-13B).  To rule out that our findings 
were a result of Snail-flag overexpression, we chose to conduct the same experiment 
again, this time treating the cells with TGF-β (Figure 4-14Α). TGF-β is a known inducer  
of EMT in cells, ultimately leading to an upregulation in endogenous Snail (303).  After 
four days of vehicle or TGF-β treatment, iGFP-Crb3a C36 cells were again subjected to 
modified pulse chase assay.  These results demonstrated that iGFP-Crb3a had a biological 
half-life of 4-6 hours (Figure 4-14B).  
Although there was no change in the biological half-life of Crb3a during the 
series of modified pulse chase experiments, there were differences in the iGFP-Crb3a 
protein profiles as shown by Western blot.  The iGFP-Crb3a C36 cells show a robust 
series of bands that are positive for Crb3a on Western blot corresponding to the predicted 
molecular weight of Crb3a with a mEGFP tag.  The highest molecular weights of 
mEGFP-Crb3a run as a doublet, and this doublet has been identified to be heavily 
modified by both N and O linked glycosylations presumably amplified due to the 
presence of a large extracellular mGFP-epitope.  Upon analysis of the iGFP-Crb3a 






Figure 4-13:  The half-life if iGFP-Crb3a.  (A) The half-life of iGFP-
Crb3a was determined by modified pulse chase assay followed by 
quantitative Western blot.  (B) Half-life was determined by estimating the 





Figure 4-14:  Half-life of iGFP-Crb3a with TGF-β.  (A) Morphology of 
iGFP-Crb3a C36 cells +/- TGF-β treatment.  (B) Half-life of iGFP-Crb3a 





Figure 4-15:  Apical identity and the maturation of iGFP-Crb3a.  (A) in 
iGFP-Crb3a C36 cells surface Crb3a is in a ratio with immature Crb3a of 
3:2.  In iGFP-Crb3a C36/Snail-flag cells, the ratio is 1:1.  (B)  In TGF-β 
treated cells the ratios are similar suggesting the presence of an apical 





combined doublet did not change when compared to control cells, there was a difference 
in the intensities of the individual single bands making up the iGFP-Crb3a doublet and 
ratios of the doublet bands to each other were different in EMT cells versus control 
cells(Figure 4-15).  In control cells the ratio of upper band to lower band was 3:2, 
suggesting an increase the more heavily glycosylated form of Crb3a.  In EMT cells, the 
ratio of bands in the doublet was 1:1, suggesting and equal distribution between modified 
forms of Crb3a.  Taken together, our results suggest that during steady state and EMT 
state, the biological half-life of mEGFP-Crb3a is approximately 3-6 hours and this does 
not change regardless of cellular context.  There seems to be, however, a difference in the 
maturation and processing of Crb3a during EMT, and the maturation is dependent on the 
absence or presence of an apical surface. 
 
4.3.7 Crb3a lateral mobility as measured by FRAP is constant regardless of cellular 
localization 
 
Although the half-life of Crb3a did not change in each condition tested, we did 
note that turnover of Crb3a is high in MDCKII cells.  All our previous data point to 
Crb3a being dynamic in polarized epithelia.  To assess the dynamics and mobility of 
Crb3a, mEGFP-Crb3a was expressed in MDCKII cells and used for fluorescence 
recovery after photobleaching (FRAP).  Using FRAP we completed comparative mobility  
analysis of Crb3a localized the apical surface and the tight junction.  FRAP against either 
the apical surface or the junction of polarized mEGFP-Crb3a cells determined that there 












Figure 4-16: FRAP analyis of mEGFP-Crb3a cells.  Both apical and 
















Figure 4-17:  Model of Crb3a exocytosis and endocytosis. 
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estimated at 157.8 s while junction recovery half-life was estimated at 161.3 s.  These 




Here we present evidence that apical recycling of mammalian Crb3a in polarized 
MDCKII cells contributes to the dynamic regulation of epithelial polarity.  Newly 
synthesized Crb3a repopulates the cell within 1-hour and Crb3a appears to have a half-
life of 4-6 hours.  However, the fate of metabolized Crb3a is not yet clear.  Inhibition of 
the MVB pathway via TSG101 knockdown prolonged the Crb3a half-life but endocytosis 
of the Crb3a was very difficult to detect.  It is possible that a significant fraction of Crb3a  
is secreted into the media via exosomes and this Crumbs3a is difficult to detect with our 
endocytosis assays.  A long-standing question in the field of epithelial polarity is how 
polarity is initially established and what processes are utilized to maintain polarity?  
Numerous studies have provided examples of the protein-protein interaction networks 
necessary for epithelial polarity, but how these networks are spatially and temporally 
regulated is not well described (12, 100, 110, 152, 153, 170, 235, 237) (254, 262).  
Previously, our lab and others has shown that expression of the Crb3a protein is regulated 
and this regulation affects the ability of epithelial cells to maintain proper polarity (69, 
133, 235, 246, 294).  The role of Crb3a trafficking in epithelial regulation has not been 
thoroughly addressed.  Trafficking and junction formation assays traditionally utilize 
calcium depletion/repletion (switch) to monitor apical membrane formation. Calcium 
switch experiments probably represent endocytosis and exocytosis under artificial 
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conditions leaving them at a disadvantage.  We believe these experiments performed 
above concerning the trafficking of Crb3a under steady-state conditions more closely 
resemble how epithelial sheets behave in vivo.   
Crb3a is necessary for apical membrane formation and Crb3a arrives at the apical 
membrane in an expedited process involving the coordinated constant production of 
Crb3a protein and exocytosis to the apical surface via established trafficking pathways 
(246).  Experiments with Den2-Crb3a demonstrated that newly synthesized Crb3a 
appears in the cell within 1-hour post photoswitch via live-cell monitoring of polarized 
epithelial cells.  Controlled, short burst of UV light were sufficient to photoswitch a small 
region of Den2-Crb3a cells from excitation at 488nm (green) to excitation at 594nm 
(red), allowing us to qualitatively monitor turnover of the protein without detectable UV 
induced damage (42, 43).  The newly synthesized Den3-Crb3a appeared first near the cell 
center and expanded to the tight junctions over time. The accumulation of new Den2-
Crb3a was seen in what appears to be a sub-apical region of the cell consistent with the 
location of AREs.  Interestingly, it has been proposed that the site of Crumbs translation 
is localized sub-apically and the localization of Crumbs transcripts is dependent on the 
Crumbs 3` untranslated region (UTR) (157).  Our data does not fit with this model, as all 
Crb3 genes used in this study are derived from cDNAs lacking the any 3` UTR yet Crb3a 
localized with markers for Golgi and endoplasmic reticulum and all cells expressing 
exogenous Crb3a appeared to function normally.  Based on our analysis we hypothesize 
that during steady state (fully polarized) conditions Crb3a is trafficked directly and 
efficiently to the apical surface and functions to reinforce apical identity.  Considering 
Crb3a localizes to the primary cilium, apical surface, and tight junction there exists the 
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possibility that Crb3a is trafficked to one location and then moves to other subcellular 
locations by diffusion or Crb3a is specifically targeted to distinct subellular localizations 
dependent on polarization.  Our data cannot discount these other possibilities and other 
experimentation is needed to investigate this question. 
Using Den2-Crb3a we were unable to determine definitively if Crb3a is 
endocytosed in cells. Although newly synthesized (green) sub-apical Den2-Crb3a appears 
to be colocalized with existing (red) Den2-Crb3a, we have no definitive method of 
delineating the exact apical boundary using this live-cell imaging technique.  This was 
due to technical limitation based on microscopic resolution and our inability to monitor a 
novel marker for the apical surface in the far-red channel (>594 nm excitation 
wavelength).  Using Den2-Crb3a cells, we were limited to the use of only 488 and 594 
excitation channels because UV-light activates the Dendra protein.  Also due to the small 
region of interest required for visualization of the movement of Crb3a, we were limited to 
only live-cell analysis.  Attempts to convert entire plates or cover slips of cells using UV 
light only resulted in partial conversions or cell death by UV induced damage.  To assess 
these limitations in the future we will have to employ immuno-electron microscopy.   
In lumen formation models (3-dimesional tissue culture) at the single cell stage, 
MDCKII cells express Crb3a on the entire plasma membrane.  As these cells go through 
mitosis and cytokinesis, Crb3a is endocytosed and then exocytosed to the cleavage 
furrow to initiate lumen formation (246).  The apical recycling system involves 
coordinated endocytosis into Rab5 positive early endosomes and then passage of vesicles 
to the Rab11 positive recycling endosomes for reinsertion into the apical membrane (30, 
36, 46, 99, 167).  Accordingly, in Rab5 null flies, there is an accumulation of apical 
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dCrumbs and neoplastic phenotypes indicative of endocytic defects (167).  In Rab11a-
DN cells, endocytosis was able to proceed; however exocytosis of Crb3a is inhibited 
(Chapter 4 and (246)). Using recycling into Rab11a-postive ARE is the basis for the 
apical recycling assay, we sought to understand how apical endocytosis and recycling 
regulates Crb3a.  Based on our lumen formation studies (see Apendix B) we expected 
Crb3a to be endocytosed and eventually traverse Rab11a-postive ARE on its way back to 
the surface. The only conditions where uptake of GFP antibody could be detected co-
localized with Rab11 were in contact naïve, yet actively dividing cells.  These cells do 
not possess apical surfaces due to lack of cell-cell contacts but will form apical surface 
upon cell-cell engagement. Surprisingly, using serum-free conditions to mimic cells in 
G0, we could not detect any appreciable GFP antibody internalization from single cells 
into Rab11 positive compartments. Fully polarized epithelial cells in monolayer are 
undergoing limited mitosis due to contact inhibition and most cells are in G0 phase.  
Similarly, we observed very little internalization of GFP antibody in full monolayers, 
suggesting that there is very little apical recycling of surface Crb3a once apical 
membranes are fully formed.  This is consistent with previous data from our lab that 
showed endocytosis of Crb3a into a Rab11a positive-compartment only when we 
eliminated junctions and membrane segregation via calcium switch yet allowed mitosis to 
occur. Results were made stronger considering that antibodies often dimerize on the 
surface of cells inducing endocytosis, yet we did not find appreciable internalization or 
apical recycling in our assays.  Biotinylation assays also concluded that endocytosis and 
protection of surface labeled Crb3a either low or extremely efficient in fully polarized 
monolayers.  The results of these experiments suggest that endocytosis and recycling of 
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Crb3a is differentially regulated, dependent on the presence or absence of a defined 
apical surface.  Our observation was verified in 4-day old mature cysts where Crb3a is 
expressed on the apical surface.  In mature cysts, apical membrane integrity is maintained 
once established.  Even during mitosis of cells in mature cysts we are unable to detect 
endocytosis or recycling of Crb3a (246).  Our data suggests that once apical integrity is 
established via a Crb3a-dependent mechanism, trafficking of Crb3a is altered to maintain 
the apical surface.  The only instances where we find Crb3a co-localized with Rab11 after 
endocytosis is when the cell is actively establishing an apical surface.  
If Crb3a is not recycled in fully polarized epithelium then that begs the question 
of how Crb3a is removed from polarized epithelial cells?  Multiple groups have 
demonstrated that over abundance of Crb3a protein cause apical overgrowth and 
neoplastic tissue formation (78, 79, 167, 192).  It is assumed that transmembrane proteins 
like Crb3a are endocytosed and degraded via established proteosomal pathways.  For the 
degradation of transmembrane proteins the multivesicular body (MVB) pathway is used 
to attenuate receptor signals (136).  In the MVB pathway, endocytosed proteins are 
passed from early endosomes and invaginated into multivesicular bodies that fuse with 
either the lysosome or the apical surface and release their contents into the lumen of an 
organ, or in our case tissue culture media. Our analysis of tissue culture supernatant 
determined that iEGFP-Crb3a could be isolated from these samples.  This is consistent 
with the presence Crb3a in urinary exosomes (82). 
When we knocked down a TSG101, a MVB protein, Crb3a protein increased and 
Crb3a increase was not caused by increased transcription.  Since, traffic into the MVB 
pathway is down stream of the AEEs, we believe the accumulation of a Crb3a signal in 
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the cytosol to represent the inability of the cell to efficiently shuttle Crb3a to the MVB 
pathway.  In Drosophila, a complete null of the homologue for TSG101 has been created 
(78, 79, 192).  These flies exhibit massive overgrowths similar to neoplastic tumors in the 
eye and show a vast increase in cytoplasmic dCrumbs protein (79, 192).  In TSG101 
mutants, cell autonomous overgrowth was attributed to changes in dCrumbs endocytosis 
and transcription (78).  Non-autonomous overgrowth in TSG101 mosaic mutant flies was 
due to increased Notch signaling (192).  In flies genetically null for endocytotic Rab5 or 
Avl, which are upstream of TSG101, development of Notch-independent neoplastic tumor 
growth is observed suggesting dCrumbs as a regulator of tumor growth (167).   TSG101 
shRNA MDCKII cells do not show cell autonomous or cell non-autonomous overgrowth 
phenotypes at 1, 6, or 12 days in either 2 or 3-dimensions.  The role of TSG101 as a 
tumor suppressor continues to remain unclear as TSG101 knockout is also embryonic 
lethal in mammals indicating the TSG101 gene is necessary for development (240). 
Transplanted NIH3T3 cells deficient in TSG101 can form neoplastic tumors in nude mice 
(155).  However in further studies, TSG101 has been identified as a tumor suppressor in 
some but not all tissues (29, 215, 286).  Accordingly, in mammalian cells it has been 
reported that TSG101 depletion increases a cells susceptibility to apoptosis (286).   Thus, 
in cultured cells, TSG101 shRNA may be self-selecting where only cells with moderate 
knockdown survive.  This could potentially lead to a moderate increase in Crb3a protein 
that we observe.  Additionally, we observed that knockdown of TSG101 in a cell 
moderately overexpressing mEGFP-Crb3a resulted in Crb3a overexpression phenotypes 
such as apical doming.  Herz and Bergmann hypothesized that the role of TSG101 as a 
tumor suppressor in mammals remains unclear due to the necessity of a “second hit” 
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resulting in resistance to apoptosis (94).  We therefore hypotheisize that overexpressed 
Crb3a could potentially act as a second genetic abrogation that results in cellular 
overgrowth.  In this model system, TSG101 knockdown combined with Crb3a 
overexpression should to lead overgrowth phenotypes.  In fact, induced iGFP-Crb3a cysts 
alone do not overgrow, but combining iGFP-Crb3a induction and TSG101 knockdown 
does cause overgrowth phenotypes.   When analyzing these cells by Western blot, we 
discovered that overexpression of Crb3a was able to induce high levels of TSG101, and 
rescue TSG101 expression.  Although speculative at this point, we conclude that 
overexpression of Crb3a in polarized MDCKII cells causes a feedback loop that results in 
upregulation of transcription of genes required to maintain cellular homeostasis.  It has 
recently been suggested that Crumbs behaves as a tumor suppressor and is a far upstream 
component of the Warts/Hippo signaling pathway controlling cell size and growth (160, 
233).  These studies are in there infancy, but we believe this represents a fertile basis for 
the study of Crb3a in endocytosis mediated signaling as a epithelial regulation 
mechanism.  
Importantly, it has been demonstrated that the majority of proteins entering into 
the ESCRT/MVB pathway proteins are ubiquitinated (135).  Crb3a contains 3 candidate 
lysines in its cytoplasmic domain, and entering the intracellular sequence of Crb3a 
through an ubiquitination prediction algorithm produced lysine 112 as having a high 
probability of ubiquitination.  Point mutations were made on Crb3a K112, however we 
could not detect any ubiquitination in a number of assays.  This suggests that Crb3a is 
either ubiquitinated on a different lysine, the ubiquitination of Crb3a is transient, Crb3a is 
not ubiquitinated, or Crb3a is removed from the cell under a mechanism other than MVB 
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formation. There is emerging evidence that ubiquitination is not an absolute necessity for 
MVB inclusion and association with ubiquitinated cargo or other cytoplasmic motifs may 
confer entry into the MVB pathway (48).  An alternative mechanism for the presence of 
Crb3a in the media can be attributed to a phenomenon call apical shedding.  It has also 
been reported that other apical membrane proteins such as prominin-1 are removed from 
the membrane surface by direct budding into the lumen from apical surfaces (178, 179).   
In either exosome biogenesis or apical shedding, the presence of proteins in media 
supernatant suggests the protein is removed from the cell via one these two pathways and 
further studies by our group are underway to determine what the exact mechanism Crb3a 
uses to leave the polarized cell. 
With Den2-Crb3a cells, after 1 minute of excitation with UV light, we were able 
to detect an increase in signal from newly synthesized (green) Den2-Crb3a within 1 hour.  
After 4 hours post photoswitch, newly synthesized Crb3a appeared to overtake the 
population of converted (old, red) Den2-Crb3a.  These initial observations led us to 
speculate that Crb3a is constantly being produced in cells.  To help maintain Crb3a 
levels, it would also require Crb3a to undergo rapid turnover and degradation.  
Continuing our analysis of the removal of Crb3a protein from the cell as a mode of 
epithelial regulation, we became interested in Crb3a protein half-life.  We wanted to 
know if the presence or absence of a defined apical surface affects the ability of Crb3a 
protein to be retained in cells.  Our iGFP-Crb3a system provided us with a method to 
circumvent technical problems associated with the endogenous Crb3a protein.  Crb3a is a 
small transmembrane protein of only 121 amino acids, and contains only one methionine 
that is the start methionine and part of the cleaved signal peptide.  The sequence of Crb3a 
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does not contain any cysteine residues therefore S35 labeling of Crb3a could only be 
undertaken by engineering a construct complete with sulfur containing residues in order 
to successfully metabolically label cells.  We believe this method to be unreliable due to 
the transient nature of the protein and the possibility that introduction of sulfur containing 
amino-acids could possibly affect our results by the potential of creating disulfide 
linkages where none previously exist.  We have also discovered that Crb3a is a highly 
post-translational modified protein in MDCKII cells containing both N and O linked 
glycosylations.  We have only been able to authenticate one post-translational 
modification, an N-linked glycosylation event on asparagine-36 (170).  Unfortunately, 
previous work in the lab determined that this N-linked glycosylation was not necessary 
for proper function of Crb3a in MDCKII cells (170).  
We utilized modified pulse chase to calculate the Crb3a half-life in both fully 
polarized MDCKII cells and cells that have gone through the epithelial to mesenchymal 
transition (EMT) by exogenous expression of the oncogene Snail (33, 294).  Surprisingly, 
our results suggest that the half-life of Crb3a is approximately 3-6 hours and the half-life 
is not affected by a non-polarized EMT state.  These data were generated by looking at 
production of Crb3a without influence of the endogenous promoter that can be under 
EMT transcription factor control (133, 294).  Even though the half-life of Crb3a did not 
change during EMT conditions, there was a significant difference in the maturation of the 
iGFP-Crb3a protein suggesting that part of the EMT program is a restructuring of 
trafficking machinery in cells.  In iGFP-Crb3a/Snail-flag cells, iGFP-Crb3a is still found 
on the surface albeit at lower concentrations, and this may signify that polarization is 
required for the optimum delivery of Crb3a to the surface.  Furthermore, our data also 
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suggest that EMT is a transcriptional process, changing cell morphology by genetic 
rearrangement and not through upregulation of conventional protein degradation 
machinery, at least in terms of Crb3a degradation.  A half-life of 3-6 hours of Crb3a 
becomes significant when one considers that E-cadherin has a half-life of  > 40 hours 
(166).  During EMT, the levels of Crb3a will fall quite fast and this can contribute to the 
loss of cell polarization.  Additionally, FRAP analysis on fully polarized MDCKII cells 
showed that both apical and junctional pools of mEGFP-Crb3a have very similar 
motilities relative to each other in fully polarized monolayers.  Conventionally in the field 
of epithelial polarity it as been argued that the apical surface is very dynamic while the 
junctions are static in nature. It has been demonstrated that the tight junction structural 
protein ZO-1 is also mobile during steady-state (252).  This data has often been unfairly 
dismissed due to ZO-1 being a purely cytosolic protein, however, further studies have 
also demonstrated other mobile tight junction components (137).  Our data demonstrates 
that a transmembrane protein, Crb3a, is also dynamic at both the apical membrane and 
tight junction.   This data strongly implies that epithelial tight junctions are dynamic 
structures undergoing constant remodeling.  Furthermore, since Crb3a is such as strong 
inducer of polarity and has a relatively short life span, it can also be implied that polarity 




Chapter 5  
 
Conclusions, Perspectives, and Future Directions 
 
 
 The ability for cells to establish cell polarity represents a major evolutionary 
milestone where organisms could begin to form specialized germ layers that will 
eventually give rise to complex tissues.  The epithelial cell layer represents a highly 
specialized cell layer that demonstrates a structure-function relationship of polarized 
cells.  Over the last 20 years, our understanding of the molecular mechanisms governing 
the establishment, maintenance, and regulation of epithelial integrity has grown 
exponentially.  The identification of the Crumbs, Par, and Scribble polarity complexes 
and the realization that these proteins represent conserved developmental mechanisms in 
a variety of organisms has set the basis for the study of polarization.  The initial 
descriptions of the protein-protein interactions that are required for epithelial polarity 
represent only the first clues about the complexity of this system.  
 The work represented in this thesis explores the regulatory mechanisms governing 
the conserved Crumbs polarity complex.  The Crumbs complex consists of the proteins 
Crumbs3A (Crb3a), protein associated with Lin-7 1 (PALS1), and PALS1 associated tight 
junction protein (PATJ) and each member of the complex has been demonstrated to be 
involved with the formation of the tight junction (235, 254, 262).  Both PALS1 and PATJ 
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are cytosolic scaffold proteins consisting of multiple protein-protein interaction domains.  
PALS1 and PATJ are both regulated by their abilities to interact with each other and other 
accessory proteins found at the tight junction.  Lin-7 is one of these accessory proteins, 
and although not part of the conserved Crumbs complex, Lin-7 is necessary to stabilize 
PALS1 in MDCKII cells (Chapter 2 and (261)).  It has been previously demonstrated that 
PALS1 in turn stabilizes PATJ in MDCKII cells, leading us to conclude that during tight 
junction formation, Lin-7 is upstream of PALS1 and PATJ, stabilizing the formation of 
the Crumbs polarity complex.  We believe this stabilization occurs due to the nature of 
Lin-7-PALS1-PATJ binding, which is mediated by L27-domain dimerization that would 
require proteins to be in proper conformation to interact with one another (156).   
What our studies in Chapter 2 do not address is the spatial and temporal 
association of the Lin-7-PALS1-PATJ interaction and how these two important variables 
will ultimately affect the ability for cells to form tight junctions and specialized 
membrane domains. Our lab has briefly investigated the affect of depleting PALS1 on 
events leading to the trafficking of proteins.  In 2007, Wang et al demonstrated that 
knockdown of PALS1 had an effect on the exocyst and trafficking of basolateral E-
cadherin suggesting a role between tight junction formation and the ability to sequester 
proteins to their proper subcellular domains (288).  Lin-7 stabilizes PALS1, and PALS1 
stabilizes PATJ it is conceivable that depletion of either Lin-7 or PATJ would also affect 
trafficking of proteins.  In our Lin-7 shRNA study (Chapter 2) we did not find any 
adherens junction defects associated with abrogated E-cadherin traffic suggesting that 
Lin-7 functions at the lateral membrane.  At this time, we do not know where PALS1 and 
PATJ interact; however it has been proposed that this interaction is dependent on the 
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conformation of both proteins.  A proposed technique that we could utilize to determine 
when and where these interactions occur is a fluorescence resonance energy transfer 
(FRET).  We must also keep in consideration that PATJ is a large protein consisting of 
many PDZ binding domains, and not all of these domains have identified binding 
partners.  Although the interaction between PALS1 and PATJ is clearly defined, we 
cannot rule out any influences between unknown proteins that may contribute to either 
the conformation or targeting of PATJ.  Recently, the identification of angiomotin 
(AMOT) as a PATJ binding partner lends credence to the influence of Lin-7-PALS1-PATJ 
on trafficking.  AMOT is associated with Rho-GTPase family members such as Rich1 
and Cdc42 directly linking AMOT and its binding partner PATJ to the cytoskeleton (265, 
293).  Therefore, further biochemical studies are required to better characterize the 
influences of Lin-7-PALS1-PATJ as molecular scaffolds in the establishment of 
membrane domains. 
It has become increasingly apparent that genetic control of transcription is 
necessary to establish and maintain epithelial polarity.  We cited the use of RNA 
interference over the course of this work to demonstrate the affect of depletion of 
members of the Crumbs, Par, and Scribble protein complexes on epithelial phenotypes 
but we must also consider the consequences of directly inhibiting the genes from which 
these proteins are derived.  From our results found in Chapter 3, we were able to identify 
a subset of genes expressed to promote the formation of tight junctions.  Interestingly 
genes encoding conserved polarity complex proteins, only one gene, that for the protein 
Crb3, was specifically under transcriptional control regulating tight junction formation 
(Chapter 3). This data suggests that Crb3 is one of the master regulators of apico-basal 
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polarity.  In a paper by Aigner et al., PATJ was also shown to be under transcripitional 
regulation by the EMT transcriptional repressor ZEB1 (4).  However, Whiteman et al. 
demonstrated that both PATJ and PALS1 were only moderately affected by Snail-
mediated transcriptional silencing (294).  Given the multiple signaling pathways that feed 
into the EMT program, it is quite likely that individual transcription factors target only 
specific genes that control epithelial polarity.  However, interesting questions still remain 
on the secondary effects of EMT mediated transcription.  Since cells undergoing EMT 
undergo dramatic alterations in gene expression, there are presumably changes in 
transcription on genes not directly under the influence of EMT transcription repressors.  
Future work needs to be completed on the secondary affects of EMT and how these 
effects reinforce or work to overcome EMT phenotypes.  Fortunately, advances in large-
scale genomics and proteomics will allow these questions to be attacked using 
computational methods.  The ability to data mine and investigate questions using high-
throughput analysis will provide new insights to transcriptional networks and how these 
networks relate to changes in cellular phenotypes. 
One of the major problems associated with bioinformatics based approaches to 
generating new data is after the data is acquired it must be validated.  In the field of 
epithelial cell biology, validations of data previously involved using molecular biology to 
clone genes of interest and then insert these genes in the researcher’s model of choice.  
Unfortunately, this method is not always practical and characterizations especially for 
phenotypes that aren’t initially obvious.  In the case of in vitro tissue culture modeling, 
genetic manipulation can be done with relative ease, however pitfalls such as clonal 
artifacts or cell death quite common.  Additionally, it has become apparent that cells 
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behave differently in 2-dimesional and 3-dimensional contexts.  Three-dimensional tissue 
culture is a technique that is growing in popularity because it takes into consideration the 
behavior of a cell in space (214, 245).  Using space as a variable allows scientists to more 
sensitively monitor the relationship between generation of polarity and maintenance of 
apico-basal cell polarity.  
In this work, we have attempted to consider the role of 3-dimensional growth 
when considering the role of Crb3a in epithelial cell polarity.   Our studies contained here 
have illustrated that Crb3a is a strong inducer of polarity and that polarity is a dynamic 
process.  Through trafficking of Crb3a, epithelial cells can form junctions, define 
surfaces, and importantly maintain epithelial integrity.  When we consider individual 
epithelial cells in 3-dimensional space, as part of an entire functional epithelial sheet, we 
find that each cell must function as part of a whole to maintain the integrity of the 
epithelial sheet.  Although our understanding on how Crb3a is trafficked is only 
beginning to become clear, we believe this work represents some of the first attempts to 
understand how polarity is controlled and maintain in the context of 3-dimensions.  We 
still have limited understanding of why Crb3a is recycled only preceding apical 
membrane formation.  Importantly, during apical lumen formation we do not understand 
the signals that trigger endocytosis of Crb3a into the cell, the signals that target Crb3a to 
the spindle pole, and the signals that insert Crb3a at the site of apical membrane.  Work is 
currently being done in the lab to address these questions.  Experiments conducted in this 
thesis indicate that Crb3a is a dynamic protein capable of defining the apical surface of 
polarized epithelial cells.  Mobility assays demonstrate that apical and junctional Crb3a 
moves efficiently through the cell.  A mobile fraction of Crb3a combined with the 
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bypassing of the apical recycling systems suggests the very nature of polarization is 
dynamic rather than static.  The obvious question then becomes, what advantage does 
dynamic polarity give to complex organisms?  Considering that the kidney is one of the 
major organ systems of the body responsible for filtering waste from the blood and 
maintaining ion balance, it can be hypothesized that the natural and constant replacement 
of the apical surface serves as a defense mechanism against invasion and infection.  There 
also lies the possibility that apical shedding or exomsome secretion provides a signaling 
function in epithelial sheets.  In the intestine for example, there are documented examples 
of exosomes in signaling against in host defense and growth control (171).  Thus far 
exosome signaling has not been demonstrated in the mammalian kidney but as mentioned 
there does exist some precedence for the study of this phenomenon (82).  We have 
actually tested to see if Crb3a has some signaling function in what we can only label as 
paracrine signaling.  Since apical Crb3a has no defined function in mammalian cells (as 
of yet) we asked the question as to whether Crb3a in the media provides a signal to 
neighboring cells to facilitate any downstream signaling events.  Initially, we just used 
media from mEGFP-Crb3a cells and placed it on wild type MDCKII cells to see if cells 
have the ability to uptake Crb3a from the media.  These experiments were unsuccessful, 
however we cannot discount that there is no other signaling event taking place.   
For example, in Drosophila, work in the last year has suggested that Crumbs is 
one of the upstream most components of the Warts/Hippo pathway and positively 
controls pathway activation by binding the FERM-binding protein Expanded (14, 77, 88, 
90, 160, 233).  A mammalian homologue of Expanded is yet to be identified.  In the 
Warts/Hippo pathway, Yes-associated protein (YAP) is downstream transcription factor 
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and localizes to the nucleus during Warts/Hippo activation (304).  However, when we 
overexpress Crb3a in MDCKII cells we cannot appreciably detect nuclear YAP 
suggesting that Crb3a overexpression may not regulate Warts/Hippo signaling in 
mammalian cells.  It should be noted that Drosophila Crumbs is most similar to 
mammalian Crb1, and that flies do not possess a protein similar to mammalian Crb3a.  
This raises the interesting question of what is the evolutionary advantage of Crb3a in 
mammalian systems?  Crb3a is obviously necessary for development of mammals so it 
must have a striking role in the building the complex body systems of mammals.  We 
hope to address this issue further in the Margolis lab by building mice by both GFP-
“knock-in” and conditional knockout strategies.  We hope these mice will provides us 
insight to the role of Crb3a in the development of the kidney and other tissues as well as 




FRT and FRTL5 Complete Microarray Data Sets 
 
 In Chapter 3 we presented microarray data comparing amounts of transcripts in 
wild type FRT cells relative to wild type FRTL5 cells.  In the tables below, we have 
included the entire data sets for genes upregulated in both FRT cells and FRTL5 cells.  
Positive t-statistics indicate the gene is upregulated in FRT cells relative to FRTL5 cells 
and negative t-statistics indicate the gene is upregulated in FRTL5 cells relative to FRT 
cells. 
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Genes upregulated in FRT cells relative to FRTL5 cells 
 
 
Symbol Description GenBank t-statistic Fold Change 
Tspan8 tetraspanin 8 NM_133526 67.09 9.9 
Cdh1 cadherin 1 NM_031334 62.82 8.57 
Tacstd1 tumor-associated calcium signal transducer 1 BG376410 62.66 8.45 
Cldn8 claudin 8 BI292090 57.71 8.64 
S100a11 S100 calcium binding protein A11 (calizzarin) BG378926 55.46 7.56 
  BM387197 55.08 8.37 
Ubqln2_predicted ubiquilin 2 (predicted) BF398140 53.22 8.58 
Scd2 stearoyl-Coenzyme A desaturase 2 NM_031841 52.09 8.11 
Slco4a1 solute carrier organic anion transporter family, member 4a1 AI180349 50.81 7.44 
  BE108949 50.45 7.13 
  AI501237 49.28 7.14 
S100a6 S100 calcium binding protein A6 (calcyclin) AF140232 49.13 8.1 
  BI288769 48.49 6.65 
Gpx1 glutathione peroxidase 1 S41066 48.34 7.08 
S100a4 S100 calcium-binding protein A4 NM_012618 46.98 6.45 
Lgals3 lectin, galactose binding, soluble 3 NM_031832 45.91 7 
Manba mannosidase, beta A, lysosomal BM388852 45.79 6.84 
Capg capping protein (actin filament), gelsolin-like BM384693 45.33 6.67 
LOC315883 similar to phospholipid scramblase 2 AI411594 45.27 7.27 
Cd74 
CD74 antigen (invariant polypeptide of 
major histocompatibility complex, class II 
antigen-associated) 
NM_013069 45.04 7.14 
Sema4a 
sema domain, immunoglobulin domain (Ig), 
transmembrane domain (TM) and short 
cytoplasmic domain, (semaphorin) 4A 
AI228417 44.69 6.31 
Pof1b_predicted premature ovarian failure 1B (predicted) BG375052 44.62 7.47 
Ggh gamma-glutamyl hydrolase NM_012960 44.39 6.09 
Tacstd2 tumor-associated calcium signal transducer 2 AA891826 43.56 6.95 
RGD1308059 similar to DNA segment, Chr 4, Brigham & Womens Genetics 0951 expressed AI408727 43.46 7.02 
Fabp5 fatty acid binding protein 5, epidermal U13253 43.45 6.94 
  BG376453 42.74 7.24 
RGD1308084 similar to hypothetical protein FLJ11342 BM389654 42.63 6.27 
  AI599072 42.48 6.01 
Gata3 GATA binding protein 3 BE118901 41.91 6.29 
Cldn4 claudin 4 BE328951 41.83 7.49 
Krt2-8 keratin complex 2, basic, gene 8 BF281337 41.49 6.96 
Foxa1 forkhead box A1 BM383972 41.23 6.12 
Nppb natriuretic peptide precursor type B NM_031545 41.03 5.95 
LOC299339  BI278479 40.93 5.65 
Atox1 ATX1 (antioxidant protein 1) homolog 1 (yeast) NM_053359 40.64 6.08 
Muc1 mucin 1, transmembrane BI274326 40.35 6.28 
Anxa8 annexin A8 BM389254 39.23 5.53 
Prom1 prominin 1 NM_021751 38.98 6.04 
Pof1b_predicted premature ovarian failure 1B (predicted) BI291859 38.94 6.12 
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Cldn1 claudin 1 AI137640 38.68 5.36 
Msln mesothelin NM_031658 38.01 6.41 
Lamb3 laminin, beta 3 BE101834 37.91 6.51 
Axl AXL receptor tyrosine kinase AI406520 37.52 6.21 
Crb3 crumbs homolog 3 (Drosophila) BI283883 37.45 5.23 
Pls1_predicted plastin 1 (I isoform) (predicted) BM392070 37.43 5.29 
  AW522833 37.42 6.53 
Rab25_predicted RAB25, member RAS oncogene family (predicted) AA945861 37.28 5.89 
Tmed6_predicted transmembrane emp24 protein transport domain containing 6 (predicted) BI294972 37.11 6.54 
Clca6 chloride channel calcium activated 6 BI292185 37.1 5.49 
LOC500040 similar to Testis derived transcript AI177869 37.08 6.38 
Myo1b myosin Ib NM_053986 36.93 5.68 
  BF416794 36.88 6.36 
Tmprss2 transmembrane protease, serine 2 AI412136 36.66 5.78 
  AI600031 36.66 5.47 
Igsf4a immunoglobulin superfamily, member 4A H31111 36.21 5.07 
Fxyd2 FXYD domain-containing ion transport regulator 2 AF129400 36.01 7.02 
Plk2 polo-like kinase 2 (Drosophila) NM_031821 35.81 7.31 
Mapk12 mitogen-activated protein kinase 12 NM_021746 35.7 5.78 
Spint1 serine peptidase inhibitor, Kunitz type 1 BI280343 35.56 5.13 
Spop speckle-type POZ protein BF283504 35.49 5.3 
Cnksr3 Cnksr family member 3 AW253242 35.29 6.74 
  AA891842 35.12 5.38 
  BI274357 34.99 5.22 
  BM383684 34.91 5.54 
Igsf4a immunoglobulin superfamily, member 4A BE117767 34.88 5.83 
Eva1_predicted epithelial V-like antigen 1 (predicted) BI282616 34.77 6.02 
  BM387197 34.7 6.99 
RGD1564216_predicted similar to Myoferlin (Fer-1 like protein 3) (predicted) AW917760 34.67 4.69 
  BI274321 34.65 4.71 
Htra1 HtrA serine peptidase 1 NM_031721 34.51 6.29 
Itgb6 integrin, beta 6 AI070686 34.5 5.06 
  BM383423 34.32 5.94 
Mal myelin and lymphocyte protein, T-cell differentiation protein NM_012798 34.23 4.69 
Tspan1 tetraspanin 1 BE349699 34.14 5.62 
LOC498222 similar to specifically androgen-regulated protein BI291703 34.07 6.32 
Plat plasminogen activator, tissue NM_013151 33.88 4.96 
  AW522835 33.87 4.56 
RGD1560481_predicted similar to hypothetical protein FLJ20171 (predicted) BM387466 33.78 4.79 
Scd2 stearoyl-Coenzyme A desaturase 2 BE107760 33.61 4.89 
Gdpd3_predicted glycerophosphodiester phosphodiesterase domain containing 3 (predicted) BM389800 33.32 4.96 
  BF389666 33.25 4.77 
Hmga1 high mobility group AT-hook 1 BG378885 33.2 4.53 
  BF284677 33.18 4.47 
Trim35 tripartite motif protein 35 BE111791 33.13 4.56 
  AI111707 33.03 4.54 
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Sfn_predicted stratifin (predicted) BI286166 32.86 6 
Slco4a1 solute carrier organic anion transporter family, member 4a1 NM_133608 32.8 4.95 
  BM389293 32.8 4.48 
L1cam L1 cell adhesion molecule NM_017345 32.57 4.42 
Crim1_predicted cysteine-rich motor neuron 1 (predicted) BI289620 32.54 4.48 
Chrna4 cholinergic receptor, nicotinic, alpha polypeptide 4 BF394332 32.47 4.54 
  BI284288 32.36 4.62 
  BI288775 32.23 4.62 
Tmc4 transmembrane channel-like gene family 4 AI556940 32.07 4.41 
Plac1 placenta-specific 1 BI293691 32.05 5.96 
  AI069912 31.97 5.34 
Cdh3 cadherin 3, type 1, P-cadherin (placental) AI010270 31.91 4.68 
Fcgr3 Fc receptor, IgG, low affinity III NM_053843 31.88 4.54 
B4galnt1 beta-1,4-N-acetyl-galactosaminyl transferase 1 NM_022860 31.87 4.33 
  AA893164 31.85 5.26 
  AI576177 31.7 5.91 
Ppm1h protein phosphatase 1H (PP2C domain containing) AI548159 31.65 4.71 
Bace2 beta-site APP-cleaving enzyme 2 BF408665 31.62 5.57 
RGD1311155 similar to RIKEN cDNA 9230117N10 AI716248 31.5 7.13 
Gjb5 gap junction membrane channel protein beta 5 NM_019241 31.44 4.88 
Ly6a_predicted lymphocyte antigen 6 complex, locus A (predicted) BI291986 31.35 5.23 
Hrasls3 HRAS like suppressor 3 BG378637 31.31 5.46 
Vldlr very low density lipoprotein receptor AA849857 31.29 5.26 
Mgst2_predicted microsomal glutathione S-transferase 2 (predicted) BI290559 31 4.29 
LOC498796 hypothetical protein LOC498796 BF283267 30.69 4.16 
  BE109274 30.66 4.32 
Elf3 E74-like factor 3 BI279615 30.64 4.96 
Hs3st1 heparan sulfate (glucosamine) 3-O-sulfotransferase 1 AF177430 30.61 5.76 
  BF412036 30.56 4.58 
Akap5 A kinase (PRKA) anchor protein 5 AW523875 30.48 4.44 
LOC299339  AI103284 30.37 5.74 
LOC304000 cell adhesion molecule JCAM BF411017 30.3 4.5 
Akr1b8 aldo-keto reductase family 1, member B8 AI233740 30.24 4.77 
Anxa1 annexin A1 NM_012904 30.23 4.29 
Tmem54 transmembrane protein 54 BG377582 30.18 4.1 
  BI292758 30.06 4.52 
Mtap_predicted methylthioadenosine phosphorylase (predicted) BE107396 29.95 4.36 
F2r coagulation factor II (thrombin) receptor NM_012950 29.87 4.12 
Timp1 tissue inhibitor of metalloproteinase 1 NM_053819 29.77 4.21 
Lad1_predicted ladinin (predicted) AA799544 29.76 4.35 
Cdkn2a cyclin-dependent kinase inhibitor 2A AF474976 29.64 4.94 
Atp8b1_predicted ATPase, Class I, type 8B, member 1 (predicted) BM384161 29.56 4.13 
RGD1311580_predicted 
similar to actin filament associated protein; 
actin filament-associated protein, 110 kDa 
(predicted) 
BE101285 29.48 4.39 
Cldn1 claudin 1 NM_031699 29.36 4.71 
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Hgfac hepatocyte growth factor activator BE119649 29.35 5.32 
Lamc2 lamimin, gamma 2 BM385282 29.32 4.83 
Vldlr very low density lipoprotein receptor NM_013155 29.26 6.06 
Akr7a3 aldo-keto reductase family 7, member A3 (aflatoxin aldehyde reductase) NM_013215 29.1 4.68 
  BF419515 29.08 4.73 
Ppp2r3a protein phosphatase 2 (formerly 2A), regulatory subunit B'', alpha AI717707 29.07 4.03 
Cldn1 claudin 1 AW917275 29.04 4.79 
  BE106581 29.04 3.96 
Epn3 epsin 3 BM387330 28.98 5.01 
  AA997873 28.6 4.61 
  BM389496 28.58 4.53 
Meis1_predicted Meis1, myeloid ecotropic viral integration site 1 homolog (mouse) (predicted) AW532697 28.44 4.1 
RGD1305347_predicted similar to RIKEN cDNA 2610528J11 (predicted) AA819329 28.42 5.04 
  AI102833 28.41 4.45 
Mawbp MAWD binding protein AY083160 28.36 4.03 
  AW534142 28.34 4.13 
Lphn2 latrophilin 2 AF081153 28.33 3.96 
Elavl2 ELAV (embryonic lethal, abnormal vision, Drosophila)-like 2 (Hu antigen B) AI145457 28.32 4.07 
  AA819254 28.32 4 
  BE096535 28.3 4.04 
  AA800701 28.23 5.15 
Cav2 caveolin 2 BE349669 28.11 4.09 
RGD1561662_predicted similar to AI661453 protein (predicted) AI716243 28.09 4.34 
  AI233227 28.07 4.14 
Cxadr coxsackie virus and adenovirus receptor BG665433 28.07 4.1 
  AI703807 28.04 4 
Frk fyn-related kinase NM_024368 28.02 5.33 
Sphk1 sphingosine kinase 1 AB049572 27.97 3.8 
Dpysl3 dihydropyrimidinase-like 3 BF420803 27.94 4.21 
Pkp1_predicted plakophilin 1 (predicted) BG371843 27.9 4.75 
LOC361623  AI406517 27.9 3.8 
Elavl2 ELAV (embryonic lethal, abnormal vision, Drosophila)-like 2 (Hu antigen B) BF563441 27.8 4.07 
  AI709768 27.78 5.34 
Mbp myelin basic protein BG374506 27.78 4.16 
Gstm5 glutathione S-transferase, mu 5 U86635 27.76 6.84 
  AI045201 27.75 6.04 
RT1-Da RT1 class II, locus Da Y00480 27.74 3.82 
Irf6_predicted interferon regulatory factor 6 (predicted) BF410603 27.7 4.87 
Crim1_predicted cysteine-rich motor neuron 1 (predicted) AI600057 27.58 4.61 
Gabrp gamma-aminobutyric acid A receptor, pi NM_031029 27.56 5.6 
  BF392317 27.53 4.06 
Klf5 Kruppel-like factor 5 BM382886 27.45 3.92 
Id2 inhibitor of DNA binding 2 AI008792 27.33 5.35 
LOC500877 Ab1-152 AA891922 27.29 4.79 
  BG377362 27.29 3.81 
Cldn7 claudin 7 AJ011811 27.23 6.03 
Slc22a18 solute carrier family 22 (organic cation transporter), member 18 BM391436 27.23 5.05 
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Irx2 Iroquois related homeobox 2 (Drosophila) BF563976 27.19 3.99 
Abcc3 ATP-binding cassette, sub-family C (CFTR/MRP), member 3 AF072816 27.18 3.91 
Cd59 CD59 antigen NM_012925 27.12 4.81 
LOC365960 similar to semaF cytoplasmic domain associated protein 2 BF285490 27.02 4.07 
  AW534737 26.98 4.15 
Foxq1 forkhead box Q1 NM_022858 26.89 4.51 
Rrad Ras-related associated with diabetes NM_053338 26.83 6.22 
Cav2 caveolin 2 BE349669 26.83 3.95 
Tmc4 transmembrane channel-like gene family 4 AI556940 26.79 5.05 
  BE111796 26.78 6.88 
RT1-Bb RT1 class II, locus Bb BI279526 26.73 3.96 
  AI178222 26.7 4.76 
Nqo1 NAD(P)H dehydrogenase, quinone 1 J02679 26.7 4.73 
Tpo1 developmentally regulated protein TPO1 NM_133395 26.67 5.85 
RGD1308297 similar to CG10084-PA BE117193 26.57 3.78 
Bk brain and kidney protein U30831 26.52 4.02 
Tmc4 transmembrane channel-like gene family 4 BF545988 26.46 5 
Serinc2 serine incorporator 2 BF419780 26.4 6.93 
  BF551377 26.32 3.65 
  BI285447 26.26 4.02 
RGD1309720 similar to Hypothetical protein MGC19163 BI289108 26.21 4.29 
Klf4 Kruppel-like factor 4 (gut) NM_053713 26.17 3.54 
Phlda2_predicted pleckstrin homology-like domain, family A, member 2 (predicted) AI029402 26.1 4.73 
  AW528448 26.09 3.98 
  AI145306 26.08 5.17 
Sh3bgrl3_predicted SH3 domain binding glutamic acid-rich protein-like 3 (predicted) BG666075 26.05 5.63 
  BI285850 26.03 3.95 
  BF558478 25.97 3.65 
Fez2 fasciculation and elongation protein zeta 2 (zygin II) AA955230 25.75 4.69 
  AA998383 25.65 3.97 
Id2 inhibitor of DNA binding 2 NM_013060 25.64 4.67 
RGD1561394_predicted similar to MLTK-beta (predicted) BM390528 25.57 3.45 
Ahnak AHNAK nucleoprotein (desmoyokin) AI407114 25.45 3.49 
Klf5 Kruppel-like factor 5 NM_053394 25.34 4 
Prps2 phosphoribosyl pyrophosphate synthetase 2 NM_012634 25.32 4.95 
  AA800593 25.31 4.71 
Aplp1 amyloid beta (A4) precursor-like protein 1 AW435479 25.29 4.19 
RGD1565540_predicted similar to ctla-2-beta protein (141 AA) (predicted) AI230591 25.27 3.88 
  BF396739 25.25 3.44 
Il24 interleukin 24 NM_133311 25.18 4.43 
RGD1307875_predicted similar to FLJ23471 protein (predicted) BG373522 25.09 4.06 
  BE109381 24.93 3.68 
Ndrg4 N-myc downstream regulated gene 4 BG666709 24.85 4.05 
Pctk2 PCTAIRE-motif protein kinase 2 AI716206 24.81 3.37 
Cln6_predicted ceroid-lipofuscinosis, neuronal 6 (predicted) AI105369 24.76 4.09 
Ttr transthyretin BE098869 24.69 5.04 
Lphn2 latrophilin 2 NM_134408 24.67 4.82 
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  AI059853 24.64 4.62 
Phyhd1 phytanoyl-CoA dioxygenase domain containing 1 BI275763 24.51 3.31 
Cdx2 caudal type homeo box 2 NM_023963 24.45 3.44 
Bdh1 3-hydroxybutyrate dehydrogenase, type 1 NM_053995 24.44 3.77 
Mina myc induced nuclear antigen BI278157 24.4 3.44 
Casp3 caspase 3, apoptosis related cysteine protease U84410 24.38 3.35 
Gstm1 glutathione S-transferase, mu 1 AI169331 24.33 5.15 
Dpysl3 dihydropyrimidinase-like 3 BI294841 24.26 5.57 
Fxyd4 FXYD domain-containing ion transport regulator 4 NM_022388 24.25 6.14 
Ankrd1 ankyrin repeat domain 1 (cardiac muscle) NM_013220 24.25 4.66 
RT1-Ba RT1 class II, locus Ba AF307302 24.14 3.35 
  BI279363 24.07 3.63 
Bcor_predicted Bcl6 interacting corepressor (predicted) BI289386 24.06 3.5 
Cst6 cystatin E/M NM_133566 24.05 4.2 
  BI291373 24.04 4.01 
Lcn2 lipocalin 2 NM_130741 23.98 3.27 
  BF397870 23.92 4.2 
Kif16b_predicted kinesin family member 16B (predicted) BF420465 23.84 3.68 
  BI278449 23.82 3.25 
Dnajc6_predicted DnaJ (Hsp40) homolog, subfamily C, member 6 (predicted) AW523481 23.76 3.89 
  BF560932 23.76 3.5 
Cav2 caveolin 2 NM_131914 23.71 4.11 
Prkcdbp protein kinase C, delta binding protein NM_134449 23.63 5.28 
Marveld2_predicted MARVEL (membrane-associating) domain containing 2 (predicted) BI280967 23.56 3.38 
Bspry B-box and SPRY domain containing AW529938 23.55 6 
  AI180454 23.51 3.44 
Cldn6_predicted claudin 6 (predicted) AI030970 23.48 3.97 
Rnf39 ring finger protein 39 NM_134374 23.46 4.27 
Htatip2_predicted HIV-1 tat interactive protein 2, homolog (human) (predicted) BG378579 23.44 3.41 
Cldn3 claudin 3 NM_031700 23.4 4.01 
Ces2 carboxylesterase 2 (intestine, liver) NM_133586 23.39 4.44 
Eps8l1_predicted EPS8-like 1 (predicted) AI715477 23.34 3.5 
  BE107296 23.29 5.28 
Aqp9 aquaporin 9 NM_022960 23.29 3.44 
Sox4_predicted SRY-box containing gene 4 (predicted) AA956294 23.29 3.28 
RGD1309219 similar to hypothetical protein HSPC129 BI291413 23.25 4.61 
Cd79b CD79B antigen NM_133533 23.22 3.18 
Tspan8 tetraspanin 8 AI229420 23.18 4.98 
Pak1 p21 (CDKN1A)-activated kinase 1 BI281735 23.18 3.94 
Casp3 caspase 3, apoptosis related cysteine protease BM387008 23.18 3.23 
LOC309169 tangerin BI287221 23.12 3.7 
  BF546029 23.12 3.2 
  BM389843 23.03 3.88 
Krt2-7 keratin complex 2, basic, gene 7 BI284344 22.97 6.61 
Thbs1  BF558056 22.92 3.31 
Cav2 caveolin 2 AI406385 22.87 3.59 
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Sigirr single immunoglobulin and toll-interleukin 1 receptor (TIR) domain AA818702 22.86 3.33 
Tnxa tenascin XA BM390128 22.82 3.94 
Cryab crystallin, alpha B NM_012935 22.78 4.5 
Epn3 epsin 3 BI280079 22.78 3.69 
  BM388029 22.72 4.15 
RGD1565016_predicted similar to bruno-like 5, RNA binding protein (predicted) AI012571 22.72 3.87 
Ehf_predicted ets homologous factor (predicted) BF417773 22.71 3.71 
Gm2a GM2 ganglioside activator protein AI717483 22.67 3.18 
RGD1308084 similar to hypothetical protein FLJ11342 BE103244 22.66 4.92 
RGD1304623_predicted similar to KIAA1749 protein (predicted) AI008974 22.65 3.51 
RGD1311155 similar to RIKEN cDNA 9230117N10 BF390510 22.64 6.06 
RGD1563344_predicted similar to OTU domain containing 1 (predicted) AI717553 22.61 3.58 
Gata3 GATA binding protein 3 NM_133293 22.6 4.19 
  AW433942 22.47 3.23 
  BF396636 22.42 3.82 
Hadhsc L-3-hydroxyacyl-Coenzyme A dehydrogenase, short chain AA799574 22.41 4.68 
Reep6 receptor accessory protein 6 BG376982 22.35 3.75 
Dtnb dystrobrevin, beta BE113690 22.35 3.2 
  BM391896 22.32 3.24 
  AI407547 22.27 3.17 
Dsp desmoplakin AW144509 22.22 5.05 
  BG378310 22.22 3.26 
RGD1311316 similar to RIKEN cDNA 5730470L24 AI178732 22.11 3.07 
Yc2  AA945082 22.1 4.1 
  AA819868 22.08 3.41 
Gjb3 gap junction membrane channel protein beta 3 NM_019240 22.02 4.07 
  AI113261 22 4.79 
  BM392237 21.99 3.9 
Gbp2 guanylate nucleotide binding protein 2 NM_133624 21.98 3.39 
Serpinb7 serine (or cysteine) proteinase inhibitor, clade B, member 7 BI292651 21.96 4.91 
  AI230650 21.87 3.88 
Pea15 phosphoprotein enriched in astrocytes 15 BE112895 21.8 3.53 
  AI013361 21.79 4.14 
Il17re interleukin 17 receptor E BM383766 21.78 3.18 
  BI291629 21.74 3.58 
Dpysl3 dihydropyrimidinase-like 3 AF389425 21.71 3.41 
Cd96 CD96 antigen BE121026 21.7 3.89 
Ankrd1 ankyrin repeat domain 1 (cardiac muscle) L81174 21.63 4.18 
Acp5 acid phosphatase 5, tartrate resistant NM_019144 21.62 3.79 
Ugt1a7 UDP glycosyltransferase 1 family, polypeptide A7 AF461738 21.59 3.33 
Reep6 receptor accessory protein 6 AI070350 21.49 3.88 
Tm6sf1_predicted transmembrane 6 superfamily member 1 (predicted) BI283829 21.4 5.38 
Cd9 CD9 antigen AI227627 21.4 2.96 
Csf3 colony stimulating factor 3 (granulocyte) NM_017104 21.39 3.9 
Sdc1 syndecan 1 NM_013026 21.35 5.13 
Itgb4 integrin beta 4 NM_013180 21.34 3.17 
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Ugt1a6 UDP glycosyltransferase 1 family, polypeptide A6 J02612 21.32 3.68 
Plaur plasminogen activator, urokinase receptor AF007789 21.2 3.8 
Myo1b myosin Ib AA859008 21.19 3.05 
Grb2 growth factor receptor bound protein 2 BM386610 21.1 2.94 
Homer2 homer homolog 2 (Drosophila) NM_053309 21.09 3.42 
LOC685067  BE108569 21.08 2.94 
Lxn latexin NM_031655 21.04 3.09 
  AI045970 20.96 3.1 
Crb3 crumbs homolog 3 (Drosophila) AI072527 20.95 3.84 
  AA850472 20.95 3.09 
RGD1561472_predicted similar to mKIAA2005 protein (predicted) BG670441 20.94 3.02 
Bcl2l1 Bcl2-like 1 AF279286 20.93 3.12 
LOC299339  BF389535 20.91 4.01 
RGD1562428_predicted similar to C20orf95 (predicted) BF387347 20.88 5.45 
LOC502782 similar to RIKEN cDNA 2610022G08 AW918690 20.87 2.91 
Prkch protein kinase C, eta AA799981 20.87 2.82 
Arhgap27 Rho GTPase activating protein 27 BE100015 20.83 3.47 
Daf1 decay accelarating factor 1 AB032395 20.81 3.63 
Elmo3 engulfment and cell motility 3, ced-12 homolog (C. elegans) BI291645 20.79 4.66 
LOC316326 similar to lung inducible neuralized-related C3HC4 RING finger protein BF416847 20.79 3.67 
Sox4_predicted SRY-box containing gene 4 (predicted) BI297183 20.73 3.74 
Scrn1 secernin 1 BI276031 20.73 3.4 
Bcat1 branched chain aminotransferase 1, cytosolic AI102790 20.7 3.6 
Ifitm1_predicted interferon induced transmembrane protein 1 (predicted) BG380285 20.68 3.2 
Sync_predicted syncoilin (predicted) BF284235 20.68 2.92 
Pctk2 PCTAIRE-motif protein kinase 2 BM384057 20.65 3.07 
  AW536022 20.54 2.82 
LOC363091 similar to hypothetical protein FLJ30973 AI103939 20.43 3.18 
Sgk serum/glucocorticoid regulated kinase NM_019232 20.34 3.31 
Sox4_predicted SRY-box containing gene 4 (predicted) BE115519 20.3 3.86 
Hrasls5 HRAS-like suppressor family, member 5 BF409874 20.3 2.74 
  BM390713 20.29 3.48 
  AI178901 20.23 2.78 
Clu clusterin AF314657 20.16 3.23 
  AA892299 20.13 2.98 
RGD1309676 similar to RIKEN cDNA 5730469M10 AI169367 20.11 2.94 
  AA819035 20.1 3.23 
RGD1561161_predicted similar to BC067074 protein (predicted) AI009517 20.09 3.28 
RGD1562732_predicted similar to Glutathione S-transferase, theta 3 (predicted) BM390378 20.04 4.85 
Bace2 beta-site APP-cleaving enzyme 2 BG381587 20.02 3.11 
Serpinb1a serine (or cysteine) proteinase inhibitor, clade B, member 1a BF411331 19.99 4.9 
Tpbg trophoblast glycoprotein NM_031807 19.97 3.21 
Gsn gelsolin BI285576 19.94 5.98 
Grb2 growth factor receptor bound protein 2 AI408674 19.94 3.59 
LOC363060 similar to RIKEN cDNA 1600029D21 AI599133 19.93 2.9 
LOC685652  BI282860 19.91 4.82 
  BI296644 19.86 2.83 
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Vat1 vesicle amine transport protein 1 homolog (T californica) BI284849 19.85 3.14 
RGD1309138_predicted similar to hypothetical protein MGC9912 (predicted) AW433895 19.83 3.74 
Optn optineurin BI294994 19.83 2.92 
Pak1 p21 (CDKN1A)-activated kinase 1 U23443 19.81 2.67 
  AI411375 19.8 3.84 
Aqp3 aquaporin 3 NM_031703 19.76 3.15 
Dixdc1 DIX domain containing 1 BI296216 19.75 4.1 
Dtnb dystrobrevin, beta BM390663 19.71 2.92 
Tuft1_predicted tuftelin 1 (predicted) BE114778 19.66 2.88 
Thnsl1 threonine synthase-like 1 BF565324 19.62 2.81 
Agrn agrin M64780 19.6 3.05 
  BI295515 19.57 2.9 
  BM385296 19.55 2.77 
Sh3tc1_predicted SH3 domain and tetratricopeptide repeats 1 (predicted) AI237897 19.54 2.74 
Kat3 kynurenine aminotransferase III BI295878 19.53 3.03 
Bk brain and kidney protein U30831 19.52 3.35 
Slc1a1 
solute carrier family 1 (neuronal/epithelial 
high affinity glutamate transporter, system 
Xag), member 1 
D63772 19.47 2.82 
Mppe1_predicted metallophosphoesterase 1 (predicted) BE113263 19.38 3.23 
Sdccag8 serologically defined colon cancer antigen 8 BI299261 19.28 2.66 
Ccl2 chemokine (C-C motif) ligand 2 NM_031530 19.2 3.85 
Sdc1 syndecan 1 BG375315 19.2 3.24 
RGD1564315_predicted similar to RIKEN cDNA 9330161F08 (predicted) AA859508 19.13 3.96 
Cpne3_predicted copine III (predicted) AI237636 19.07 3.3 
RGD1303271 similar to chromosome 1 open reading frame 172 BM385475 18.98 2.58 
  BE114751 18.95 3.1 
RGD1561472_predicted similar to mKIAA2005 protein (predicted) AW533923 18.95 2.57 
  BM388843 18.89 2.86 
  AW524711 18.88 3.15 
Spna1 spectrin alpha 1 AI639523 18.85 3.91 
Kif12 kinesin family member 12 BI296819 18.82 2.68 
  BE113381 18.79 3.65 
Krt1-18 keratin complex 1, acidic, gene 18 BI286012 18.76 6.01 
Bin2 bridging integrator 2 BM386830 18.74 3.05 
  BF408350 18.71 2.84 
  BI276505 18.71 2.64 
Ocil osteoclast inhibitory lectin NM_130402 18.71 2.62 
  AI406912 18.69 3.5 
Osbpl5 oxysterol binding protein-like 5 BG372522 18.61 2.82 
Cblc Casitas B-lineage lymphoma c BM384014 18.6 3.81 
Mmp19_predicted matrix metalloproteinase 19 (predicted) BI294977 18.6 2.52 
Zfp64 zinc finger protein 64 BI296003 18.55 3.06 
Crb3 crumbs homolog 3 (Drosophila) BF553130 18.52 3.68 
  AI070306 18.5 3.06 
  AA901088 18.49 2.97 
Fcer2a Fc receptor, IgE, low affinity II, alpha polypeptide AI410068 18.43 2.69 
  BI291029 18.41 3.81 
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Ifit2 interferon-induced protein with tetratricopeptide repeats 2 AI009765 18.4 3.62 
RGD1563437_predicted similar to KIAA1217 (predicted) BF291123 18.36 2.59 
Kifc3 kinesin family member C3 BI295100 18.35 3.45 
Serpinb7 serine (or cysteine) proteinase inhibitor, clade B, member 7 NM_130404 18.32 3.83 
Bcl2l1 Bcl2-like 1 U72350 18.32 2.48 
  AI236141 18.3 2.71 
  BE328978 18.28 2.52 
  BG378715 18.26 5.12 
RGD1563506_predicted similar to junction-mediating and regulatory protein (predicted) AI112776 18.26 3.79 
Tmprss2 transmembrane protease, serine 2 NM_130424 18.2 2.76 
Rab27a RAB27A, member RAS oncogene family AI043615 18.2 2.53 
Mfi2_predicted 
antigen p97 (melanoma associated) 
identified by monoclonal antibodies 133.2 
and 96.5 (predicted) 
BF417890 18.18 4.49 
Faim2 Fas apoptotic inhibitory molecule 2 AF044201 18.18 2.69 
RGD1563547_predicted RGD1563547 (predicted) BG378463 18.16 2.93 
Plcd1 phospholipase C, delta 1 NM_017035 18.16 2.69 
  AI412601 18.1 2.56 
RGD1309930 similar to 2810022L02Rik protein BI275911 18.09 2.62 
Pik3ap1_predicted phosphoinositide-3-kinase adaptor protein 1 (predicted) AW916092 18.09 2.54 
Tgm1 transglutaminase 1 NM_031659 18.07 3.52 
Sytl2_predicted synaptotagmin-like 2 (predicted) BG670294 18.07 3.08 
Kcnq1 potassium voltage-gated channel, subfamily Q, member 1 NM_032073 18.07 2.79 
Tmem8_predicted transmembrane protein 8 (five membrane-spanning domains) (predicted) AW527467 18.06 2.6 
Ttll1 tubulin tyrosine ligase-like 1 AA818423 18.04 2.63 
Coro2a coronin, actin binding protein 2A AW529016 17.99 3.61 
Dock6_predicted dedicator of cytokinesis 6 (predicted) AI102881 17.99 2.46 
  AI713223 17.97 2.47 
RGD1309644_predicted similar to Hypothetical protein KIAA0469 (predicted) BG380058 17.96 2.56 
S100a10 S100 calcium binding protein A10 (calpactin) NM_031114 17.95 3.12 
Marcks myristoylated alanine rich protein kinase C substrate BE111604 17.94 2.56 
Vwa1 von Willebrand factor A domain containing 1 BF413643 17.92 3.2 
Epb4.1l5 erythrocyte protein band 4.1-like 5 AA858925 17.9 2.63 
RGD1308111_predicted 
similar to zinc finger protein Cezanne; 
cellular zinc finger anti-NF-kappaB 
Cezanne (predicted) 
AI716026 17.88 2.77 
  BF391800 17.87 3.2 
RGD1563506_predicted similar to junction-mediating and regulatory protein (predicted) AW532426 17.86 5.18 
Kcnk6 potassium channel, subfamily K, member 6 NM_053806 17.86 3.06 
RGD1307357_predicted similar to hypothetical protein DKFZp434A1319 (predicted) BI280278 17.86 2.44 
  AI029006 17.84 2.88 
Inpp1 inositol polyphosphate-1-phosphatase BF523172 17.84 2.5 
Mbnl3_predicted muscleblind-like 3 (Drosophila) (predicted) AI010322 17.83 3.24 
Gja4 gap junction membrane channel protein alpha 4 NM_021654 17.79 3.01 
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RGD1311580_predicted 
similar to actin filament associated protein; 
actin filament-associated protein, 110 kDa 
(predicted) 
BF409567 17.79 2.41 
  BI277442 17.77 2.41 
Plxnb1_predicted plexin B1 (predicted) BI288540 17.76 2.45 
Bspry B-box and SPRY domain containing NM_022261 17.73 4.05 
LOC501285  BF390736 17.73 2.71 
Asl argininosuccinate lyase NM_021577 17.73 2.42 
Pkp3_predicted plakophilin 3 (predicted) BI286045 17.71 3.94 
Asb2 ankyrin repeat and SOCS box-containing protein 2 BI295982 17.69 3.18 
  BE115155 17.69 3.09 
  AW526790 17.67 2.51 
Slc40a1 solute carrier family 39 (iron-regulated transporter), member 1 AI229664 17.67 2.42 
  BM391779 17.66 3.35 
  BM391096 17.66 2.44 
Ifit2 interferon-induced protein with tetratricopeptide repeats 2 BE118697 17.65 4.5 
  BI274487 17.63 3 
Lamc2 lamimin, gamma 2 AW527269 17.61 3.64 
Gas2l1_predicted growth arrest-specific 2 like 1 (predicted) AI172537 17.58 2.76 
LOC362564  AW252401 17.51 3.33 
Rassf7_predicted Ras association (RalGDS/AF-6) domain family 7 (predicted) BM385768 17.49 3.02 
Prkch protein kinase C, eta NM_031085 17.47 2.43 
Sec14l2 SEC14-like 2 (S. cerevisiae) AI575603 17.44 2.42 
Gstp2 glutathione S-transferase, pi 2 X02904 17.43 2.7 
RGD1560915_predicted similar to Hypothetical protein MGC30714 (predicted) AA819250 17.42 2.66 
  AI059968 17.41 3.28 
Mylk_predicted myosin, light polypeptide kinase (predicted) AI177055 17.39 2.68 
Znrf1_predicted zinc and ring finger 1 (predicted) BE109004 17.38 2.48 
Kif16b_predicted kinesin family member 16B (predicted) BF397930 17.34 2.39 
Inpp1 inositol polyphosphate-1-phosphatase BI275516 17.3 2.38 
Ptpn18 protein tyrosine phosphatase, non-receptor type 18 AW916153 17.29 3.39 
Slc9a3r1 solute carrier family 9 (sodium/hydrogen exchanger), isoform 3 regulator 1 NM_021594 17.29 2.48 
RGD1566310_predicted similar to RIKEN cDNA 0610012C01 (predicted) BF283013 17.26 3.08 
  BM389786 17.23 2.61 
Ggt1 gamma-glutamyltransferase 1 NM_053840 17.22 2.49 
  BE100609 17.17 2.8 
  BF283674 17.14 2.66 
Nkiras2_predicted NFKB inhibitor interacting Ras-like protein 2 (predicted) AI406810 17.1 2.55 
Cybasc3 cytochrome b, ascorbate dependent 3 AI179227 17.09 2.35 
RGD1308967_predicted similar to hypothetical protein MGC16491 (predicted) BG372643 17.03 3.37 
LOC503164 hypothetical protein LOC503164 BI289459 17.02 2.35 
Marcks myristoylated alanine rich protein kinase C substrate M59859 16.97 2.88 
Cdh23 cadherin 23 (otocadherin) AI548870 16.96 2.57 
Fut1 fucosyltransferase 1 NM_031236 16.95 2.86 
  BF398618 16.89 2.28 
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  BE109548 16.79 2.54 
Grb7 growth factor receptor bound protein 7 NM_053403 16.77 2.78 
Cdc25b cell division cycle 25 homolog B (S. cerevisiae) NM_133572 16.76 2.78 
  BM388214 16.76 2.41 
RGD1308967_predicted similar to hypothetical protein MGC16491 (predicted) BG373221 16.74 2.8 
Inhbe inhibin beta E NM_031815 16.73 3.76 
  BI274116 16.7 2.77 
Cpeb2_predicted cytoplasmic polyadenylation element binding protein 2 (predicted) BG666316 16.69 2.69 
  AI170382 16.65 2.7 
RGD1564014_predicted similar to ubiquitin-conjugating enzyme E2 variant 1 (predicted) AI712728 16.64 2.72 
LOC498662 similar to RIKEN cDNA 2610019F03 BI296812 16.62 2.6 
Mbp myelin basic protein BE109730 16.6 3.31 
Naprt1 nicotinate phosphoribosyltransferase domain containing 1 BF416417 16.6 2.33 
RGD1304601 similar to RIKEN cDNA 5730457F11 BI274660 16.55 3.08 
RGD1308297 similar to CG10084-PA BI275975 16.54 2.34 
Nudt7_predicted nudix (nucleoside diphosphate linked moiety X)-type motif 7 (predicted) AA944380 16.5 2.3 
Mall mal, T-cell differentiation protein-like BM390763 16.44 2.87 
Sh3gl2 SH3-domain GRB2-like 2 BM385941 16.4 2.78 
Syt8 synaptotagmin 8 NM_053325 16.35 2.62 
Pcbd1 
pterin 4 alpha carbinolamine 
dehydratase/dimerization cofactor of 
hepatocyte nuclear factor 1 alpha (TCF1) 1 
BF281220 16.35 2.48 
Stx3 syntaxin 3 BI295918 16.35 2.31 
Arhgap24 Rho GTPase activating protein 24 BG377201 16.34 3.72 
Hspb2 heat shock 27kDa protein 2 NM_130431 16.34 2.79 
RGD1565800_predicted similar to hypothetical protein FLJ20674 (predicted) BI292079 16.31 2.23 
Sh3gl3 SH3-domain GRB2-like 3 NM_031238 16.3 3.17 
Casp8 caspase 8 NM_022277 16.3 2.27 
  BF398462 16.29 2.5 
Padi4 peptidyl arginine deiminase, type IV AB008803 16.29 2.35 
RGD1311294_predicted similar to Hypothetical protein C6orf60 (predicted) BI296237 16.28 2.58 
  AI764288 16.27 2.63 
Mapt microtubule-associated protein tau BE107978 16.27 2.4 
  BM392135 16.21 2.36 
Cmas cytidine monophospho-N-acetylneuraminic acid synthetase AI172078 16.21 2.25 
Stx3 syntaxin 3 NM_031124 16.2 2.25 
  BE113211 16.19 2.19 
Freq frequenin homolog (Drosophila) BE102100 16.17 5.26 
St14 suppression of tumorigenicity 14 (colon carcinoma) AB049189 16.16 2.26 
RGD1560538_predicted similar to hypothetical protein FLJ21148 (predicted) BF417345 16.12 2.47 
Sertad2 SERTA domain containing 2 BI295862 16.1 2.33 
  BI277442 16.07 2.34 
Cacybp calcyclin binding protein AW918443 16.07 2.18 
Scmh1_predicted sex comb on midleg homolog 1 (predicted) AA924088 16.06 2.22 
LOC497848  BM385981 16.05 2.35 
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  AW524894 16.04 3.13 
  AW433901 16.01 2.78 
Ralgps2 Ral GEF with PH domain and SH3 binding motif 2 BF525299 15.93 2.47 
RGD1562149_predicted similar to mixed-lineage protein kinase 1 (predicted) AA892737 15.93 2.4 
Thbs1  AI406660 15.92 2.47 
Kif3c kinesin family member 3C AF083330 15.89 2.53 
  BM390322 15.88 2.47 
  BF284519 15.87 3.87 
E030032D13Rik E030032D13Rik gene AI136523 15.86 3.67 
Prkcd protein kinase C, delta NM_133307 15.85 2.82 
Prss22_predicted protease, serine, 22 (predicted) BM389391 15.84 4.27 
RGD1310262_predicted hypothetical LOC304650 (predicted) AA891356 15.82 2.31 
Timp2 tissue inhibitor of metalloproteinase 2 BF523128 15.81 2.95 
  AW533071 15.79 2.47 
Slc40a1 solute carrier family 39 (iron-regulated transporter), member 1 NM_133315 15.76 2.22 
Evi1_predicted ecotropic viral integration site 1 (predicted) BI288681 15.7 2.85 
  AI102173 15.68 2.89 
MGC93975 similar to 2310044H10Rik protein BI301512 15.67 2.49 
Ifit3 interferon-induced protein with tetratricopeptide repeats 3 AW531805 15.65 2.26 
  BE112469 15.65 2.11 
Cdh23 cadherin 23 (otocadherin) BM384374 15.64 3.29 
RGD1559427_predicted similar to BH3-only member B protein (predicted) BF418697 15.63 2.17 
Foxq1 forkhead box Q1 AI070944 15.58 5.03 
Egln3 EGL nine homolog 3 (C. elegans) NM_019371 15.58 2.29 
  AI102382 15.53 3.71 
  AW533313 15.51 2.82 
LOC294560  BE119446 15.51 2.61 
  AI102364 15.51 2.33 
Dusp14_predicted dual specificity phosphatase 14 (predicted) AI236997 15.5 2.61 
  AI677633 15.5 2.14 
LOC498796 hypothetical protein LOC498796 BF549748 15.49 2.51 
Gnao guanine nucleotide binding protein, alpha o AF413212 15.49 2.46 
Adra1d adrenergic receptor, alpha 1d NM_024483 15.47 3.83 
  BF393945 15.44 2.72 
  AI408920 15.44 2.22 
  BI293248 15.43 2.2 
Ppap2a phosphatidic acid phosphatase 2a NM_022538 15.4 2.14 
Pir pirin AI176041 15.39 3.22 
Lama3 laminin, alpha 3 U61261 15.34 2.16 
Frag1 FGF receptor activating protein 1 AI408972 15.32 2.48 
  AA899278 15.32 2.45 
Unc93b1 unc-93 homolog B1 (C. elegans) AI234533 15.3 2.62 
Jag2 jagged 2 BI274746 15.3 2.15 
2-Mar membrane-associated ring finger (C3HC4) 3 BI298096 15.28 2.14 
  BE098181 15.27 2.95 
Ramp2 receptor (calcitonin) activity modifying protein 2 NM_031646 15.27 2.55 
  BI281808 15.24 2.09 
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Irf6_predicted interferon regulatory factor 6 (predicted) BF557891 15.23 3.26 
Il15 interleukin 15 AF015718 15.23 2.1 
  AW527783 15.19 2.34 
  AA997863 15.11 2.07 
  AI136703 15.1 2.76 
RGD1309285_predicted similar to KIAA1636 protein (predicted) BF522970 15.09 2.1 
  AW251632 15.07 2.09 
Ivns1abp_predicted influenza virus NS1A binding protein (predicted) AI408553 15.06 2.05 
Klf5 Kruppel-like factor 5 BF561079 15.05 2.78 
  AI169140 15.04 3.48 
Clcf1 cardiotrophin-like cytokine factor 1 AI575844 15.04 2.28 





NM_022950 15.03 2.2 
  AI178231 15.02 2.59 
Frag1 FGF receptor activating protein 1 BG373817 15.02 2.41 
LOC294560  BF563922 15 2.2 
  AI229183 14.99 2.07 
RGD1559427_predicted similar to BH3-only member B protein (predicted) BF291168 14.98 2.23 
  BE116775 14.97 2.21 
Vsnl1 visinin-like 1 AI227991 14.95 2.1 
RGD1565561_predicted similar to O-acyltransferase (membrane bound) domain containing 1 (predicted) AI716936 14.94 4.11 
Perp_predicted PERP, TP53 apoptosis effector (predicted) BI286396 14.92 2.19 
  AA801395 14.91 2.74 
B3galt3 UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 3 AA799400 14.91 2.7 
  AA817953 14.91 2.12 
  AW433598 14.9 2.41 
Emp1 epithelial membrane protein 1 BI275741 14.9 2.28 
Atrn attractin AB038388 14.89 2.1 
RGD1564628_predicted similar to ubiquitin specific protease 27, X chromosome (predicted) BE108241 14.88 2.53 
Sh3yl1_predicted Sh3 domain YSC-like 1 (predicted) AW527403 14.87 3.1 
  BI288580 14.86 2.32 
Kcnk1 potassium channel, subfamily K, member 1 NM_021688 14.86 2.19 
  AI177743 14.84 2.02 
Marcks myristoylated alanine rich protein kinase C substrate M59859 14.79 2.6 
  BI273710 14.75 2.05 
  BF418523 14.74 2.22 
  BI275934 14.72 2.59 
Dennd2d_predicted DENN/MADD domain containing 2D (predicted) AI059486 14.72 2.11 
RGD1310006 similar to RIKEN cDNA 5730421E18 AW142960 14.69 2.12 
LOC685932  AI599362 14.67 3.2 
Tmem5 transmembrane protein 5 BG375242 14.64 2.04 
Pdgfa platelet derived growth factor, alpha BE100812 14.63 2 
  BF396512 14.62 2.23 
Mtap_predicted methylthioadenosine phosphorylase (predicted) BI278369 14.6 2.04 
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  AI409862 14.59 3.06 
Metrnl meteorin, glial cell differentiation regulator-like BM389126 14.59 2.37 
Slc25a30 solute carrier family 25, member 30 AW530647 14.58 2.61 
  AA819332 14.57 2.14 
  AI230625 14.55 3 
Rps6ka4_predicted ribosomal protein S6 kinase, polypeptide 4 (predicted) BM388595 14.54 2.2 
  BF521753 14.51 2.02 
Cln3 ceroid lipofuscinosis, neuronal 3, juvenile (Batten, Spielmeyer-Vogt disease) BI285912 14.5 2.14 
LOC498662 similar to RIKEN cDNA 2610019F03 AA964146 14.47 2.62 
  BF394727 14.46 2.35 
  BF290953 14.46 2.22 
  BE121375 14.43 3.01 
RGD1308432_predicted similar to cDNA sequence BC020002 (predicted) AA892645 14.42 2.09 
Nek6 NIMA (never in mitosis gene a)-related expressed kinase 6 BF282365 14.37 3.11 
Slc1a1 
solute carrier family 1 (neuronal/epithelial 
high affinity glutamate transporter, system 
Xag), member 1 
U39555 14.34 2.56 
Arid5b_predicted AT rich interactive domain 5B (Mrf1 like) (predicted) AW530903 14.32 2.27 
  BG667918 14.3 2.73 
RGD1561596_predicted similar to JM11 protein (predicted) BF396751 14.3 2.02 
Nfe2l3_predicted nuclear factor, erythroid derived 2, like 3 (predicted) BE108222 14.29 2.34 
Basp1 brain abundant, membrane attached signal protein 1 BG380454 14.29 2.06 
Gas2l1_predicted growth arrest-specific 2 like 1 (predicted) BG371690 14.26 2.24 
  AI409900 14.25 2.8 
  AW915533 14.25 2.29 
Tpmt thiopurine methyltransferase NM_031329 14.24 2.22 
  BF416405 14.24 2.1 
  AI233825 14.22 2.27 
  BI302830 14.22 2.04 
Cdyl2_predicted chromodomain protein, Y chromosome-like 2 (predicted) AA819458 14.21 2.34 
RGD1305081_predicted similar to ionized calcium binding adapter molecule 2 (Iba2) (predicted) BF408518 14.21 2.18 
RGD1563692_predicted similar to hypothetical protein FLJ22671 (predicted) AI717274 14.2 2.68 
Ezh1_predicted enhancer of zeste homolog 1 (Drosophila) (predicted) AA998678 14.2 2.25 
  BI283868 14.19 2.29 
S100a16_predicted S100 calcium binding protein A16 (predicted) AI406499 14.17 2.28 
Il23a Interleukin 23, alpha subunit p19 NM_130410 14.16 2.56 
Ankrd1 ankyrin repeat domain 1 (cardiac muscle) AW251306 14.1 3.16 
Gabarapl2 GABA(A) receptor-associated protein like 2 BI303388 14.09 2 
  AI179616 14.08 2.37 
  AA858498 14.08 2.14 
Slc9a3r1 solute carrier family 9 (sodium/hydrogen exchanger), isoform 3 regulator 1 AI577532 14.05 2.28 
Basp1 brain abundant, membrane attached signal protein 1 NM_022300 14.04 2.39 
RGD1308904 similar to RIKEN cDNA 5430432M24 AA901194 14.02 2.21 
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Emp1 epithelial membrane protein 1 NM_012843 14.01 2.62 
Fbxo2 F-box only protein 2 NM_053511 14.01 2.35 
Nipsnap1 
4-nitrophenylphosphatase domain and non-
neuronal SNAP25-like protein homolog 1 
(C. elegans) 
BF554891 14.01 2.24 
RGD1306284 similar to RIKEN cDNA 1110005A03 AA866227 14 2.02 
  BF411062 13.97 2.42 
Pea15 phosphoprotein enriched in astrocytes 15 BG662875 13.94 2.11 
Vldlr very low density lipoprotein receptor NM_013155 13.9 3.17 
Epn2 epsin 2 AW521110 13.89 2.26 
Il17re interleukin 17 receptor E BM383766 13.84 2.63 
  AW522302 13.82 2.44 
Aldh3b1 aldehyde dehydrogenase 3 family, member B1 BF412690 13.8 2.5 
  BF566725 13.8 2.11 
  BE099804 13.79 2.27 
Asahl_predicted N-acylsphingosine amidohydrolase (acid ceramidase)-like (predicted) AI412627 13.79 2.13 
Arpc1b actin related protein 2/3 complex, subunit 1B NM_019289 13.72 2.17 
Ua20 putative UA20 protein AI409922 13.67 2.07 
RGD1309748_predicted similar to CG4768-PA (predicted) BF397406 13.64 2.07 
Slc5a10_predicted solute carrier family 5 (sodium/glucose cotransporter), member 10 (predicted) BI289660 13.63 2.14 
RGD1306809_predicted similar to hypothetical protein FLJ30596 (predicted) BF549700 13.62 2.17 
Ctsz cathepsin Z AA849399 13.56 2.85 
Pdgfa platelet derived growth factor, alpha L06238 13.56 2.04 
Daf1 decay accelarating factor 1 AB026903 13.55 3.09 
  AI406341 13.52 3.41 
Gata4 GATA binding protein 4 L22761 13.47 2.18 
RGD1565927_predicted similar to 4631422O05Rik protein (predicted) BM389685 13.43 3.16 
Crb3 crumbs homolog 3 (Drosophila) BI283883 13.42 3.04 
  BI285519 13.42 2.09 
Ca3 carbonic anhydrase 3 AB030829 13.41 2.97 
  BI296427 13.41 2.43 
Trio triple functional domain (PTPRF interacting) BF554226 13.4 2.49 
RGD1306658 similar to 5830411E10Rik protein BI295501 13.4 2.03 
  BE108178 13.39 2.08 
Nes nestin NM_012987 13.37 2.5 
  AT005674 13.36 2.48 
Tcf2 transcription factor 2 NM_013103 13.35 3.81 
  AI013328 13.34 2.22 
  AW533482 13.34 2.16 
  AI071024 13.33 2.44 
  AA893087 13.32 2.13 
  AA851361 13.32 2.12 
Lypd3 Ly6/Plaur domain containing 3 NM_021759 13.31 2.17 
  BF420433 13.3 2.31 
Btc betacellulin NM_022256 13.3 2.2 
Sh3glb1 SH3-domain GRB2-like B1 (endophilin) BF283873 13.3 2.08 
Mmp2 matrix metallopeptidase 2 U65656 13.26 2.96 
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  AI176941 13.23 2.16 
RGD1560880_predicted similar to RIKEN cDNA 2310002J15 (predicted) BI300388 13.23 2.13 
Cugbp2 CUG triplet repeat, RNA binding protein 2 AF090695 13.19 2.02 
RGD1309804 similar to hypothetical protein FLJ11218 AI044348 13.18 3.61 
Ctbs chitobiase, di-N-acetyl- NM_031023 13.18 2.08 
RGD1311307 similar to 1300014I06Rik protein BM385779 13.16 3.76 
RGD1562244_predicted similar to SEC14 and spectrin domains 1 (predicted) AA892491 13.15 2.15 
  AI577848 13.14 2.53 
  BG670559 13.04 2.24 
Procr protein C receptor, endothelial AI137406 13 2.58 
Cd96 CD96 antigen AI764706 12.98 2.57 
Slc44a4 solute carrier family 44, member 4 BI289103 12.97 3.78 
  BM385170 12.96 2.02 
  BI299977 12.93 2.85 
  AA943752 12.92 2.11 
  BM387460 12.88 2.16 
RGD1308876_predicted similar to 2610027C15Rik protein (predicted) AI179588 12.88 2.14 
  BG667935 12.85 2.37 
Efha2 EF hand domain family, member A2 BF404514 12.84 2.86 
Phactr1 phosphatase and actin regulator 1 AA996943 12.82 3.34 
Slc25a30 solute carrier family 25, member 30 H35736 12.82 2.16 
Mawbp MAWD binding protein AW532101 12.81 2.79 
  BE111349 12.8 2.37 
  AI229167 12.79 2.02 
Prkar1b protein kinase, cAMP dependent regulatory, type I, beta BG375376 12.78 2.08 
  AI454052 12.78 2.07 
LOC500013  BF408536 12.77 2.06 
Nipsnap1 
4-nitrophenylphosphatase domain and non-
neuronal SNAP25-like protein homolog 1 
(C. elegans) 
BI289807 12.74 2.35 
Dcxr dicarbonyl L-xylulose reductase NM_134387 12.74 2.01 
Ces1 carboxylesterase 1 AB023630 12.69 2.69 
Perp_predicted PERP, TP53 apoptosis effector (predicted) AI598971 12.69 2.08 
  AI012613 12.68 2.13 
RGD1308329_predicted similar to KIAA0869 protein (predicted) BM390702 12.66 2.78 
  AI010312 12.65 2.97 
Argbp2 Arg/Abl-interacting protein ArgBP2 NM_053770 12.62 2.8 
Bhlhb3 basic helix-loop-helix domain containing, class B3 NM_133303 12.53 2.12 
Fcgr3 Fc receptor, IgG, low affinity III NM_053843 12.52 2.34 
Pem placentae and embryos oncofetal gene NM_022175 12.51 2.01 
RGD1565681_predicted similar to Prr6 protein (predicted) AW523199 12.49 2.68 
Slfn3 schlafen 3 NM_053687 12.48 5.34 
  BF408801 12.46 2.96 
Gcnt2 glucosaminyl (N-acetyl) transferase 2, I-branching enzyme AI234819 12.4 2.94 
RGD1311316 similar to RIKEN cDNA 5730470L24 BE102137 12.4 2.26 
Krt1-19 keratin complex 1, acidic, gene 19 BI279605 12.39 2.24 
Arhgap22_predicted Rho GTPase activating protein 22 (predicted) BM384457 12.38 2.18 
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Sdpr serum deprivation response protein AI009714 12.37 2.49 
RGD1307414_predicted similar to RIKEN cDNA 1110067D22 (predicted) BE095833 12.37 2.01 
Ebpl_predicted emopamil binding protein-like (predicted) AI179635 12.23 2.65 
Zfp655 zinc finger protein 655 BI292731 12.17 2.41 
Cyba cytochrome b-245, alpha polypeptide AI232788 12.16 3.25 
Slc36a4_predicted solute carrier family 36 (proton/amino acid symporter), member 4 (predicted) AI058947 12.14 2.59 
  BF409131 12.13 2.26 
RGD1562954_predicted similar to aldo-keto reductase family 1, member C12 (predicted) BF566188 12.12 2.71 
Bik Bcl2-interacting killer NM_053704 12.07 3.19 
  AI030349 12.02 2.23 
  AI600082 11.93 2.02 
RGD1560766_predicted similar to putative protein product of HMFN2073 (predicted) BM384831 11.89 2.4 
  BF398806 11.78 2.15 
  BF283210 11.77 2.45 
Dap death-associated protein NM_022526 11.76 2.1 
  AI137052 11.75 2.33 
Lta lymphotoxin A AI113237 11.66 2.11 
Slc4a11_predicted solute carrier family 4, sodium bicarbonate transporter-like, member 11 (predicted) BI293444 11.62 2.52 
Ptprj protein tyrosine phosphatase, receptor type, J NM_017269 11.33 2.03 
Mx1 myxovirus (influenza virus) resistance 1 X52711 11.3 3.39 
LOC310013  BF409912 11.17 2.24 
  BI294751 11.17 2.02 
RGD1305179_predicted similar to Nedd4 binding protein 1 (predicted) AA965076 11.13 2.27 
  BI274116 11.13 2.25 
  AI715259 11.08 2 
RGD1311019_predicted similar to hypothetical protein DKFZp434H2010 (predicted) BG372342 11.01 2.41 
  BM384387 11.01 2.23 
Rab27a RAB27A, member RAS oncogene family BM389524 10.97 2.35 
  BF555947 10.86 2.66 
  BF550404 10.85 2.07 
Centa1 centaurin, alpha 1 U51013 10.84 2.43 
  AW527651 10.84 2.17 
Gmip_predicted Gem-interacting protein (predicted) BF544982 10.81 2.2 
  AI598434 10.74 3.74 
RGD1309720 similar to Hypothetical protein MGC19163 AI059270 10.74 2.25 
Centa1 centaurin, alpha 1 NM_133567 10.73 2.68 
Klhl2_predicted kelch-like 2, Mayven (Drosophila) (predicted) AI145435 10.7 2.12 
Kif3c kinesin family member 3C NM_053486 10.68 2.26 
Plekha6_predicted pleckstrin homology domain containing, family A member 6 (predicted) BF547014 10.63 2.12 
Hbegf heparin-binding EGF-like growth factor NM_012945 10.59 2.8 
Usp43_predicted ubiquitin specific protease 43 (predicted) BE120893 10.57 2.04 
Mmp3 matrix metallopeptidase 3 NM_133523 10.53 2.31 
Il1rn interleukin 1 receptor antagonist NM_022194 10.52 2.29 
Npm2 nucleophosmin/nucleoplasmin 2 BE105805 10.49 2.24 
Anxa1 annexin A1 AI236455 10.45 5.13 
 177 
Symbol Description GenBank t-statistic Fold Change 
LOC498662 similar to RIKEN cDNA 2610019F03 AA964146 10.43 2.11 
Dzip1l DAZ interacting protein 1-like BI290883 10.43 2 
  BM385061 10.41 2.38 
RGD1560915_predicted similar to Hypothetical protein MGC30714 (predicted) AA801227 10.38 2.16 
  BI296243 10.35 2.82 
  BM385772 10.24 2.15 
  BF419721 10.21 2.02 
Trim27_predicted tripartite motif protein 27 (predicted) BI294862 10.15 2.22 
Cpeb2_predicted cytoplasmic polyadenylation element binding protein 2 (predicted) AI010275 10.11 2.03 
Bicc1_predicted bicaudal C homolog 1 (Drosophila) (predicted) BF389151 9.98 2.71 
  AI408264 9.98 2.44 
Lnx1_predicted ligand of numb-protein X 1 (predicted) BE120953 9.96 2.94 
RGD1305647_predicted similar to hypothetical protein FLJ23375 (predicted) AI406343 9.95 2.46 
RGD1563148_predicted similar to osteoclast inhibitory lectin (predicted) BI292042 9.92 2.11 
RGD1311463 similar to RIKEN cDNA 2700007P21 AW526652 9.86 2.03 
Rap2b RAP2B, member of RAS oncogene family BE116619 9.81 2.01 
Trpv6 transient receptor potential cation channel, subfamily V, member 6 AI101583 9.66 2.27 
RGD1306100_predicted similar to RRP22 (predicted) BF414261 9.66 2.17 
Ptpn18 protein tyrosine phosphatase, non-receptor type 18 BM386565 9.64 2.03 
Fgfbp1 fibroblast growth factor binding protein 1 NM_022603 9.56 2.18 
Cxadr coxsackie virus and adenovirus receptor AI137518 9.52 2 
RGD1562031_predicted similar to GTPase activating protein testicular GAP1 (predicted) AA818889 9.49 2.09 
  BI294737 9.47 2.89 
  BF399504 9.47 2.06 
LOC502782 similar to RIKEN cDNA 2610022G08 AW434228 9.44 2.32 
  BI286340 9.36 2.78 
Ankrd1 ankyrin repeat domain 1 (cardiac muscle) BE113012 9.34 2.92 
Gna14 guanine nucleotide binding protein, alpha 14 BI289045 9.29 2.1 
  AI175104 9.27 2.23 
Dyrk3 dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 3 BE103067 9.14 2.53 
Sult2b1_predicted sulfotransferase family, cytosolic, 2B, member 1 (predicted) BM390571 9.03 2.09 
  AI176265 9.02 2.93 
Shank2 SH3/ankyrin domain gene 2 NM_133440 8.98 2.26 
Dao1 D-amino acid oxidase 1 NM_053626 8.94 2.39 
RGD1307749_predicted similar to RIKEN cDNA 1600013K19 (predicted) BG377375 8.94 2.38 
Siahbp1 
siah binding protein 1; FBP interacting 
repressor; pyrimidine tract binding splicing 
factor; Ro ribonucleoprotein-binding 
protein 1 
BE100353 8.91 2.61 
  AA942816 8.72 2.69 
Rap2b RAP2B, member of RAS oncogene family NM_133410 8.55 2.27 
Vgll1_predicted vestigial like 1 homolog (Drosophila) (predicted) BI289790 8.5 2.02 
Tead2_mapped TEA domain family member 2 (mapped) AW142018 8.27 2.13 
MGC116202  BE097451 8.17 2.3 
Nrp1 neuropilin 1 AF016296 8.02 2 
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Rnase4 ribonuclease, RNase A family 4 BI284831 7.98 2.06 
Sla src-like adaptor AI500952 7.78 2.12 
Grb14 growth factor receptor bound protein 14 NM_031623 7.56 2.07 
  BF387305 7.52 2.05 
Myo5b myosin 5B NM_017083 7.09 2.06 
Prss35 protease, serine, 35 AA866443 7.06 3.37 
Cxcl2 chemokine (C-X-C motif) ligand 2 NM_053647 7.04 4.39 
Gdf15 growth differentiation factor 15 NM_019216 6.76 2.83 
  AA900645 6.75 2.11 
  BM389322 6.32 2.74 
Cd83_predicted CD83 antigen (predicted) AI412355 6.08 2.5 
  BI278180 6.05 2.33 
Dusp5 dual specificity phosphatase 5 BE111304 5.81 3.54 
Cxcl1 chemokine (C-X-C motif) ligand 1 NM_030845 5.28 2.81 
Sdpr serum deprivation response protein AI603408 5.17 2.13 
  AI008409 3.6 2.16 























Genes upregulated in FRTL5 cells relative to FRT cells 
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Sdc2 syndecan 2 AI574779 -64.02 -9.09 
Ctgf connective tissue growth factor NM_022266 -61.13 -9 
Lbp lipopolysaccharide binding protein BF289368 -60.48 -8.98 
Tg thyroglobulin AF221622 -58.84 -8.88 
Etnk1_predicted ethanolamine kinase 1 (predicted) BM391283 -55.82 -8.18 
Pgcp plasma glutamate carboxypeptidase NM_031640 -55.67 -8.31 
  AA893192 -55.42 -8.25 
Sdc2 syndecan 2 AI169682 -55.08 -8.67 
Mal2 mal, T-cell differentiation protein 2 AI102073 -54.38 -7.39 
Rgc32 response gene to complement 32 NM_054008 -51.47 -7.25 
Hhex hematopoietically expressed homeobox NM_024385 -50.35 -7.17 
Klf2_predicted Kruppel-like factor 2 (lung) (predicted) BM385790 -50.21 -8.01 
Gpm6a glycoprotein m6a BF394166 -49.68 -7 
Sectm1 secreted and transmembrane 1 AI009823 -49.65 -6.91 
Id4 inhibitor of DNA binding 4 BE116009 -48.74 -6.88 
  BE107419 -48.07 -7.07 
Cd48 CD48 antigen X13016 -47.84 -7.2 
Ctsc cathepsin C AW920064 -47.3 -6.76 
Pros1 protein S (alpha) U06230 -47.25 -6.67 
  BF388057 -46.87 -7.09 
LOC207125 unknown protein BE118080 -46.69 -6.93 
Dact2_predicted dapper homolog 2, antagonist of beta-catenin (xenopus) (predicted) BI288833 -46.51 -6.3 
  AI112057 -46.06 -6.27 
RGD1305677 similar to RIKEN cDNA 1810020E01 BE107851 -45.99 -6.21 
  BG662710 -45.78 -6.37 
Timp3 tissue inhibitor of metalloproteinase 3 (Sorsby fundus dystrophy, pseudoinflammatory) AI009159 -45.67 -7.6 
Tceal8 transcription elongation factor A (SII)-like 8 AI230334 -45.54 -6.3 
Ndrg2 N-myc downstream regulated gene 2 NM_133583 -45.27 -7.05 
Pla2g4a phospholipase A2, group IVA (cytosolic, calcium-dependent) NM_133551 -45.08 -7.65 
Wbp5_predicted WW domain binding protein 5 (predicted) BG378874 -45.04 -7.5 
MGC108778 similar to RIKEN cDNA 1810057C19 BM391248 -44.95 -6.22 
  BF409024 -44.74 -6.51 
Tg thyroglobulin M35965 -44.53 -7.25 
  AI175045 -44.52 -7.5 
Nptx1 neuronal pentraxin 1 U18772 -44.44 -6.08 
Sftpc surfactant associated protein C AI009659 -44.42 -6.06 
Sepp1 selenoprotein P, plasma, 1 AA799627 -44.42 -6.68 
Tsnax translin-associated factor X BI283853 -43.99 -6.45 
Cxcr4 chemokine (C-X-C motif) receptor 4 U54791 -43.97 -5.97 
Cybrd1 cytochrome b reductase 1 AI010267 -43.53 -5.91 
LOC362065 CG6210-like BF394235 -43.15 -6.45 
  AI577833 -42.95 -6.99 
Slc25a4 solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 4 BG666999 -42.73 -8.18 
Emb embigin NM_053719 -42.46 -6.62 
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  AI103213 -42.4 -6.44 
Thrsp thyroid hormone responsive protein AI169092 -42.24 -7.99 
Icam1 intercellular adhesion molecule 1 NM_012967 -42.2 -5.83 
Timp3 tissue inhibitor of metalloproteinase 3 (Sorsby fundus dystrophy, pseudoinflammatory) AA893169 -42.02 -9.16 
Pvrl3_predicted poliovirus receptor-related 3 (predicted) AW525315 -41.37 -6.52 
Tspyl testis-specific protein, Y-encoded-like BF407207 -41.32 -7.38 
  BE112341 -41.21 -6.62 
Cobl_predicted cordon-bleu (predicted) AI028942 -41.19 -5.58 
  BE108374 -41.18 -5.58 
Mageh1 melanoma antigen, family H, 1 H32543 -41.1 -5.79 
Pgf placental growth factor NM_053595 -41.01 -5.88 
  BI283881 -40.99 -6.15 
Ania4 activity and neurotransmitter-induced early gene protein 4 (ania-4) NM_021584 -40.74 -6.07 
Cstf2t_predicted cleavage stimulation factor, 3' pre-RNA subunit 2, tau (predicted) AW522557 -40.71 -6.6 
Fkbp9 FK506 binding protein 9 AI236786 -40.7 -5.53 
  AA956784 -40.55 -5.58 
  AI111767 -40.55 -6.58 
RGD1560913_predicted similar to expressed sequence AW413625 (predicted) AA799328 -40.43 -6.86 
  BI291849 -40.38 -6.33 
  BG668816 -40.2 -5.66 
  AA859937 -40.01 -5.45 
RGD1311589_predicted similar to RIKEN cDNA E130201N16 (predicted) BE113624 -39.91 -6.49 
Pgf placental growth factor BF281271 -39.89 -6.47 
LOC501039  BI296353 -39.66 -6.27 
  AA818380 -39.44 -5.98 
Tm4sf12 transmembrane 4 superfamily member 12 AI410264 -39.44 -6.05 
Napsa napsin A aspartic peptidase NM_031670 -39.34 -6.97 
Nqo2 NAD(P)H dehydrogenase, quinone 2 AA945624 -39.32 -5.54 
Timp3 tissue inhibitor of metalloproteinase 3 (Sorsby fundus dystrophy, pseudoinflammatory) NM_012886 -39.22 -5.94 
Pvrl3_predicted poliovirus receptor-related 3 (predicted) AI103913 -39.11 -5.41 
Gpc4 glypican 4 AI071251 -39.08 -5.5 
  AW142650 -39.03 -6.5 
RGD1311381_predicted similar to hypothetical protein FLJ20037 (predicted) BI294811 -38.73 -5.26 
Btg3 B-cell translocation gene 3 NM_019290 -38.72 -6.73 
  BF392884 -38.62 -5.37 
Tceal1 transcription elongation factor A (SII)-like 1 BF418812 -38.47 -5.26 
Txnip upregulated by 1,25-dihydroxyvitamin D-3 U30789 -38.36 -6.54 
Hist1h2ai_predicted histone 1, H2ai (predicted) AI176481 -38.3 -5.51 
Pcp4 Purkinje cell protein 4 NM_013002 -38.28 -5.9 
  BG669741 -38.13 -5.72 
Cybrd1 cytochrome b reductase 1 BF419070 -38.12 -5.83 
Prkar2b protein kinase, cAMP dependent regulatory, type II beta M12492 -38.08 -6.05 
Fzd1 frizzled homolog 1 (Drosophila) AA944349 -38.06 -5.25 
Slc4a5 solute carrier family 4, sodium bicarbonate cotransporter, member 5 AW529483 -37.92 -5.12 
Timp3 tissue inhibitor of metalloproteinase 3 (Sorsby fundus dystrophy, pseudoinflammatory) AI599265 -37.9 -7.03 
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Spon1 spondin 1 M88469 -37.85 -5.28 
Sult1d1 sulfotransferase family 1D, member 1 NM_021769 -37.58 -5.4 
LOC290704  BM391364 -37.44 -5.62 
Dsc2 desmocollin 2 BI279663 -37.38 -5.46 
Id4 inhibitor of DNA binding 4 AI412150 -37.18 -5.07 
Foxa2 forkhead box A2 NM_012743 -37.08 -5.06 
  BM384088 -37.08 -5.19 
Angptl4 angiopoietin-like 4 AA818262 -36.83 -5.08 
Fhl1 four and a half LIM domains 1 BG673187 -36.71 -5.53 
Cdkn3_predicted cyclin-dependent kinase inhibitor 3 (predicted) BE113362 -36.44 -5.9 
MGC72567 similar to coiled-coil domain containing 8 BE107413 -36.4 -4.91 
LOC499677  AA800950 -36 -4.92 
Cmkor1 chemokine orphan receptor 1 NM_053352 -35.95 -6.13 
Sod3 superoxide dismutase 3, extracellular NM_012880 -35.93 -6.38 
Mal2 mal, T-cell differentiation protein 2 BF555523 -35.86 -5.06 
  BF396607 -35.86 -5.84 
  BI286077 -35.51 -7.93 
Setbp1_predicted SET binding protein 1 (predicted) BF396686 -35.48 -5.25 
RGD1307524_predicted similar to Friedreich ataxia region gene X123 (predicted) AI231799 -35.35 -6.02 
Crym crystallin, mu NM_053955 -35.34 -5.52 
Ngfrap1 nerve growth factor receptor (TNFRSF16) associated protein 1 NM_053401 -35.32 -5.64 
Slc5a5 solute carrier family 5 (sodium iodide symporter), member 5 NM_052983 -35.21 -6.06 
Pex2 peroxin 2 AF324454 -35.19 -5.1 
Egr3 early growth response 3 AA964492 -35.15 -5.2 
Cxcr4 chemokine (C-X-C motif) receptor 4 AA945737 -35.04 -6 
MGC114427 similar to melanoma antigen family A, 5 AI179244 -34.91 -4.94 
  BM388725 -34.8 -6.58 
LOC499677  BF390321 -34.65 -4.74 
Tekt1 tektin 1 NM_053508 -34.63 -6.62 
Adra1b adrenergic receptor, alpha 1b NM_016991 -34.55 -5.49 
Tacc1 transforming, acidic coiled-coil containing protein 1 AI008689 -34.5 -5.89 
  AI236027 -34.45 -5.23 
Sdc2 syndecan 2 BG668421 -34.42 -7.74 
Ass argininosuccinate synthetase BF283456 -34.2 -5.15 
RGD1564851_predicted similar to putative anion transporter (predicted) AI555358 -33.93 -4.87 
  BI282914 -33.75 -6.13 
RGD1564105_predicted similar to RIKEN cDNA B130052G07 (predicted) AI409065 -33.74 -5.92 
RGD1309065_predicted similar to RIKEN cDNA 4931407K02 (predicted) AW535172 -33.7 -4.91 
Acta1 actin, alpha 1, skeletal muscle NM_019212 -33.64 -5.39 
Ddt D-dopachrome tautomerase NM_024131 -33.3 -5.21 
MGC94782 similar to hypothetical protein MGC33926 AI010157 -33.28 -4.75 
  BM386869 -33.18 -4.53 
Slc25a29 solute carrier family 25 (mitochondrial carrier, palmitoylcarnitine transporter), member 29 BF555120 -33.13 -4.94 
  AI231999 -33.06 -5.8 
LOC681395  AW524822 -32.79 -5.02 
Gpd1 glycerol-3-phosphate dehydrogenase 1 (soluble) BI277042 -32.77 -5.69 
Titf1 thyroid transcription factor 1 BF389361 -32.73 -4.91 
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Tsnax translin-associated factor X AF262357 -32.55 -6.32 
  BE109132 -32.5 -4.78 
  BG380430 -32.47 -6.57 
Ptges prostaglandin E synthase AB048730 -32.3 -5.05 
  AI073219 -32.21 -4.57 
RGD1309036_predicted hypothetical LOC292874 (predicted) AA925385 -32.01 -5.28 
Rora_predicted RAR-related orphan receptor alpha (predicted) AI235414 -31.97 -5.87 
Cxcr4 chemokine (C-X-C motif) receptor 4 AA945737 -31.95 -5.36 
P2ry14 purinergic receptor P2Y, G-protein coupled, 14 U76206 -31.92 -5.93 
  BE105961 -31.88 -4.65 
Ctsc cathepsin C AI409046 -31.83 -5.71 
Rhob ras homolog gene family, member B NM_022542 -31.8 -5.3 
Tpo thyroid peroxidase NM_019353 -31.72 -6.83 
LOC362065 CG6210-like AI072254 -31.71 -4.69 
  BM385741 -31.67 -4.51 
  AI010048 -31.52 -4.69 
Entpd1 ectonucleoside triphosphate diphosphohydrolase 1 AI009808 -31.48 -4.36 
Ppp1r3c protein phosphatase 1, regulatory (inhibitor) subunit 3C BM390827 -31.27 -5.21 
  BE119164 -31.24 -4.59 
RGD1559803_predicted similar to maestro (predicted) BF283408 -31.17 -4.87 
RGD1309807 similar to Fam13a1 protein BF563961 -31.15 -4.9 
  BF386199 -31.11 -4.42 
  AI409042 -31.07 -4.3 
Rnf125_predicted ring finger protein 125 (predicted) AA925710 -30.91 -5.67 
  AI009713 -30.87 -4.49 
Smpd3 sphingomyelin phosphodiesterase 3, neutral NM_053605 -30.79 -5.03 
RGD1563869_predicted sim ilar to glucocorticoid induced gene 1 (predicted) BI295240 -30.77 -5.2 
Plod2 procollagen lysine, 2-oxoglutarate 5-dioxygenase 2 BI279641 -30.71 -6.02 
Npepl1_predicted aminopeptidase-like 1 (predicted) AI411240 -30.54 -4.28 
  AI406271 -30.53 -4.3 
Lhx2 LIM homeobox protein 2 L06804 -30.52 -4.28 
Cp ceruloplasmin AF202115 -30.52 -4.59 
RGD1566248_predicted similar to hypothetical protein FLJ14345 (predicted) AI556490 -30.48 -4.37 
Emp3 epithelial membrane protein 3 NM_030847 -30.38 -4.27 
Hsd11b1 hydroxysteroid 11-beta dehydrogenase 1 NM_017080 -30.34 -4.43 
Acy1 aminoacylase 1 AI411530 -30.33 -4.57 
  BF415056 -30.32 -4.21 
Enpp3 ectonucleotide pyrophosphatase/phosphodiesterase 3 NM_019370 -30.28 -4.2 
  AA964074 -30.18 -4.21 
Hspa4l_predicted heat shock 70kDa protein 4-like (predicted) BF401583 -30.16 -5.98 
Edg2 endothelial differentiation, lysophosphatidic acid G-protein-coupled receptor, 2 NM_053936 -30.03 -5.13 
Rasd2 RASD family, member 2 AF134409 -29.96 -4.73 
Pts 6-pyruvoyl-tetrahydropterin synthase NM_017220 -29.9 -5.2 
Slc25a21 solute carrier family 25 (mitochondrial oxodicarboxylate carrier), member 21 NM_133614 -29.88 -4.25 
Asph_predicted aspartate-beta-hydroxylase (predicted) BF561145 -29.86 -4.71 
Fhl1 four and a half LIM domains 1 BI298356 -29.84 -4.33 
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  AW535515 -29.8 -4.04 
RGD1562987_predicted similar to cDNA sequence BC031181 (predicted) AI231196 -29.65 -5.7 
Thrsp thyroid hormone responsive protein NM_012703 -29.53 -7.65 
LOC499677  AI112117 -29.49 -4.36 
  BE115085 -29.36 -4.75 
Kcnj15 potassium inwardly-rectifying channel, subfamily J, member 15 NM_133321 -29.24 -4.11 
Duox2 dual oxidase 2 NM_024141 -29.12 -4.06 
  AI548028 -29.1 -4.09 
  BI276341 -29.1 -4.54 
  AI029492 -28.98 -5.39 
RGD1311732 similar to hypothetical protein MGC15407 AI044859 -28.79 -4.94 
  BM391853 -28.64 -4.8 
Ctsc cathepsin C NM_017097 -28.62 -4.75 
LOC501039  AI233213 -28.6 -6.09 
Gmpr guanosine monophosphate reductase NM_057188 -28.57 -4.03 
Cd99  AI235284 -28.49 -4.21 
Nedd9 neural precursor cell expressed, developmentally down-regulated gene 9 BM392374 -28.49 -4.71 
Pdpn podoplanin NM_019358 -28.37 -3.92 
  BF565756 -28.32 -3.91 
Ppp1r3c protein phosphatase 1, regulatory (inhibitor) subunit 3C AW530361 -28.25 -4.05 
  BG380393 -28.23 -4.76 
LOC361346 similar to chromosome 18 open reading frame 54 BF412754 -28.18 -5.15 
Zdhhc2 zinc finger, DHHC domain containing 2 AF228917 -28.14 -4.29 
Epb4.1l5 erythrocyte protein band 4.1-like 5 BE109260 -28.03 -5.19 
Klhl13 kelch-like 13 (Drosophila) AI179828 -27.85 -4.73 
Dhrs3 dehydrogenase/reductase (SDR family) member 3 BI276935 -27.85 -4.86 
Klf2_predicted Kruppel-like factor 2 (lung) (predicted) BF288243 -27.84 -6.65 
Calml3 calmodulin-like 3 AI030853 -27.83 -5.29 
Tfcp2l4_predicted transcription factor CP2-like 4 (predicted) BE109781 -27.72 -4.9 
  BE111819 -27.68 -3.77 
Olfml3_predicted olfactomedin-like 3 (predicted) BI274355 -27.64 -4.37 
  BI293607 -27.58 -5.07 
Ptger4 prostaglandin E receptor 4 (subtype EP4) AI549199 -27.54 -4.03 
Wnt5a wingless-type MMTV integration site 5A NM_022631 -27.26 -4.58 
  AI411542 -27.13 -5.18 
  BF549971 -26.95 -3.69 
Cerk_predicted ceramide kinase (predicted) AW525194 -26.94 -3.7 
RGD1305283_predicted similar to RIKEN cDNA 2010110K16 (predicted) BF403524 -26.86 -3.85 
  AI408151 -26.86 -6.42 
  AW524892 -26.85 -4.74 
Mybph myosin binding protein H AI408557 -26.79 -5.13 
RT1-S3 RT1 class Ib, locus S3 AJ243974 -26.69 -4.56 
Gcg glucagon NM_012707 -26.65 -5.18 
Id4 inhibitor of DNA binding 4 AW916745 -26.63 -4.56 
  AI410941 -26.58 -3.69 
  AI410438 -26.45 -3.66 
Evl Ena-vasodilator stimulated phosphoprotein NM_024147 -26.44 -3.94 
Thrsp thyroid hormone responsive protein NM_012703 -26.44 -5.56 
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RGD1306981_predicted 
similar to bM410K19.2.2 (novel protein similar 
to extra-cellular matrix proteins and chondroitin 
sulfate proteoglycans, variant 2) (predicted) 
BM392227 -26.41 -3.62 
  BG379594 -26.37 -4.47 
Pip5k1a phosphatidylinositol-4-phosphate 5-kinase, type 1 alpha BF406008 -26.33 -6.09 
Dnaja4 DnaJ (Hsp40) homolog, subfamily A, member 4 AI104324 -26.31 -3.69 
Nfia nuclear factor I/A AB060652 -26.15 -3.54 
Prdx4 peroxiredoxin 4 BI282076 -26.14 -6.29 
  BI289330 -26.13 -3.99 
  AI175666 -26.06 -5.18 
  BI303636 -26.01 -3.94 
  BM389611 -26.01 -4.02 
Adora1 adenosine A1 receptor NM_017155 -26.01 -4.31 
Itpr2 inositol 1,4,5-triphosphate receptor 2 BF417289 -25.84 -4.34 
Mdfic_predicted MyoD family inhibitor domain containing (predicted) AI411065 -25.8 -3.54 
Tmem16a_predicted transmembrane protein 16A (predicted) BF288508 -25.64 -3.58 
RT1-S3 RT1 class Ib, locus S3 AJ243973 -25.63 -4.32 
Adora1 adenosine A1 receptor M69045 -25.49 -4.48 
Plekhc1 pleckstrin homology domain containing, family C (with FERM domain) member 1 BM386598 -25.44 -3.52 
  AI175507 -25.4 -3.73 
LOC310877 TRAF2 binding protein BM384466 -25.37 -3.77 
Kdelc2 KDEL (Lys-Asp-Glu-Leu) containing 2 BM384752 -25.25 -3.49 
Osbpl1a oxysterol binding protein-like 1A BI289884 -25.23 -3.41 
  BE111762 -25.23 -3.66 
Cnn1 calponin 1 NM_031747 -25.22 -4.18 
Maf v-maf musculoaponeurotic fibrosarcoma oncogene homolog (avian) AI180340 -25.21 -5.07 
  AA818342 -25.17 -3.91 
RT1-S3 RT1 class Ib, locus S3 AJ243973 -25.17 -4.17 
Metrn meteorin, glial cell differentiation regulator BG378672 -25.11 -5.62 
  BE096857 -25.09 -4.73 
Cdh2 cadherin 2 NM_031333 -25.08 -3.7 
  AI599873 -25.03 -4.08 
Enpp5 ectonucleotide pyrophosphatase/phosphodiesterase 5 AI409048 -24.98 -3.44 
  BM385726 -24.94 -3.74 
Irf8 interferon regulatory factor 8 BF284262 -24.79 -3.54 
LOC498425 
similar to U2 small nuclear ribonucleoprotein 
auxiliary factor 35 kDa subunit related-protein 1 
(U2(RNU2) small nuclear RNA auxillary factor 
1-like 1) (SP2) 
AW527413 -24.77 -3.66 
Tscot_predicted thymic stromal cotransporter (predicted) BE108346 -24.77 -4.29 
  AA925373 -24.68 -3.48 
  BF389689 -24.68 -3.99 
Jam3 junctional adhesion molecule 3 AA998207 -24.65 -3.38 
  BG669921 -24.63 -3.5 
Dmpk_predicted dystrophia myotonica-protein kinase (predicted) AI044427 -24.62 -4.51 
RGD1564451_predicted similar to Tribbles homolog 2 (predicted) AI010430 -24.6 -4.32 
Klf15 Kruppel-like factor 15 NM_053536 -24.59 -4.33 
  BG379055 -24.58 -3.81 
  BI283685 -24.57 -4.22 
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  AA899900 -24.49 -3.64 
  AA996921 -24.48 -3.76 
LOC361346 similar to chromosome 18 open reading frame 54 AW521797 -24.47 -4.47 
  BE107167 -24.46 -3.6 
LOC296935  AI453854 -24.45 -4.9 
  BI275030 -24.43 -3.46 
Smad3 MAD homolog 3 (Drosophila) AA997679 -24.43 -4.19 
  BM385437 -24.36 -3.97 
  AI578003 -24.35 -3.38 
Fgfr3 fibroblast growth factor receptor 3 BF410980 -24.31 -3.87 
Gfra3 glial cell line derived neurotrophic factor family receptor alpha 3 BG377887 -24.26 -3.87 
Pdlim1 PDZ and LIM domain 1 (elfin) NM_017365 -24.21 -3.95 
Angptl2 angiopoietin-like 2 NM_133569 -24.17 -4.31 
RGD1310681_predicted similar to RIKEN cDNA 6720467C03 (predicted) BE114214 -24.03 -4.86 
MGC72974 Unknown (protein for MGC:72974) BM385898 -23.98 -3.86 
Kctd6_predicted potassium channel tetramerisation domain containing 6 (predicted) AI235964 -23.97 -3.35 
Rcbtb2 regulator of chromosome condensation (RCC1) and BTB (POZ) domain containing protein 2 BE119554 -23.95 -4.09 
Pmp22 peripheral myelin protein 22 AA943163 -23.93 -4.34 
Azi2 5-azacytidine induced gene 2 AI177093 -23.9 -3.81 
Silv_predicted silver homolog (mouse) (predicted) BI300443 -23.9 -3.98 
Nucb2 nucleobindin 2 NM_021663 -23.88 -3.22 
Pde3b phosphodiesterase 3B NM_017229 -23.86 -3.37 
RGD1305664 similar to KIAA0672 gene product BG380767 -23.83 -3.26 
Edg2 endothelial differentiation, lysophosphatidic acid G-protein-coupled receptor, 2 AI502597 -23.77 -3.41 
  BI292917 -23.73 -3.29 
  BI278550 -23.73 -3.35 
Slc38a1 solute carrier family 38, member 1 AF075704 -23.72 -3.25 
RT1-S3 RT1 class Ib, locus S3 AF029241 -23.72 -3.45 
  BF549971 -23.7 -3.43 
Scarb2 scavenger receptor class B, member 2 NM_054001 -23.64 -3.28 
  AI408734 -23.57 -4.62 
  BI289692 -23.49 -4.02 
Atf3 activating transcription factor 3 NM_012912 -23.48 -6.58 
Nr4a3 nuclear receptor subfamily 4, group A, member 3 NM_031628 -23.46 -4.12 
Krt10 keratin 10 BI282479 -23.41 -3.96 
  AW144676 -23.36 -3.72 
Sult1a1 sulfotransferase family 1A, phenol-preferring, member 1 AF394783 -23.31 -4.37 
Hspb8 heat shock 22kDa protein 8 BG380282 -23.29 -3.35 
  BM384930 -23.27 -4.16 
  BI281630 -23.25 -3.43 
  AF023090 -23.2 -3.83 
Slit2 slit homolog 2 (Drosophila) BF391439 -23.2 -5.23 
Slc7a7 solute carrier family 7 (cationic amino acid transporter, y+ system), member 7 AF200684 -23.17 -3.16 
  BM387112 -23.13 -4.36 
  AI059603 -23.12 -4.01 
RGD1561255_predicted similar to Leucine-rich and immunoglobulin-like domains 3 (predicted) BI300956 -23.11 -3.15 
  AA956757 -23.07 -4.96 
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Rrbp1_predicted ribosome binding protein 1 homolog 180kDa (dog) (predicted) BI282760 -23.06 -3.24 
  BG371995 -23.01 -3.19 
Plekhc1 pleckstrin homology domain containing, family C (with FERM domain) member 1 BE128738 -23.01 -3.47 
Nr4a1 nuclear receptor subfamily 4, group A, member 1 NM_024388 -22.99 -4.29 
  AI176713 -22.89 -3.19 
  AA996491 -22.88 -3.08 
  AI412803 -22.87 -3.22 
  BF282184 -22.84 -3.17 
Plekha5 pleckstrin homology domain containing, family A member 5 AI009219 -22.83 -4 
  AA996760 -22.79 -3.18 
Steap2_predicted six transmembrane epithelial antigen of prostate 2 (predicted) AA957889 -22.79 -3.56 
Parp12_predicted poly (ADP-ribose) polymerase family, member 12 (predicted) BI285978 -22.78 -3.57 
  AI578745 -22.78 -4.12 
Pdzrn3_predicted PDZ domain containing RING finger 3 (predicted) AW532566 -22.78 -4.65 
Gsta4 glutathione S-transferase, alpha 4 AI234527 -22.77 -3.91 
  BI283314 -22.75 -4.41 
Abca1 ATP-binding cassette, sub-family A (ABC1), member 1 AW918387 -22.73 -3.96 
RGD1311732 similar to hypothetical protein MGC15407 AI547622 -22.72 -3.49 
Slc14a1 solute carrier family 14 (urea transporter), member 1 BF562962 -22.7 -3.08 
As3mt arsenic (+3 oxidation state) methyltransferase NM_080890 -22.68 -3.21 
MGC94142 similar to cDNA sequence BC003324 AI408907 -22.68 -3.4 
Sat2_predicted spermidine/spermine N1-acetyl transferase 2 (predicted) AI410221 -22.68 -4.29 
Pde8a phosphodiesterase 8A BG377379 -22.66 -3.26 
  BF398716 -22.64 -3.81 
  BI274857 -22.63 -3.32 





NM_019123 -22.58 -3.95 
  AI010234 -22.57 -3.22 
  BF398185 -22.57 -3.24 
Mcam melanoma cell adhesion molecule AB035507 -22.52 -3.11 
Cck cholecystokinin NM_012829 -22.51 -3.48 
Rora_predicted RAR-related orphan receptor alpha (predicted) BE106199 -22.4 -5.23 
Glul glutamate-ammonia ligase (glutamine synthase) NM_017073 -22.39 -3.15 
Dpp7 dipeptidylpeptidase 7 NM_031973 -22.35 -4.9 
RGD1306323_predicted similar to Protein C8orf1 (hT41) (predicted) BM390497 -22.29 -3.02 
LOC499129  BG373314 -22.28 -3.2 
  AI412099 -22.28 -3.39 
  AI639162 -22.25 -3.04 
  AI072788 -22.21 -3.06 
RGD1562587_predicted similar to cis-Golgi matrix protein GM130 (predicted) AA944162 -22.21 -4.22 
  BE103235 -22.2 -5.05 
  AA800708 -22.18 -3.51 
LOC689490  AW253690 -22.17 -3.39 
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Tm4sf2_mapped transmembrane 4 superfamily member 2 (mapped) AI234044 -22.14 -3.07 
  BE116043 -22.14 -3.58 
Ppic peptidylprolyl isomerase C BI291292 -22.12 -3.28 
Igfbp5 insulin-like growth factor binding protein 5 BE104060 -22.11 -3.63 
Ptges prostaglandin E synthase AF280967 -22.06 -2.97 
Pde4d phosphodiesterase 4D, cAMP specific NM_017032 -22 -3.56 
Crem cAMP responsive element modulator AW529408 -21.99 -3.42 
RGD1563825_predicted similar to ENSANGP00000020885 (predicted) AI180253 -21.94 -3.06 
RGD1562272_predicted 
similar to TAF11 RNA polymerase II, TATA box 
binding protein (TBP)-associated factor 
(predicted) 
BE111277 -21.92 -3.14 
  AI175668 -21.92 -4.27 
RGD1566282_predicted similar to RIKEN cDNA D330045A20 (predicted) AW142796 -21.84 -3.35 
Enpp1 ectonucleotide pyrophosphatase/phosphodiesterase 1 NM_053535 -21.83 -3.34 
LOC314323 transporter AI180408 -21.77 -2.98 
Id4 inhibitor of DNA binding 4 AA944139 -21.77 -3.2 
Oat ornithine aminotransferase NM_022521 -21.73 -3.17 
  AI407797 -21.67 -3.46 
LOC310721 similar to 4930431B09Rik protein BI289723 -21.66 -3.47 
Map1lc3a microtubule-associated protein 1 light chain 3 alpha AI177372 -21.65 -3.94 
  BG374285 -21.64 -3.33 
Fgfr1 Fibroblast growth factor receptor 1 S54008 -21.61 -4.28 
Hyal3 hyaluronoglucosaminidase 3 BF417430 -21.57 -3.21 
RGD1309350_predicted similar to transthyretin (4L369) (predicted) BM387540 -21.52 -4.89 
Gpd1 glycerol-3-phosphate dehydrogenase 1 (soluble) NM_022215 -21.51 -3.29 
Foxe1 forkhead box E1 (thyroid transcription factor 2) Y11321 -21.51 -4.18 
  AI102035 -21.51 -5.82 
Ppp2r5a_predicted protein phosphatase 2, regulatory subunit B (B56), alpha isoform (predicted) BG673380 -21.48 -2.98 
RGD1306073_predicted similar to sallimus CG1915-PC (predicted) BE099622 -21.38 -3.02 
Tgm2 transglutaminase 2, C polypeptide NM_019386 -21.38 -5.02 
RGD1559612_predicted similar to tigger transposable element derived 2 (predicted) AI228340 -21.32 -2.89 
Sord sorbitol dehydrogenase BI285149 -21.32 -3.09 
Abca1 ATP-binding cassette, sub-family A (ABC1), member 1 BF284523 -21.32 -4.14 
  BE108519 -21.3 -3.19 
  BI294541 -21.3 -4.3 
Fbxo39 F-box protein 39 AI073001 -21.11 -3.57 
Pde4b phosphodiesterase 4B, cAMP specific AA858930 -21.06 -2.93 
  BF404460 -20.97 -2.95 
  AI072498 -20.94 -3.24 
  AI317824 -20.94 -3.69 
  AI410144 -20.93 -2.89 
  BE114427 -20.79 -3.76 
Spata6 spermatogenesis associated 6 NM_134392 -20.74 -3.31 
Maoa monoamine oxidase A D00688 -20.7 -3.16 
Asb9_predicted ankyrin repeat and SOCS box-containing protein 9 (predicted) BI288318 -20.69 -3.52 
Kif7_predicted kinesin family member 7 (predicted) BG380625 -20.68 -3.14 
Cd38 CD38 antigen NM_013127 -20.67 -2.89 
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Entpd1 ectonucleoside triphosphate diphosphohydrolase 1 NM_022587 -20.67 -2.92 
RGD1564019_predicted similar to GTPase activating RANGAP domain-like 3 (predicted) BE098382 -20.63 -2.89 
  BE116385 -20.62 -2.93 
RGD1565583_predicted similar to Protein C20orf129 homolog (predicted) AA800742 -20.56 -2.97 
Sord sorbitol dehydrogenase NM_017052 -20.55 -3.29 
LOC499617 similar to regulatory factor X-associated protein BG379771 -20.54 -2.99 
Btbd3_predicted BTB (POZ) domain containing 3 (predicted) AI230481 -20.52 -3.37 
RGD1561817_predicted similar to Traf2 and NCK interacting kinase, splice variant 4 (predicted) AW526268 -20.51 -2.79 
  AW921706 -20.51 -2.8 
Qki quaking homolog, KH domain RNA binding (mouse) BE113281 -20.47 -4.86 
Plcb4 phospholipase C, beta 4 NM_024353 -20.46 -4.06 
  AA858978 -20.43 -3.67 
  AI235503 -20.42 -2.81 
Dnajc3 DnaJ (Hsp40) homolog, subfamily C, member 3 NM_022232 -20.41 -2.87 
Sema3g sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3G BE108859 -20.37 -3.49 
Notch2 notch gene homolog 2 (Drosophila) AI011448 -20.35 -2.91 
Ddr2 discoidin domain receptor family, member 2 AI575451 -20.31 -2.89 
Man2a1 mannosidase 2, alpha 1 AI178793 -20.28 -2.74 
  AI137898 -20.24 -3.88 
Slc38a3 solute carrier family 38, member 3 AF273025 -20.19 -3.01 
  AI548924 -20.17 -2.84 
Uhrf1_mapped ubiquitin-like, containing PHD and RING finger domains, 1 (mapped) BE098732 -20.17 -2.88 
Harpb64 hypertrophic agonist responsive protein B64 BG666916 -20.16 -4.88 
  BM386534 -20.14 -2.72 
RGD1561817_predicted similar to Traf2 and NCK interacting kinase, splice variant 4 (predicted) BG666454 -20.12 -2.87 
Prelp proline arginine-rich end leucine-rich repeat protein AI011747 -20.12 -4.59 
RGD1566112_predicted similar to pleckstrin homology domain protein (5V327) (predicted) AW521621 -20.09 -3.49 
RGD1559720_predicted RGD1559720 (predicted) BI295767 -20.08 -3.4 
Mtmr1_predicted myotubularin related protein 1 (predicted) AI029734 -20.06 -3.33 
RGD1561985_predicted similar to dystrobrevin alpha isoform 1 (predicted) AI228002 -20.05 -2.72 
RGD1310174_predicted hypothetical LOC298504 (predicted) AI178784 -20.05 -3.13 
Mtac2d1 membrane targeting (tandem) C2 domain containing 1 BI302544 -20.05 -3.36 
Stom stomatin BI295949 -20.01 -3.22 
Tshr thyroid stimulating hormone receptor NM_012888 -20.01 -4.88 
RGD1566181_predicted similar to Deltex3 (predicted) BI297929 -20 -3.44 
Csen calsenilin, presenilin binding protein, EF hand transcription factor NM_032462 -19.97 -2.82 
Arid5a AT rich interactive domain 5A (Mrf1 like) AI715395 -19.95 -2.73 
  AW529927 -19.95 -3.51 
  BM388957 -19.94 -3.75 
  BF551311 -19.9 -2.78 
Cp ceruloplasmin AF202115 -19.9 -2.81 
Wnt4 wingless-related MMTV integration site 4 NM_053402 -19.82 -4.81 
Dio1 deiodinase, iodothyronine, type I NM_021653 -19.75 -4 
Mt3 metallothionein 3 NM_053968 -19.73 -3.84 
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Cachd1_predicted cache domain containing 1 (predicted) AI010254 -19.71 -3.64 
Glul glutamate-ammonia ligase (glutamine synthase) BI275294 -19.7 -2.99 
Mybpc2_predicted myosin binding protein C, fast-type (predicted) BG378588 -19.69 -3.19 
Itga6 integrin, alpha 6 AI137931 -19.68 -2.67 
Akap14 A kinase (PRKA) anchor protein 14 NM_021703 -19.63 -2.93 
Osbpl1a oxysterol binding protein-like 1A AI137224 -19.63 -3.19 
  AA818098 -19.62 -2.72 
Moxd1 monooxygenase, DBH-like 1 AI555053 -19.55 -4.89 
RGD1561749_predicted similar to hypothetical protein MGC5528 (predicted) AW251849 -19.54 -2.93 
Sulf2 sulfatase 2 AA963797 -19.52 -4.36 
  AW527767 -19.51 -3.24 
Scarb1 scavenger receptor class B, member 1 AF071495 -19.5 -3.31 
MGC114410 similar to Ras association (RalGDS/AF-6) domain family 6 BM383783 -19.5 -4.82 
  BF283569 -19.47 -5.14 
Herc3_predicted hect domain and RLD 3 (predicted) BI295026 -19.46 -3.48 
LOC360627 similar to 65kDa FK506-binding protein BI282959 -19.45 -3.88 
LOC499417 similar to Ubiquitin-like protein SMT3A precursor (Ubiquitin-related protein SUMO-2) BI279654 -19.41 -2.79 
Maf v-maf musculoaponeurotic fibrosarcoma oncogene homolog (avian) AA957811 -19.39 -2.77 
Klf9 Kruppel-like factor 9 BE101336 -19.38 -2.74 
  BF407452 -19.36 -2.99 
Abhd4_predicted abhydrolase domain containing 4 (predicted) AI407868 -19.35 -2.96 
Hsd17b7 hydroxysteroid (17-beta) dehydrogenase 7 NM_017235 -19.35 -3.77 
  AW521711 -19.34 -2.71 
Tead3 TEA domain family member 3 BG372018 -19.34 -2.82 
Prm2 protamine 2 NM_012873 -19.31 -3.49 
Fgfr1 Fibroblast growth factor receptor 1 BI275155 -19.28 -4.1 
Pdk4 pyruvate dehydrogenase kinase, isoenzyme 4 NM_053551 -19.26 -3.65 
Tmepai_predicted transmembrane, prostate androgen induced RNA (predicted) BI274101 -19.25 -3.15 
Fzd7_predicted frizzled homolog 7 (Drosophila) (predicted) BF411054 -19.25 -3.62 
  AI235281 -19.21 -2.61 
RGD1306694_predicted similar to hypothetical protein (predicted) BF523573 -19.21 -2.94 
  BE108896 -19.19 -2.91 
Clcn4-2 putative chloride channel 4-2 BG378827 -19.17 -2.67 
Crem cAMP responsive element modulator NM_017334 -19.16 -3.53 
  AI411989 -19.14 -2.73 
Tcn2 transcobalamin 2 NM_022534 -19.12 -3.02 
Polr3k  AI105044 -19.09 -2.89 
P34 p34 protein NM_134398 -19.08 -3.17 
Cxadr coxsackie virus and adenovirus receptor AI412564 -19.06 -2.67 
Lrp5_predicted low density lipoprotein receptor-related protein 5 (predicted) AW435376 -19.05 -2.7 
  AI639181 -19.04 -3.2 
  BI279384 -19.02 -2.71 
RGD1309079 similar to Ab2-095 AI407536 -19.02 -2.75 
Gpd2 glycerol-3-phosphate dehydrogenase 2, mitochondrial U08027 -18.99 -2.63 
Efemp2 EGF-containing fibulin-like extracellular matrix protein 2 BF551426 -18.99 -2.73 
Grhl1_predicted grainyhead-like 1 (Drosophila) (predicted) BM386731 -18.94 -2.58 
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  AI137509 -18.88 -2.78 
  AW524563 -18.87 -2.67 
Akap2 A kinase (PRKA) anchor protein 2 AI072144 -18.85 -3.04 
Irak2 interleukin-1 receptor-associated kinase 2 BI274988 -18.83 -2.93 
  AA892818 -18.82 -3.17 
  AI317854 -18.8 -2.74 
  AI548994 -18.74 -2.96 
Mosc2 MOCO sulphurase C-terminal domain containing 2 NM_134410 -18.74 -3 
Pak3 p21 (CDKN1A)-activated kinase 3 NM_019210 -18.74 -3.12 
  BG371864 -18.69 -2.66 
RGD1564596_predicted similar to RIKEN cDNA 2010001H14 (predicted) AI454360 -18.69 -2.99 
Fads2 fatty acid desaturase 2 NM_031344 -18.67 -3.42 
  AI555801 -18.63 -2.61 
RGD1561724_predicted similar to mKIAA0716 protein (predicted) AI045668 -18.63 -3.09 
Pde10a phosphodiesterase 10A NM_022236 -18.63 -3.29 
RGD1565166_predicted similar to MGC45438 protein (predicted) BI274344 -18.61 -2.6 
  BM389225 -18.59 -3.42 
Por P450 (cytochrome) oxidoreductase NM_031576 -18.57 -2.58 
RGD1566282_predicted similar to RIKEN cDNA D330045A20 (predicted) BE112948 -18.55 -2.61 
  BM386808 -18.53 -2.63 
Ptprg protein tyrosine phosphatase, receptor type, G AI556884 -18.52 -2.79 
Mbip_predicted MAP3K12 binding inhibitory protein 1 (predicted) AI454309 -18.46 -2.51 
Pde4b phosphodiesterase 4B, cAMP specific AF202733 -18.44 -2.66 
Ptpre protein tyrosine phosphatase, receptor type, E D78610 -18.43 -3.36 
Parvb_predicted parvin, beta (predicted) BI296756 -18.41 -2.8 
Tst thiosulfate sulfurtransferase AI411117 -18.4 -2.81 
Wnt5a wingless-type MMTV integration site 5A AI639128 -18.36 -5.11 
Scarb1 scavenger receptor class B, member 1 NM_031541 -18.32 -3.38 
Acp6 acid phosphatase 6, lysophosphatidic BF555852 -18.31 -2.72 
LOC652955 goliath BM391371 -18.31 -3.73 
Usp2 ubiquitin specific peptidase 2 AF106659 -18.28 -2.65 
  BM384251 -18.26 -3.07 
Pfkp phosphofructokinase, platelet BM389769 -18.23 -2.51 
Efemp2 EGF-containing fibulin-like extracellular matrix protein 2 AI112299 -18.2 -2.89 
RGD1561555_predicted similar to CDNA sequence BC022692 (predicted) BI302694 -18.18 -3.28 
RGD1305797_predicted similar to hypothetical protein FLJ33868 (predicted) BF412784 -18.17 -2.5 
Nedd9 neural precursor cell expressed, developmentally down-regulated gene 9 BF555968 -18.16 -4.09 
  AA892565 -18.1 -3.89 
Acp6 acid phosphatase 6, lysophosphatidic BM386224 -18.09 -2.69 
  BE097091 -18.09 -3.8 
Apln apelin, AGTRL1 ligand AI177057 -18.08 -3 
Arid5a AT rich interactive domain 5A (Mrf1 like) AI177813 -18.07 -2.72 
  BE329352 -18.07 -3.15 
Aurkb aurora kinase B NM_053749 -18.02 -3.35 
Rasa3 RAS p21 protein activator 3 AI170661 -18.02 -3.59 
  AI407050 -17.98 -3.04 
Qki quaking homolog, KH domain RNA binding (mouse) BE102226 -17.98 -3.48 
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  BI286775 -17.95 -3.62 
Nol3 nucleolar protein 3 (apoptosis repressor with CARD domain) NM_053516 -17.94 -3.5 
RGD1305387 similar to RIKEN cDNA 2610207I16 BI288527 -17.93 -2.76 
Abcb6 ATP-binding cassette, sub-family B (MDR/TAP), member 6 NM_080582 -17.93 -3.28 
RGD1306126 similar to hypothetical protein MGC2494 BF284299 -17.91 -2.97 
Hist1h2ai_predicted histone 1, H2ai (predicted) BE113430 -17.89 -2.78 
  BE112927 -17.87 -3.76 
Fzd3 frizzled homolog 3 (Drosophila) AI029226 -17.86 -2.97 





AA891414 -17.83 -2.71 
  AI169572 -17.81 -2.4 
  BE108258 -17.79 -3.06 
Dnaja4 DnaJ (Hsp40) homolog, subfamily A, member 4 BM386931 -17.78 -2.43 
Gprk5 G protein-coupled receptor kinase 5 NM_030829 -17.75 -2.6 
  AW535897 -17.72 -2.68 
Por P450 (cytochrome) oxidoreductase AI407454 -17.71 -2.43 
  BF406329 -17.7 -2.98 
  AW915423 -17.68 -2.46 
Wwp1 WW domain containing E3 ubiquitin protein ligase 1 BM383223 -17.67 -2.42 
Tle1_predicted transducin-like enhancer of split 1, homolog of Drosophila E(spl) (predicted) BG380534 -17.62 -2.52 
Rgs3 regulator of G-protein signalling 3 NM_019340 -17.62 -2.57 
RGD1563952_predicted similar to Mospd2 protein (predicted) BG667374 -17.62 -3.16 
LOC499014 similar to zinc finger, DHHC domain containing 14 BI296586 -17.59 -2.53 
  AI556018 -17.59 -2.73 
Kif21a_predicted kinesin family member 21A (predicted) BE103004 -17.57 -2.73 
Trp53rk_predicted TP53 regulating kinase (predicted) BI274525 -17.53 -2.39 
Col8a1_predicted procollagen, type VIII, alpha 1 (predicted) BE128699 -17.52 -2.45 
  AI146051 -17.47 -2.57 
Zfp110 zinc finger protein 110 AI137283 -17.46 -2.41 
Oprk1 opioid receptor, kappa 1 NM_017167 -17.46 -2.73 
Tmem34 transmembrane protein 34 AA962979 -17.4 -2.4 
  BM383081 -17.37 -2.87 
  BG372099 -17.37 -3.2 
Tle3 transducin-like enhancer of split 3, E(spl) homolog (Drosophila) NM_053400 -17.36 -2.49 
  AA858791 -17.36 -2.79 
  BG378238 -17.35 -2.41 
Boc_predicted 
biregional cell adhesion molecule-related/down-
regulated by oncogenes (Cdon) binding protein 
(predicted) 
BE110539 -17.35 -2.61 
Prkcz protein kinase C, zeta AW533298 -17.31 -2.59 
  AA945751 -17.29 -4.51 
Aspm_predicted asp (abnormal spindle)-like, microcephaly associated (Drosophila) (predicted) AW528001 -17.27 -2.82 
Pde4d phosphodiesterase 4D, cAMP specific BF565001 -17.23 -3.18 
  BF549570 -17.22 -2.97 
  AI144863 -17.18 -2.35 
L3mbtl3_predicted l(3)mbt-like 3 (Drosophila) (predicted) BI275119 -17.17 -2.7 
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LOC317274 hypothetical protein LOC317274 BI288003 -17.16 -2.36 
  AI410262 -17.15 -3.18 
  AA819279 -17.14 -2.45 
RGD1563119_predicted 
similar to MADS box transcription enhancer 
factor 2, polypeptide C (myocyte enhancer factor 
2C) (predicted) 
BE104219 -17.14 -3.22 
RGD1562629_predicted similar to neurobeachin (predicted) BM388077 -17.13 -3.47 
Sesn3_predicted sestrin 3 (predicted) AI113325 -17.12 -2.96 
RGD1305898_predicted similar to hypothetical protein FLJ40283 (predicted) AI555224 -17.11 -3.2 
RGD1305387 similar to RIKEN cDNA 2610207I16 AA964752 -17.07 -2.41 
Ghr growth hormone receptor AI170771 -16.98 -2.65 
Ctsl cathepsin L AI232474 -16.97 -2.94 
  AI113157 -16.95 -3.04 
Enpp4_predicted ectonucleotide pyrophosphatase/phosphodiesterase 4 (predicted) AI170859 -16.93 -4.01 
  AI043958 -16.92 -2.6 
Bok Bcl-2-related ovarian killer protein AF051093 -16.91 -2.51 
Impact  AI408713 -16.9 -3.22 
  BF417576 -16.9 -5.38 
Perc64 PE responsive protein c64 BI278571 -16.88 -2.53 
  BF523321 -16.88 -2.64 
  AI103161 -16.86 -2.28 
  BI295776 -16.85 -2.31 
  BF415532 -16.85 -2.97 
Jundp2 Jun dimerization protein 2 BF394170 -16.83 -2.33 
  AW915435 -16.83 -3.06 
Pbk_predicted PDZ binding kinase (predicted) BG663837 -16.81 -2.64 
Mic2l1 MIC2 like 1 NM_134459 -16.79 -3.74 
RGD1306534_predicted similar to P-Rex1 (predicted) AI060225 -16.75 -2.68 
Pxk PX domain containing serine/threonine kinase AW920759 -16.71 -2.26 
MGC72974 Unknown (protein for MGC:72974) BI275851 -16.71 -2.47 
  AW529817 -16.7 -2.55 
Top2a topoisomerase (DNA) 2 alpha BM385445 -16.67 -2.65 
Cdh2 cadherin 2 AF097593 -16.67 -4.09 
  BG380768 -16.64 -2.83 
  BI276554 -16.6 -2.58 
Ptpn22_predicted protein tyrosine phosphatase, non-receptor type 22 (lymphoid) (predicted) AI176755 -16.52 -2.53 
  BE104039 -16.51 -2.99 
Lrp4 low density lipoprotein receptor-related protein 4 AI070976 -16.5 -2.24 
RGD1563224_predicted similar to 4930438D12Rik protein (predicted) BF284719 -16.48 -2.3 
  BG379394 -16.48 -2.46 
  BM383329 -16.47 -2.35 
Degs1 degenerative spermatocyte homolog 1 (Drosophila) NM_053323 -16.47 -2.51 
  AW917731 -16.45 -3.43 
  BE116572 -16.44 -2.38 
Herpud1 homocysteine-inducible, endoplasmic reticulum stress-inducible, ubiquitin-like domain member 1 NM_053523 -16.39 -2.41 
  BG376458 -16.38 -2.23 
  AI406729 -16.37 -2.32 
LOC497083 XK-related protein 5 AW252094 -16.37 -2.77 
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Pex2 peroxin 2 BE121134 -16.34 -2.76 
  AA799503 -16.33 -2.5 
  BG381486 -16.31 -2.31 
RGD1563950_predicted similar to NF-kappa-B-repressing factor (Transcription factor NRF) (predicted) BF288000 -16.29 -2.43 
  BE108354 -16.29 -3.26 
Dlgap1 discs, large (Drosophila) homolog-associated protein 1 NM_022946 -16.27 -3.39 
  BF407449 -16.26 -3.8 
Zfp354a zinc finger protein 354A NM_052798 -16.25 -2.73 





NM_022926 -16.2 -2.68 
  BF285316 -16.2 -2.9 
  BE110753 -16.19 -2.36 
  BE109363 -16.18 -2.42 
RGD1562933_predicted similar to product is unknown~seizure-related gene (predicted) BM389543 -16.15 -2.92 
Ngfrap1 nerve growth factor receptor (TNFRSF16) associated protein 1 BG381021 -16.12 -2.9 
RGD1564451_predicted similar to Tribbles homolog 2 (predicted) BE114077 -16.11 -2.32 
Man2a1 mannosidase 2, alpha 1 H32368 -16.1 -2.47 
Dpep1 dipeptidase 1 (renal) L07316 -16.08 -2.6 
RGD1307336 similar to hypothetical protein AW522732 -16.08 -3.73 
  BM389326 -16.06 -2.78 
Impact  BG664101 -16.04 -3.5 
  BG665568 -16.02 -3.58 
Bai2_predicted brain-specific angiogenesis inhibitor 2 (predicted) AA924656 -16.01 -2.21 
  AA818967 -16 -2.23 
Vangl1_predicted vang, van gogh-like 1 (Drosophila) (predicted) AI703874 -16 -2.6 
Eif2ak3 eukaryotic translation initiation factor 2 alpha kinase 3 NM_031599 -15.99 -2.37 
Abhd4_predicted abhydrolase domain containing 4 (predicted) BM383152 -15.99 -2.61 
Nmnat3 nicotinamide nucleotide adenylyltransferase 3 AA963282 -15.99 -2.67 
RGD1561724_predicted similar to mKIAA0716 protein (predicted) AI100942 -15.95 -2.18 
Cbs cystathionine beta synthase NM_012522 -15.93 -2.19 
Impact  AA850890 -15.88 -2.72 
Ppp1r1b protein phosphatase 1, regulatory (inhibitor) subunit 1B AA942959 -15.86 -2.73 
  BI294633 -15.85 -2.23 
Tcf4 transcription factor 4 BG377130 -15.8 -2.5 
  BE102374 -15.8 -3.21 
Elovl6 ELOVL family member 6, elongation of long chain fatty acids (yeast) BF396857 -15.79 -2.15 
Slc6a9 solute carrier family 6 (neurotransmitter transporter, glycine), member 9 M95413 -15.79 -2.52 
Tparl TPA regulated locus AW523924 -15.75 -2.13 
Sec11l3 Sec11-like 3 (S. cerevisiae) AB022714 -15.75 -2.47 
Azi2 5-azacytidine induced gene 2 AI045510 -15.73 -2.17 
Sema3a sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3A NM_017310 -15.73 -2.33 
  AI412606 -15.73 -2.68 
  AI704285 -15.73 -2.76 
Rab38 Rab38, member of RAS oncogene family M94043 -15.71 -2.2 
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Srebf1 sterol regulatory element binding factor 1 BF398848 -15.67 -2.21 
Rab27b RAB27B, member RAS oncogene family NM_053459 -15.64 -2.17 
RGD1559673_predicted similar to hypothetical protein PP1665 (predicted) AA963795 -15.64 -2.27 
Sc65 synaptonemal complex protein SC65 NM_021581 -15.64 -2.45 
  BI294141 -15.64 -2.61 
Chd7_predicted chromodomain helicase DNA binding protein 7 (predicted) BF523068 -15.63 -2.38 
S100a1 S100 calcium binding protein A1 AI228548 -15.63 -2.8 
  BE118107 -15.63 -3.98 
Acot8 acyl-CoA thioesterase 8 BF282933 -15.62 -2.3 
Pnldc1 poly(A)-specific ribonuclease (PARN)-like domain containing 1 AW521201 -15.61 -2.46 
Mki67_predicted antigen identified by monoclonal antibody Ki-67 (predicted) AI714002 -15.61 -2.99 
Top2a topoisomerase (DNA) 2 alpha BM385445 -15.61 -3.03 
RGD1561019_predicted similar to hypothetical protein (predicted) AW530090 -15.6 -2.77 
Bok Bcl-2-related ovarian killer protein AI227742 -15.58 -2.86 
  R47022 -15.57 -2.46 
  BM386212 -15.53 -2.1 
  BE103021 -15.53 -2.69 
  AI101660 -15.52 -2.15 
  AI406363 -15.52 -2.49 
  AI228600 -15.5 -2.23 
RGD1307264_predicted similar to hypothetical protein FLJ20302; similar to CG31653-PA (predicted) BF285339 -15.47 -2.15 
Agpat4 1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta) NM_133406 -15.46 -2.43 
Chchd2 coiled-coil-helix-coiled-coil-helix domain containing 2 AA799736 -15.44 -2.54 
Srebf1 sterol regulatory element binding factor 1 AF286470 -15.41 -2.38 
Kif4 kinesin family member 4 AA859926 -15.4 -2.48 
Nfia nuclear factor I/A D78019 -15.39 -2.15 
Prc1_predicted protein regulator of cytokinesis 1 (predicted) BI284262 -15.38 -3.48 
LOC290341  AI169116 -15.37 -2.15 
RGD1564664_predicted similar to LOC387763 protein (predicted) AI454658 -15.37 -2.16 
Rpa2 replication protein A2 BM385924 -15.36 -2.27 
Slc6a9 solute carrier family 6 (neurotransmitter transporter, glycine), member 9 AW141210 -15.35 -2.53 
RGD1306939 similar to mKIAA0386 protein AI010237 -15.35 -3.6 
Ctsc cathepsin C AA858815 -15.34 -2.58 
Lgals8 lectin, galactoside-binding, soluble 8 AI411914 -15.33 -2.09 
Sels selenoprotein S AF367467 -15.33 -2.15 
Ggtl3 gamma-glutamyltransferase-like 3 NM_130423 -15.32 -2.45 
  BM386385 -15.31 -2.76 
  BF288135 -15.31 -2.88 
  BF409676 -15.31 -2.91 
Bub1b budding uninhibited by benzimidazoles 1 homolog, beta (S. cerevisiae) BF557145 -15.3 -3.3 
  BI290860 -15.26 -2.22 
  BF394102 -15.25 -2.74 
Mycn_mapped v-myc myelocytomatosis viral related oncogene, neuroblastoma derived (avian) (mapped) BI275570 -15.24 -3.29 
Lrrc8d leucine rich repeat containing 8 family, member D AI101427 -15.22 -2.21 
Maged1 melanoma antigen, family D, 1 NM_053409 -15.2 -2.3 
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Rab40b_predicted Rab40b, member RAS oncogene family (predicted) AA924620 -15.19 -2.19 
  BI290853 -15.19 -2.61 
LOC360997  BM385804 -15.17 -2.13 
  BI289642 -15.14 -2.54 
Rrbp1_predicted ribosome binding protein 1 homolog 180kDa (dog) (predicted) BI279795 -15.12 -2.18 
Slc15a2 solute carrier family 15 (H+/peptide transporter), member 2 NM_031672 -15.12 -2.29 
Nt5dc2 5'-nucleotidase domain containing 2 BI285551 -15.11 -2.56 
Zfp347 zinc finger protein 347 AB047638 -15.1 -2.19 
  AA851385 -15.1 -3.49 
  BI296506 -15.07 -2.09 
  BI281837 -15.07 -2.56 
Abcg3 ATP-binding cassette, sub-family G (WHITE), member 3 BF282804 -15.06 -3.48 
Armet_predicted arginine-rich, mutated in early stage tumors (predicted) AI170666 -15.02 -2.07 
Pdia4 protein disulfide isomerase associated 4 NM_053849 -15.02 -2.86 
  BF550315 -15.02 -3.16 
Ece1 endothelin converting enzyme 1 NM_053596 -15.01 -2.13 
  AW531791 -15 -2.16 
  BG377427 -15 -2.76 
Kifc1 kinesin family member C1 AW253880 -15 -2.8 
Ucp2 uncoupling protein 2 (mitochondrial, proton carrier) NM_019354 -14.98 -2.24 
Cebpd CCAAT/enhancer binding protein (C/EBP), delta NM_013154 -14.98 -2.65 
  BM382988 -14.92 -3.21 
Map1b microtubule-associated protein 1b BG672052 -14.9 -2.45 
LOC309891 similar to septin 10 isoform 1 AI136863 -14.88 -2.31 
Bub1_predicted budding uninhibited by benzimidazoles 1 homolog (S. cerevisiae) (predicted) BF388785 -14.87 -2.77 
  BE103930 -14.87 -3.19 





BG375792 -14.85 -3.05 
Cst3 cystatin C BG666933 -14.84 -2.05 
  BF409598 -14.83 -2.23 
Slc4a1 solute carrier family 4, member 1 BE113640 -14.83 -2.53 
Dlg7_predicted discs, large homolog 7 (Drosophila) (predicted) AA874827 -14.82 -2.63 
  AW533569 -14.82 -2.66 
  AI412190 -14.81 -2.05 
  AI601956 -14.8 -2.6 
Mmp14 matrix metallopeptidase 14 (membrane-inserted) X83537 -14.79 -2.13 
RGD1307569_predicted similar to Protein C21orf63 homolog precursor (predicted) BF408325 -14.77 -2.34 
  AW535380 -14.77 -2.4 
RGD1309969 similar to RIKEN cDNA 2600010E01 AI059078 -14.77 -2.65 
RGD1561413_predicted similar to BC021442 protein (predicted) AI137632 -14.76 -2.5 
Cachd1_predicted cache domain containing 1 (predicted) BF567204 -14.75 -2.18 
LOC294762  BE105494 -14.75 -3.15 
Prickle1 prickle-like 1 (Drosophila) AI171526 -14.74 -2.65 
  BI280277 -14.73 -2.55 
  BM389711 -14.67 -2.12 
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Nid2 nidogen 2 BM389302 -14.65 -3.27 
  AA818098 -14.61 -3.02 
RGD1310360 similar to 3000004C01Rik protein AI410054 -14.58 -2.29 
Elovl2_predicted 
elongation of very long chain fatty acids 
(FEN1/Elo2, SUR4/Elo3, yeast)-like 2 
(predicted) 
BG666735 -14.56 -3.26 
Tmem19 transmembrane protein 19 BF289172 -14.55 -2.21 
RGD1309971_predicted similar to KIAA1126 protein (predicted) BI296223 -14.54 -2.01 
  BF542239 -14.54 -2.33 
  AW251900 -14.52 -2.05 
Lpin1 lipin 1 BM385286 -14.52 -2.08 
  BI285321 -14.5 -2.29 
Siahbp1 
siah binding protein 1; FBP interacting repressor; 
pyrimidine tract binding splicing factor; Ro 
ribonucleoprotein-binding protein 1 
BE113111 -14.5 -2.71 
Tcfdp2_predicted transcription factor Dp 2 (predicted) AI177311 -14.5 -3.02 
Mysm1_predicted myb-like, SWIRM and MPN domains 1 (predicted) BF419160 -14.49 -2.19 
Ptgds2 prostaglandin D2 synthase 2 NM_031644 -14.48 -2.1 
Calu calumenin AJ001929 -14.48 -2.18 
Klf9 Kruppel-like factor 9 AI071565 -14.47 -2.1 
  BG371608 -14.45 -2.08 
  BF406606 -14.44 -2.11 
  AW532132 -14.42 -2.64 
  AI013502 -14.41 -2.29 
Rasd1 RAS, dexamethasone-induced 1 AF239157 -14.39 -4.38 
Hddc2_predicted HD domain containing 2 (predicted) BF409313 -14.35 -2.52 
Ca2 carbonic anhydrase 2 NM_019291 -14.34 -3.59 
Tcfcp2l2 transcription factor CP2-like 2 AI716050 -14.33 -2.21 
Itpr2 inositol 1,4,5-triphosphate receptor 2 X61677 -14.29 -2.08 
  AI105202 -14.27 -2.08 
RGD1563246_predicted similar to thrombospondin, type I, domain containing 2 (predicted) BE107414 -14.26 -2.05 
Tbc1d1_predicted TBC1 domain family, member 1 (predicted) BM383480 -14.25 -2.17 
  BI278193 -14.24 -2.44 
Slc6a9 solute carrier family 6 (neurotransmitter transporter, glycine), member 9 AA943735 -14.23 -2.33 
  BI282008 -14.23 -2.42 
  BE117009 -14.22 -2.27 
  BI300566 -14.22 -2.31 
Il2rb interleukin 2 receptor, beta chain NM_013195 -14.22 -3.79 
  BI289840 -14.2 -2.52 
  BI289126 -14.19 -2.14 
  BE096457 -14.19 -2.77 
Maf v-maf musculoaponeurotic fibrosarcoma oncogene homolog (avian) NM_019318 -14.16 -2.24 
  AI101338 -14.16 -2.3 
Itga6 integrin, alpha 6 AA955091 -14.15 -2.19 
Acvr1 activin A receptor, type 1 NM_024486 -14.12 -2.18 
  BI294306 -14.12 -2.23 
Hspb6 heat shock protein, alpha-crystallin-related, B6 D29960 -14.1 -2.59 
Smc2l1_predicted SMC2 structural maintenance of chromosomes 2-like 1 (yeast) (predicted) AW535052 -14.08 -2.06 
  BG376748 -14.08 -2.35 
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  AA963975 -14.08 -3.42 
  AI407489 -14.04 -2.18 
Ckap2_predicted cytoskeleton associated protein 2 (predicted) BI295150 -14.04 -2.38 
RGD1559690_predicted similar to hypothetical protein FLJ25416 (predicted) BE098141 -14.03 -2.43 
RGD1311381_predicted similar to hypothetical protein FLJ20037 (predicted) AA850950 -14.01 -2.32 
Lgals3bp lectin, galactoside-binding, soluble, 3 binding protein AF065438 -14.01 -2.75 
Slc4a4 solute carrier family 4, member 4 AF210250 -14 -2.26 
  BF403558 -13.97 -2.06 
  BE112536 -13.95 -2.61 
Tspan5 tetraspanin 5 BG381571 -13.91 -2.01 
Cd47 CD47 antigen (Rh-related antigen, integrin-associated signal transducer) NM_019195 -13.86 -2.06 
Mte1 mitochondrial acyl-CoA thioesterase 1 BF555448 -13.86 -2.14 
Znf183 zinc finger protein 183 (RING finger, C3HC4 type) AI231532 -13.86 -2.39 
RGD1559992_predicted similar to polycystic kidney disease 2 (predicted) AA850650 -13.84 -2.06 
Sept8_predicted septin 8 (predicted) AA943694 -13.84 -2.21 
  AA850361 -13.84 -2.29 
  BG372589 -13.82 -2.04 
  BG379401 -13.82 -2.57 
  BG381256 -13.8 -2.52 
Lr8 LR8 protein NM_134390 -13.78 -2.08 
  BI295203 -13.78 -2.11 
Elovl6 ELOVL family member 6, elongation of long chain fatty acids (yeast) BE116152 -13.77 -2.7 
Nab2 Ngfi-A binding protein 2 AI102530 -13.76 -2.03 
Ttc23 tetratricopeptide repeat domain 23 BF284579 -13.73 -2.2 
Gnpda2_predicted glucosamine-6-phosphate deaminase 2 (predicted) BG374650 -13.71 -2.36 
  BF419415 -13.71 -2.4 
  BF398091 -13.71 -2.44 
Decr1 2,4-dienoyl CoA reductase 1, mitochondrial NM_057197 -13.71 -2.8 
Nusap1_predicted nucleolar and spindle associated protein 1 (predicted) AI711233 -13.7 -2.32 
  AW525722 -13.69 -2.2 
LOC306096  AI411835 -13.68 -3.47 
Plunc palate, lung, and nasal epithelium carcinoma associated BF546645 -13.67 -2.38 
Stag3 stromal antigen 3 NM_053730 -13.66 -2.95 
  BF396316 -13.65 -2.23 
Ube2e2 ubiquitin-conjugating enzyme E2E 2 (UBC4/5 homolog, yeast) BM391175 -13.63 -2.01 
RGD1561817_predicted similar to Traf2 and NCK interacting kinase, splice variant 4 (predicted) BI291396 -13.63 -2.19 
Lysmd2_predicted LysM, putative peptidoglycan-binding, domain containing 2 (predicted) AI103948 -13.62 -2.96 
Vegfc vascular endothelial growth factor C NM_053653 -13.62 -3.46 
RGD1562686_predicted similar to genetic suppressor element 1 (predicted) AA963875 -13.58 -2.2 
  AA964466 -13.57 -2.38 
Nfasc neurofascin BI285436 -13.53 -2.18 
Slc14a2 solute carrier family 14 (urea transporter), member 2 NM_019347 -13.53 -2.76 
Sqle squalene epoxidase NM_017136 -13.52 -2.84 
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Glul glutamate-ammonia ligase (glutamine synthase) BI296610 -13.51 -2.82 
Ripk2 receptor (TNFRSF)-interacting serine-threonine kinase 2 BF412519 -13.49 -2.44 
Foxd2_predicted forkhead box D2 (predicted) BI291467 -13.48 -3.57 
Ccbl1 cysteine conjugate-beta lyase 1 BF400674 -13.47 -2.05 
  AI454332 -13.45 -2.44 
LOC305076 
similar to hypothetical protein MGC29875; novel 
putative protein similar to YIL091C yeast 
hypothetical 84 kD protein from SGA1-KTR7 
BI297073 -13.45 -2.53 
Serpinh1 serine (or cysteine) proteinase inhibitor, clade H, member 1 BI285495 -13.39 -2.12 
  BF550565 -13.37 -2.06 
LOC498425 
similar to U2 small nuclear ribonucleoprotein 
auxiliary factor 35 kDa subunit related-protein 1 
(U2(RNU2) small nuclear RNA auxillary factor 
1-like 1) (SP2) 
BF404554 -13.35 -2.3 
  AI010439 -13.35 -2.8 
  AW435415 -13.33 -2.26 
Abhd1 abhydrolase domain containing 1 AI105131 -13.3 -2.2 
  BG378763 -13.25 -2.21 
LOC302855 similar to heterogeneous nuclear ribonucleoprotein G - human BF290678 -13.24 -3.28 
Tm4sf13 transmembrane 4 superfamily member 13 AI408602 -13.21 -2.03 
Trib1 tribbles homolog 1 (Drosophila) BI290758 -13.2 -2.12 
Mphosph1_predicted M-phase phosphoprotein 1 (predicted) BE110723 -13.2 -2.41 
  AI407351 -13.16 -2.07 
  BE113449 -13.15 -2.29 
  AW529348 -13.15 -2.34 
  AW921600 -13.09 -2.12 
  AI100827 -13.09 -2.13 
Fads1 fatty acid desaturase 1 NM_053445 -13.08 -2.37 
Cdc20 cell division cycle 20 homolog (S. cerevisiae) U05341 -13.08 -2.55 
Stk6 serine/threonine kinase 6 AA996882 -13.07 -2.19 
  AA899202 -13.04 -2 
Terf1 telomeric repeat binding factor 1 AA818755 -13.03 -2.44 
Cdc20 cell division cycle 20 homolog (S. cerevisiae) U05341 -13.03 -2.61 
Kif20a_predicted kinesin family member 20A (predicted) BE111697 -13.02 -2.8 
Abhd3_predicted abhydrolase domain containing 3 (predicted) BG662490 -12.97 -2.28 
  BE107062 -12.9 -2.44 
Pltp_predicted phospholipid transfer protein (predicted) BI278687 -12.9 -3.23 
Ppfibp2 protein tyrosine phosphatase, receptor-type, F interacting protein, binding protein 2 BE106488 -12.87 -2.28 
RGD1562596_predicted similar to mKIAA0159 protein (predicted) AI407418 -12.86 -2.07 
Sfxn1 sideroflexin 1 AA819349 -12.81 -2.26 
Dnajc18 DnaJ (Hsp40) homolog, subfamily C, member 18 AI556034 -12.81 -2.63 
  BE108276 -12.79 -2.57 
Tm4sf1_predicted transmembrane 4 superfamily member 1 (predicted) AW435343 -12.78 -2.32 
Asrgl1 asparaginase like 1 AF329099 -12.78 -2.78 
C1s complement component 1, s subcomponent D88250 -12.76 -2.18 
Creld2 cysteine-rich with EGF-like domains 2 BE106888 -12.76 -2.27 
Ccna2 cyclin A2 AA998516 -12.76 -2.31 
RGD1307736 similar to Hypothetical protein KIAA0152 AI407016 -12.71 -2.01 
Dnaja4 DnaJ (Hsp40) homolog, subfamily A, member 4 BF565278 -12.69 -2.27 
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Tgm2 transglutaminase 2, C polypeptide BI275994 -12.68 -2.91 
Tra1_predicted tumor rejection antigen gp96 (predicted) BG057543 -12.67 -2.2 
  AI113308 -12.66 -2.1 
  BE349670 -12.65 -2.31 
Hmgcs2 3-hydroxy-3-methylglutaryl-Coenzyme A synthase 2 M33648 -12.65 -2.94 
  AI145951 -12.61 -2.03 
Cdca2 cell division cycle associated 2 BG381524 -12.61 -2.13 
  AI170376 -12.61 -2.42 
  AA894279 -12.6 -2.23 
Nptxr neuronal pentraxin receptor BG380575 -12.6 -2.58 
Ube2e2 ubiquitin-conjugating enzyme E2E 2 (UBC4/5 homolog, yeast) AW921519 -12.58 -2.76 
  BG374493 -12.57 -2.19 
Aldh5a1 aldehyde dehydrogenase family 5, subfamily A1 L34821 -12.57 -2.37 
Racgap1_predicted Rac GTPase-activating protein 1 (predicted) BF559151 -12.54 -2.09 
Melk_predicted maternal embryonic leucine zipper kinase (predicted) BM390710 -12.54 -2.79 
  BM384889 -12.53 -2.29 
Rassf1 Ras association (RalGDS/AF-6) domain family 1 AI103943 -12.52 -2.24 
F3 coagulation factor III NM_013057 -12.49 -3.87 
Ebf1 early B-cell factor 1 NM_053820 -12.46 -2.49 
Gloxd1 glyoxalase domain containing 1 AA957707 -12.43 -2.23 
Plcl3_predicted phospholipase C-like 3 (predicted) AI549022 -12.43 -2.98 
Sah SA rat hypertension-associated gene BE098160 -12.41 -2.07 
Spbc25 spindle pole body component 25 homolog (S. cerevisiae) AI408269 -12.38 -2.24 
Mcam melanoma cell adhesion molecule BI277043 -12.36 -2.52 
MGC72614 Unknown (protein for MGC:72614) AI385260 -12.35 -2.09 
Ril reversion induced LIM gene NM_017062 -12.35 -2.5 
  BE104167 -12.33 -2.08 
RGD1306107_predicted similar to chromosome 1 open reading frame 2 (predicted) BG376030 -12.26 -2.2 
Zcchc12 zinc finger, CCHC domain containing 12 AI101009 -12.26 -2.2 
MGC72614 Unknown (protein for MGC:72614) AI009530 -12.26 -2.74 
Gamt guanidinoacetate methyltransferase NM_012793 -12.21 -2.49 
  BF395101 -12.11 -2.08 
  AW524864 -12.08 -2.04 
Fbxo30 F-box protein 30 AI030920 -12.08 -2.17 
Atad2_predicted ATPase family, AAA domain containing 2 (predicted) AW915567 -12.06 -2.25 
Osbpl6_predicted oxysterol binding protein-like 6 (predicted) AA901035 -12.05 -2.36 
RGD1304563_predicted similar to RIKEN cDNA 4831426I19 (predicted) BI301147 -12.05 -2.75 
Ddt D-dopachrome tautomerase BE108176 -12.03 -2.09 
  AA964152 -12.01 -2.25 
Oprk1 opioid receptor, kappa 1 L22536 -11.99 -2.49 
Ube2l6 ubiquitin-conjugating enzyme E2L 6 BI279216 -11.97 -3.01 
  AA849497 -11.96 -3.03 
  AI176172 -11.95 -2.51 
RGD1559565_predicted similar to EF hand domain containing 1 (predicted) BM389214 -11.94 -2.86 
  AI101499 -11.89 -2.09 
Lzts1 leucine zipper, putative tumor suppressor 1 AA875041 -11.89 -2.41 
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Ube2t_predicted ubiquitin-conjugating enzyme E2T (putative) (predicted) AW531714 -11.89 -2.51 
Dhrs4 dehydrogenase/reductase (SDR family) member 4 AB062758 -11.88 -2.61 
  AI579823 -11.84 -2.56 
Tmod1 tropomodulin 1 NM_013044 -11.83 -2.71 
Csrp1 cysteine and glycine-rich protein 1 NM_017148 -11.81 -2.02 
Sc5d sterol-C5-desaturase (fungal ERG3, delta-5-desaturase) homolog (S. cerevisae) AB052846 -11.79 -2.15 
  AI410976 -11.78 -2.17 
Fgf1 fibroblast growth factor 1 BI285064 -11.77 -2.51 
  BE110761 -11.75 -2.95 
  BF553498 -11.73 -2.26 
Hccs_predicted holocytochrome c synthetase (predicted) BF405032 -11.7 -2.05 
  AI012120 -11.64 -2.09 
Tmem23 transmembrane protein 23 AI229404 -11.63 -2.55 
  BF408444 -11.6 -2.42 
  BE116384 -11.57 -2.61 
  AI548667 -11.55 -2.29 
  AI712476 -11.54 -2.05 
Nradd neurotrophin receptor associated death domain AI598730 -11.53 -2.07 
Espl1_predicted extra spindle poles like 1 (S. cerevisiae) (predicted) AI385371 -11.47 -2.27 
Slc25a25 solute carrier family 25 (mitochondrial carrier, phosphate carrier), member 25 AI177358 -11.46 -2.96 
Depdc1b_predicted DEP domain containing 1B (predicted) AA899893 -11.41 -2.77 
Pttg1 pituitary tumor-transforming 1 NM_022391 -11.4 -2.19 
Ptprm protein tyrosine phosphatase, receptor type, M AI639001 -11.37 -2.21 
Ccnb1 cyclin B1 L11995 -11.35 -2.39 
  BM391003 -11.35 -2.44 
Kif2c kinesin family member 2C BI274467 -11.34 -2.14 
  BI299008 -11.31 -2.27 
Smarcd3 
SWI/SNF related, matrix associated, actin 
dependent regulator of chromatin, subfamily d, 
member 3 
BG380496 -11.28 -2.07 
  AI511225 -11.24 -2.05 
Zfp278 zinc finger protein 278 BE112999 -11.21 -2.05 
Acss1_predicted acyl-CoA synthetase short-chain family member 1 (predicted) AI176565 -11.2 -2.03 
Tacc3 transforming, acidic coiled-coil containing protein 3 AI556917 -11.2 -2.34 
  BE105762 -11.19 -2.19 
  AI500762 -11.19 -2.27 
Adi1 acireductone dioxygenase 1 AA997430 -11.18 -2.17 
  AI072068 -11.18 -2.27 
  BF562797 -11.18 -2.42 
Piga_mapped phosphatidylinositol glycan, class A (mapped) BF409296 -11.16 -2.19 
Cdc2a cell division cycle 2 homolog A (S. pombe) NM_019296 -11.15 -2.32 
Reck_predicted reversion-inducing-cysteine-rich protein with kazal motifs (predicted) AW523759 -11.15 -2.7 
Lass4_predicted longevity assurance homolog 4 (S. cerevisiae) (predicted) BE111727 -11.14 -2.27 
Ccnb1 cyclin B1 X64589 -11.13 -2.21 
Il6 interleukin 6 NM_012589 -11.12 -2.6 
  BE120852 -11.09 -2.13 
Osbpl1a oxysterol binding protein-like 1A AI070135 -11.08 -2.56 
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Ca2 carbonic anhydrase 2 AI408948 -11.06 -2.64 
Arf2 ADP-ribosylation factor 2 BE112160 -11 -2.04 
Nfia nuclear factor I/A D78017 -10.93 -2.61 
  AF151710 -10.84 -2.03 
Dscr1 Down syndrome critical region homolog 1 (human) AI170193 -10.78 -2 
H2a histone 2a BE104595 -10.78 -2.15 
Crem cAMP responsive element modulator BF564195 -10.77 -2.37 
Cdca3 cell division cycle associated 3 BF417638 -10.71 -2.08 
  AA996927 -10.67 -2.13 
Ccnb2 cyclin B2 AW253821 -10.66 -2.2 
Ube2c_predicted ubiquitin-conjugating enzyme E2C (predicted) BI296084 -10.63 -2.06 
  BF397903 -10.62 -2.28 
Tmod1 tropomodulin 1 AI104913 -10.62 -2.43 
Tbx15_predicted T-box 15 (predicted) AW533075 -10.62 -2.88 
  AW917486 -10.59 -2.28 
MGC109491 similar to 1110007F12Rik protein AI071166 -10.57 -2.14 
RGD1562552_predicted similar to hypothetical protein LOC340061 (predicted) AI408343 -10.57 -2.37 
Mybpc2_predicted myosin binding protein C, fast-type (predicted) AW533848 -10.56 -2.61 
  BI303187 -10.55 -2.23 
RGD1309107 similar to RIKEN cDNA 6530401L14 gene BE109109 -10.51 -2.14 
Trib1 tribbles homolog 1 (Drosophila) BM387324 -10.44 -2.3 
  AA956340 -10.43 -2.06 
Etfb electron-transfer-flavoprotein, beta polypeptide AW252650 -10.37 -2.22 
RGD1565734_predicted similar to SNF2/RAD54 family protein (predicted) BF397986 -10.37 -2.3 
  AI232286 -10.35 -2.25 
Orc1l origin recognition complex, subunit 1-like (S.cereviaiae) AI059490 -10.33 -2.06 
Ralgps2 Ral GEF with PH domain and SH3 binding motif 2 AA926180 -10.29 -2.14 
Spag5 sperm associated antigen 5 AF111111 -10.28 -2.17 
Pard6g_predicted par-6 partitioning defective 6 homolog gamma (C. elegans) (predicted) BI295763 -10.26 -2.91 
Chd1_predicted chromodomain helicase DNA binding protein 1 (predicted) AA875265 -10.25 -3 
  BI299014 -10.18 -2.23 
  BM385249 -10.18 -2.49 
RGD1310784_predicted similar to RIKEN cDNA 2810433K01 (predicted) BE109802 -10.16 -3.04 
Gas7 growth arrest specific 7 AJ131902 -10.13 -2.12 
  BG378849 -10.09 -2.09 
  AA818382 -10.09 -2.55 
  AI234119 -10.04 -2.34 
  AI599509 -10.03 -2.29 
Troap_predicted trophinin associated protein (tastin) (predicted) BM392307 -9.96 -2.22 
  BE108208 -9.93 -2.01 
  BF396623 -9.91 -2 
Pcbp4_predicted poly(rC) binding protein 4 (predicted) AW523679 -9.87 -2.05 
  AI385201 -9.84 -3.07 
Plk4_predicted polo-like kinase 4 (Drosophila) (predicted) BE109322 -9.82 -2.75 
Hfe hemochromatosis BI299921 -9.81 -2.68 
Nradd neurotrophin receptor associated death domain NM_139259 -9.56 -2.45 
  BE102340 -9.54 -2.26 
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RGD1304592_predicted similar to KIAA0528 protein (predicted) BF543289 -9.51 -2.2 
  AI578135 -9.5 -2.07 
Cdca2 cell division cycle associated 2 AW532628 -9.46 -2.19 
Hey1 hairy/enhancer-of-split related with YRPW motif 1 BE107815 -9.37 -3.15 
Eif2ak3 eukaryotic translation initiation factor 2 alpha kinase 3 BF398966 -9.36 -2 
Stc2 stanniocalcin 2 NM_022230 -9.34 -2.03 
Bmp4 bone morphogenetic protein 4 NM_012827 -9.34 -2.76 
Rbbp6 retinoblastoma binding protein 6 BG373809 -9.12 -2.24 
Mip1 myocardial ischemic preconditioning upregulated 1 AI548984 -9.09 -2.05 
Serpina3n serine (or cysteine) peptidase inhibitor, clade A, member 3N NM_031531 -9.08 -2.67 
Acat2 acetyl-Coenzyme A acetyltransferase 2 AI412322 -8.99 -2.04 
Hmmr hyaluronan mediated motility receptor (RHAMM) AI171185 -8.96 -2.44 
Dufd1_predicted DUF729 domain containing 1 (predicted) BI295614 -8.64 -2.56 
Kif2c kinesin family member 2C NM_134472 -8.54 -2.03 
E2f8 E2F transcription factor 8 AI231053 -8.54 -2.51 
  AI103530 -8.5 -2.85 
Cyp26b1 cytochrome P450, family 26, subfamily b, polypeptide 1 BF397093 -8.47 -2.38 
Hmmr hyaluronan mediated motility receptor (RHAMM) AF336825 -8.37 -2.42 
Zfand2a zinc finger, AN1-type domain 2A AI406908 -8.32 -2.39 
Fshprh1 FSH primary response 1 NM_012955 -8.13 -2.35 
  AI177322 -8.06 -2.97 
Akap2 A kinase (PRKA) anchor protein 2 BF398063 -7.94 -2.05 
  BI289438 -7.68 -2.17 
RGD1305846_predicted similar to hypothetical protein A730008H23 (predicted) BE101323 -7.39 -2.12 
LOC501039  BF399367 -7.09 -2.43 
  AW522589 -6.53 -2.5 
  AW434394 -6.11 -2.21 
  BI298616 -6.05 -2.34 
Ddit3 DNA-damage inducible transcript 3 BF403703 -5.92 -2.27 
  BF408177 -5.9 -2.13 
Abca1 ATP-binding cassette, sub-family A (ABC1), member 1 AI502114 -5.58 -2.47 











Crb3a and Rab11a Dependent Apical Membrane Formation 
 
Introduction 
The deposition of transmembrane Crb3a in the apical plasma membrane requires 
insertion into the vesicular trafficking machinery and movement to its proper subcellular 
localizations.  Evidence has suggested that Crb3a is responsible for the formation for a 
distinct apical membrane, suggesting that the trafficking of Crb3a is an early and efficient 
process in cell polarization.  Transmembrane proteins coalesce into a post-Golgi central 
endosome and are segregated based on final location by Rab-family GTPases that act as 
sorting signals to and from each endosomal compartment (46, 99) (292).  For proteins 
destined for the apical surface, a common apical recycling endosome (ARE) that resides 
just below the apical surface is the last sorting endosome before membrane insertion (9).  
The Rab11 family GTPAses (Rab11a, Rab11b and Rab25) are associated with the ARE 
(36, 81).  Exocytic vesicles budded from the ARE fuse with the apical surface through 
Rab11-family interactions with the conserved exocyst complex and Myosin Vb based 
cytoskeletal association (17, 22, 145).  The question still remains as to how Crb3a is 
trafficked to the apical surface during apical membrane establishment.  We chose to 
 204 
investigate Crb3a trafficking using a lumen formation model to determine how Crb3a is 
trafficked to the apical surface through endosomal compartments 
 
Materials and Methods 
Cell Lines and Plasmids 
MDCKII cells were maintained in DMEM supplemented with 10% fetal-bovine 
serum and 1% penicillin-streptomycin-glutamate and appropriate selection agent where 
noted.  PCR of Rab11a was done from a complete H.s. Rab11a EST (Invitrogen Clone 
ID: 5792753).   H.s. Flag-Rab11a was cloned using the following PCR primers:  Forward 
primer: TTAATT  GGATCC CCACC ATG GAT TAC AAG GAC GAC GAT GAC AAG  
GGA GGC GGC ACC CGC GAC GAC GAG T, Reverse primer: TTTT GAATTC TTA 
GAT GTT CTG ACA GCA CTG CAC CTT TG.  Primers were engineered to insert a 
BamHI restriction site followed by a Flag-epitope sequence at the 5’ end and an EcoRI 
restriction site at the 3’ end via PCR.    H.s. Flag-Rab11a was cut with the appropriate 
restriction enzymes and ligated into pQCXIN (Clonetech) for stable transduction into 
GFP-Crb3a Clone 7 cells and selected using 200µg/mL Hyrgomycin (Invitrogen) and 
600µg/mL G418 (Invitrogen).  Flag-Rab11a S25N (dominant negative) and Flag-Rab11a 
Q70L (constitutively active) mutants were made via site-directed mutagenesis using Pfu 
Turbo (Stratagene).  The following primer sequences were used for mutagenesis.  S25N 
Forward:  
CCTTATTGGAGATTCTGGTGTTGGAAAGAATAATCTCCTGTCTCGATTTACTCG
AAATGAG  S25N Reverse:  
CTCATTTCGAGTAAATCGAGACAGGAGATTATTCTTTCCAACACCAGAATCTCC
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GCACAGATATGGGACACAGCAGGGCTAGAGCGATATCGAGCTATAACATCAGC
ATATTATCG  Q70L Reverse:  
CGATAATATGCTGATGTTATAGCTCGATATCGCTCTAGCCCTGCTGTGTCCCATAT
CTGTGC.    
 
Cyst assays and statistics 
MDCKII cells stably expressing plasmids of interest were dissociated using 
enzyme free cell dissociation buffer (Gibco Invitrogen), spun down, washed twice with 
PBS, and counted. Cells were then resuspended in complete growth media containing 4% 
Geltrex (Gibco Invitrogen) and seeded in 8-well chamber slides (Nunc), with each 
chamber containing a bed of 100% Geltrex.  Cysts were allowed to grow in complete 
growth media with 4% geltrex for days indicated.  Cysts were then fixed for 1 hour with 
4% paraformaldhyde and permiablized with 0.1% SDS/PBS for 30 minutes followed by 
blocking for 1 hour in 4% goat serum/PBS (PBSG).  After blocking, primary antibodies 
were diluted in (PBSG) and cysts were stained for 24-48 hours at 4 degrees.  After three 
30 minute washes with PBSG, secondary antibodies were diluted in PBSG and incubated 
with cysts for 24 hours.  After three 30 minute washes, cysts were placed in PBS for 
visualization. All images were obtained using an Olympus FluoView 500 confocal laser-
scanning confocal microscope at the Morphology and Image Analysis Core of the 
Michigan Diabetes Research and Training Center.   Samples were scanned with 
appropriate lasers and filter sets, and images were collected at 0.5-µm intervals on an 
Olympus IX-71 inverted microscope using an x100 oil objective.  FluoView v4.3 
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software was used to collect images, and subsequent preparation was performed using 
Adobe Creative Suite software. 
For statistical analysis of Rab11a cysts, two-cell stages positive for Flag epitope 
staining was counted based on the criteria of possessing a single, GFP-Crb3a positive 
lumen that resulted in a discontinuous band of E-cadherin staining between the two cells.  
Statistics are a culmination of two independent experiments and n numbers are indicated. 
 
Results 
Dominant negative Rab11a affects initial apical membrane formation 
 Proteins trafficking to the apical surface can traverse a Rab11a-postive ARE en 
route to their final destination (36, 46).  When single MDCKII cells are grown in a 3-
dimensional matrix they possess Crb3a on all membrane surfaces.  During mitosis and 
cytokinesis resulting in 2 daughter cells, a single Crb3a positive apical surface (lumen) is 
formed between the cells and each cell exhibits apical-basal polarity.  During mitosis, 
monomeric eGFP-Crb3a (mEGFP-Crb3a) is endocytosed from the entire cell surface into 
a cytosolic vesicles and exocytosed to the cleavage furrow to establish a lumen between 
dividing cells (245, 246).  This vesicle was revealed to be a Rab11 positive endosome 
(246).  We generated Flag-epitope tagged versions of wild type Rab11a (Rab11a-WT); 
constitutively active (Q70L) Rab11a (Rab11a-CA), and dominant negative (S25N) 
Rab11a (Rab11a-DN) and stably expressed them in cells already stably expressing 
mEGFP-Crb3a (mEGFP-Crb3a/Rablla-X cells) to determine if apical surface formation is 
Rab11a-dependent. Single mEGFP-Crb3a/Rablla-X cells were imbedded in Geltrex and 









In vector only control, mEGFP-Crb3a/Rab11a-WT, and mEGFP-Crb3a/Rab11a-CA cells 
the majority (~70%) of two-cell stages contained a mEGFP-Crb3a positive lumen that 
between two cells that was also negative for E-cadherin (Figure 4-1B).  In mEGFP-
Crb3a/Rab11a-DN cells, mEGFP-Crb3a was able to be endocytosed from the surface at 
the one-cell stage, but failed to be exocytosed at the cleavage furrow at the two-cell stage 
thus failing to form a lumen between daughter cells in a majority (~70%) of cysts 
assayed.  In mEGFP-Crb3a/Rab11a-DN cells, mEGFP-Crb3a accumulated sub-apically 
in small, dispersed puncta rather than a single, large recycling endosome.  
 
Dominant negative Rab11a affects mature cyst formation but not polarity 
 At the two-cell stage in 3-dimensions, mEGFP-Crb3a/Rab11a-DN cells failed to 
form lumens, however we noticed that when grown in 2-dimensions (i.e. monolayers) 
mEGFP-Crb3a/Rab11a-DN cells appeared to form apical surfaces (data not shown).  We 
subsequently wanted to determine if mEGFP-Crb3a/Rab11a-DN cells could form lumens 
at longer time points and to determine if Rab11a-DN affects polarity.  To this end we 
grew mEGFP-Crb3a/Rab11a cells in Geltrex for 4 days to allow them to mature into full 
cysts with large established apical surfaces.  Both mEGFP-Crb3a/Rab11a-WT and 
mEGFP-Crb3a/Rab11a-CA cells formed mature cysts with one solitary large lumen.  The 
mEGFP-Crb3a/Rab11a-DN cysts however displayed multi-lumen phenotypes. The nature 
mEGFP-Crb3a/Rab11a-DN phenotype was such that mEGFP-Crb3a was able to form 
what appears to be an apical surface, but cells in general have lost the ability to coalesce 


















trafficking as well, but in cyst assay E-cadherin localization remained cortical and did not 
appear disrupted by introduction of dominant negative Rab11a. 
 
Discussion 
Proteins trafficking to the apical membrane may traverse an apical recycling 
endosome (ARE) that is positive for the small GTPase Rab11a (36, 154, 250).  In flies, 
knockout of Rab11 leads to global trafficking defects including apical membrane defects 
(234). During mitosis from 1 mother cell to 2 daughter cells, wild type MDCKII cells can 
form a Crb3a positive apical lumen between the 2 daughter cells once mitosis is complete 
via coordinated endocytosis and exocytosis (246).  Lumen formation models confirmed 
the role of Rab11a in the regulated trafficking of Crb3a during initial apical surface 
formation and polarization.  Rab11a positive ARE have been implicated in vesicular 
trafficking during mitosis in multiple systems (98, 123).  Rab11a is localized to the 
cleavage furrow of mitotic cells by interaction with Rab11-family interacting protein 3 
(Rab11-FIP3) linking to cytoplasmic dynein (101-103, 295).  This mechanism suggests 
that if Crb3a traverses Rab11-postive ARE, then functional Rab11a ARE traveling along 
microtubules are required for deposition of Crb3a between two daughter cells to facilitate 
apical lumen formation. Cells expressing mEGFP-Crb3a and dominant negative Rab11a  
(mEGFP-Crb3a/Rab11a-DN) did not form Crb3a positive lumina.  Concurrently, during 
lumen formation in mEGFP-Crb3a/Rab11a-DN cells, mEGFP-Crb3 accumulated in 
cytosolic puncta rather than defined endosomal structures.  Importantly, mEGFP-
Crb3a/Rab11a-DN cells still managed to complete mitosis signifying that dominant-
negative Rab11a is not affecting microtubules and the ability of cells to complete mitosis.  
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Although mitosis completed, we could not significantly detect Crb3a positive membranes 
implicating Rab11a as a regulator of apical membrane formation and specifically the 
exocytosis of Crb3a.   
Growing mEGFP-Crb3a/Rab11a-DN cells in 3-dimesions for 4 days results in 
mature cysts with a multi-lumen phenotype. This phenotype is similar to those previously 
published, where cystic phenotypes appear to be dose-dependent on the amount of 
Rab11a-DN expressed (53).  In confluent monolayers, mEGFP-Crb3a/Rab11a-DN cells 
can polarize suggesting Crb3a is sufficient to at least partially rescue trafficking defects 
associated with Rab11a-DN.  In mEGFP-Crb3a/Rab11a-DN cysts, there also appears to 
be segregation of mEGFP-Crb3a onto multiple de facto apical surfaces yet, cells cannot 
establish a single lumen. Even though the cells in mEGFP-Crb3a/Rab11a-DN cysts 
polarized, apical surfaces established in these cysts appeared to be smaller relative to 
basolateral surfaces.  This is consistent with data from Rab11 null Drosophila, where 
dCrumbs (the Drosophila homologue of Crb3a) was far more sensitive to the Rab11 
knockout than other basolateral transmembrane proteins also traversing Rab-11 positive 
ARE (234).  Importantly, even in our multi-lumen cysts we did not see colocalization of 
signals for Crb3a and E-cadherin.   In polarized cells, a Rab11a-positive ARE is known to 
also contain basolateral E-cadherin in addition to apical components and Rab11a-DN 
caused mistargeting of E-cadherin to the apical surface (163).  In our system, Crb3a was 
moderately overexpressed and it appears that the combination of parental wild type 
Rab11a and overexpressed Crb3a was enough to induce polarization.  Based on previous 
data in MCF10A cells, we believe Crb3a provides a strong polarization cue in the 
establishment of tight junctions and apical membranes (69). Since Crb3a and E-cadherin 
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fail to overlay in mEGFP-Crb3a/Rab11a-DN cells, our observation strengthens the theory 
that Crb3a protein may provide a signal for segregation of apical and basolateral 
domains.  Since Rab11a-DN expression does not confer domain mixing in the presence 
of Crb3a, Rab11a likely is involved in regulating spatial organization of membrane 
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